0000080424-25-000013.txt : 20250122 0000080424-25-000013.hdr.sgml : 20250122 20250122161626 ACCESSION NUMBER: 0000080424-25-000013 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250122 DATE AS OF CHANGE: 20250122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROCTER & GAMBLE Co CENTRAL INDEX KEY: 0000080424 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 310411980 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00434 FILM NUMBER: 25546165 BUSINESS ADDRESS: STREET 1: ONE PROCTER & GAMBLE PLAZA CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 5139831100 MAIL ADDRESS: STREET 1: ONE PROCTER & GAMBLE PLAZA CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: PROCTER & GAMBLE CO DATE OF NAME CHANGE: 19920703 10-Q 1 pg-20241231.htm FY2425 Q2 OND 10-Q pg-20241231
00000804246/302025Q2falsehttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#AccountsPayableCurrenthttp://fasb.org/us-gaap/2024#AccountsPayableCurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharespg:segmentxbrli:purepg:countrypg:taxable_jurisdictionpg:audit00000804242024-07-012024-12-310000080424us-gaap:CommonStockMember2024-07-012024-12-310000080424pg:A1.375NotesDue2025Member2024-07-012024-12-310000080424pg:A0.110NotesDue2026Member2024-07-012024-12-310000080424pg:A3.250EURNotesDue2026Member2024-07-012024-12-310000080424pg:A4.875EURNotesDueMay2027Member2024-07-012024-12-310000080424pg:A1.200NotesDue2028Member2024-07-012024-12-310000080424pg:A3.150EURONotesDue2028Member2024-07-012024-12-310000080424pg:A1.250NotesDue2029Member2024-07-012024-12-310000080424pg:A1.800NotesDue2029Member2024-07-012024-12-310000080424pg:A6.250GBPNotesDueJanuary2030Member2024-07-012024-12-310000080424pg:A0.350NotesDue2030Member2024-07-012024-12-310000080424pg:A0.230NotesDue2031Member2024-07-012024-12-310000080424pg:A3.250EURNotesDue2031Member2024-07-012024-12-310000080424pg:A5.250GBPNotesDueJanuary2033Member2024-07-012024-12-310000080424pg:A3.200EURNotesDue2034Member2024-07-012024-12-310000080424pg:A1.875NotesDue2038Member2024-07-012024-12-310000080424pg:A0.900NotesDue2041Member2024-07-012024-12-3100000804242024-12-3100000804242024-10-012024-12-3100000804242023-10-012023-12-3100000804242023-07-012023-12-3100000804242024-06-300000080424us-gaap:CommonStockMember2024-09-300000080424us-gaap:PreferredStockMember2024-09-300000080424us-gaap:AdditionalPaidInCapitalMember2024-09-300000080424pg:ReserveforESOPDebtRetirementMember2024-09-300000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000080424us-gaap:TreasuryStockCommonMember2024-09-300000080424us-gaap:RetainedEarningsMember2024-09-300000080424us-gaap:NoncontrollingInterestMember2024-09-3000000804242024-09-300000080424us-gaap:RetainedEarningsMember2024-10-012024-12-310000080424us-gaap:NoncontrollingInterestMember2024-10-012024-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310000080424us-gaap:CommonStockMember2024-10-012024-12-310000080424us-gaap:TreasuryStockCommonMember2024-10-012024-12-310000080424us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310000080424us-gaap:PreferredStockMember2024-10-012024-12-310000080424us-gaap:CommonStockMember2024-12-310000080424us-gaap:PreferredStockMember2024-12-310000080424us-gaap:AdditionalPaidInCapitalMember2024-12-310000080424pg:ReserveforESOPDebtRetirementMember2024-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000080424us-gaap:TreasuryStockCommonMember2024-12-310000080424us-gaap:RetainedEarningsMember2024-12-310000080424us-gaap:NoncontrollingInterestMember2024-12-310000080424us-gaap:CommonStockMember2024-06-300000080424us-gaap:PreferredStockMember2024-06-300000080424us-gaap:AdditionalPaidInCapitalMember2024-06-300000080424pg:ReserveforESOPDebtRetirementMember2024-06-300000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000080424us-gaap:TreasuryStockCommonMember2024-06-300000080424us-gaap:RetainedEarningsMember2024-06-300000080424us-gaap:NoncontrollingInterestMember2024-06-300000080424us-gaap:RetainedEarningsMember2024-07-012024-12-310000080424us-gaap:NoncontrollingInterestMember2024-07-012024-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-12-310000080424us-gaap:CommonStockMember2024-07-012024-12-310000080424us-gaap:TreasuryStockCommonMember2024-07-012024-12-310000080424us-gaap:AdditionalPaidInCapitalMember2024-07-012024-12-310000080424us-gaap:PreferredStockMember2024-07-012024-12-310000080424pg:ReserveforESOPDebtRetirementMember2024-07-012024-12-310000080424us-gaap:CommonStockMember2023-09-300000080424us-gaap:PreferredStockMember2023-09-300000080424us-gaap:AdditionalPaidInCapitalMember2023-09-300000080424pg:ReserveforESOPDebtRetirementMember2023-09-300000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000080424us-gaap:TreasuryStockCommonMember2023-09-300000080424us-gaap:RetainedEarningsMember2023-09-300000080424us-gaap:NoncontrollingInterestMember2023-09-3000000804242023-09-300000080424us-gaap:RetainedEarningsMember2023-10-012023-12-310000080424us-gaap:NoncontrollingInterestMember2023-10-012023-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310000080424us-gaap:CommonStockMember2023-10-012023-12-310000080424us-gaap:TreasuryStockCommonMember2023-10-012023-12-310000080424us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310000080424us-gaap:PreferredStockMember2023-10-012023-12-310000080424us-gaap:CommonStockMember2023-12-310000080424us-gaap:PreferredStockMember2023-12-310000080424us-gaap:AdditionalPaidInCapitalMember2023-12-310000080424pg:ReserveforESOPDebtRetirementMember2023-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000080424us-gaap:TreasuryStockCommonMember2023-12-310000080424us-gaap:RetainedEarningsMember2023-12-310000080424us-gaap:NoncontrollingInterestMember2023-12-3100000804242023-12-310000080424us-gaap:CommonStockMember2023-06-300000080424us-gaap:PreferredStockMember2023-06-300000080424us-gaap:AdditionalPaidInCapitalMember2023-06-300000080424pg:ReserveforESOPDebtRetirementMember2023-06-300000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000080424us-gaap:TreasuryStockCommonMember2023-06-300000080424us-gaap:RetainedEarningsMember2023-06-300000080424us-gaap:NoncontrollingInterestMember2023-06-3000000804242023-06-300000080424us-gaap:RetainedEarningsMember2023-07-012023-12-310000080424us-gaap:NoncontrollingInterestMember2023-07-012023-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-12-310000080424us-gaap:CommonStockMember2023-07-012023-12-310000080424us-gaap:TreasuryStockCommonMember2023-07-012023-12-310000080424us-gaap:AdditionalPaidInCapitalMember2023-07-012023-12-310000080424us-gaap:PreferredStockMember2023-07-012023-12-310000080424pg:ReserveforESOPDebtRetirementMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:FabricCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:FabricCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:FabricCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:FabricCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:HomeCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:HomeCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:HomeCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:FabricHomeCareSegmentMemberpg:HomeCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:BabyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:BabyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:BabyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:BabyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FamilyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FamilyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FamilyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FamilyCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:HairCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:HairCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:HairCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:HairCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:GroomingSegmentMemberpg:GroomingMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:GroomingSegmentMemberpg:GroomingMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:GroomingSegmentMemberpg:GroomingMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:GroomingSegmentMemberpg:GroomingMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:OralCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:OralCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:OralCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:OralCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:PersonalHealthCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:PersonalHealthCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:PersonalHealthCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:HealthCareSegmentMemberpg:PersonalHealthCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FeminineCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FeminineCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FeminineCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BabyFeminineFamilyCareSegmentMemberpg:FeminineCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:PersonalCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:PersonalCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:PersonalCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:PersonalCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:SkinCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:SkinCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:SkinCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberpg:BeautySegmentMemberpg:SkinCareMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000080424us-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-12-310000080424us-gaap:ProductConcentrationRiskMemberus-gaap:OperatingSegmentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2024-10-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2024-07-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2023-10-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2023-07-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2024-10-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2024-07-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2023-10-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2023-07-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2024-10-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2024-07-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2023-10-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2023-07-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2024-10-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2024-07-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2023-10-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2023-07-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2024-10-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2024-07-012024-12-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2023-10-012023-12-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2023-07-012023-12-310000080424us-gaap:CorporateNonSegmentMember2024-10-012024-12-310000080424us-gaap:CorporateNonSegmentMember2024-07-012024-12-310000080424us-gaap:CorporateNonSegmentMember2023-10-012023-12-310000080424us-gaap:CorporateNonSegmentMember2023-07-012023-12-310000080424pg:BeautySegmentMember2024-06-300000080424pg:GroomingSegmentMember2024-06-300000080424pg:HealthCareSegmentMember2024-06-300000080424pg:FabricHomeCareSegmentMember2024-06-300000080424pg:BabyFeminineFamilyCareSegmentMember2024-06-300000080424pg:BeautySegmentMember2024-07-012024-12-310000080424pg:GroomingSegmentMember2024-07-012024-12-310000080424pg:HealthCareSegmentMember2024-07-012024-12-310000080424pg:FabricHomeCareSegmentMember2024-07-012024-12-310000080424pg:BabyFeminineFamilyCareSegmentMember2024-07-012024-12-310000080424pg:BeautySegmentMember2024-12-310000080424pg:GroomingSegmentMember2024-12-310000080424pg:HealthCareSegmentMember2024-12-310000080424pg:FabricHomeCareSegmentMember2024-12-310000080424pg:BabyFeminineFamilyCareSegmentMember2024-12-310000080424pg:GilletteMember2024-12-310000080424pg:A25BpsIncreaseDiscountRateMemberus-gaap:IndefinitelivedIntangibleAssetsMemberpg:GilletteMember2024-12-310000080424pg:A25bpsDecreaseLongTermGrowthMemberus-gaap:IndefinitelivedIntangibleAssetsMemberpg:GilletteMember2024-12-310000080424pg:A50BpsDecreaseLongTermRoyaltyMemberus-gaap:IndefinitelivedIntangibleAssetsMemberpg:GilletteMember2024-12-310000080424us-gaap:EmployeeStockOptionMember2024-10-012024-12-310000080424us-gaap:EmployeeStockOptionMember2023-10-012023-12-310000080424us-gaap:EmployeeStockOptionMember2024-07-012024-12-310000080424us-gaap:EmployeeStockOptionMember2023-07-012023-12-310000080424us-gaap:PensionPlansDefinedBenefitMember2024-10-012024-12-310000080424us-gaap:PensionPlansDefinedBenefitMember2023-10-012023-12-310000080424us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-12-310000080424us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-12-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-10-012024-12-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-10-012023-12-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-12-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-12-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2024-12-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2024-06-300000080424us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2024-12-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2024-06-300000080424us-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000080424us-gaap:DesignatedAsHedgingInstrumentMember2024-06-300000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-12-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-06-300000080424us-gaap:UnderlyingOtherMemberus-gaap:FairValueHedgingMember2024-06-300000080424us-gaap:UnderlyingOtherMemberus-gaap:FairValueHedgingMember2024-12-310000080424us-gaap:UnderlyingOtherMemberus-gaap:NetInvestmentHedgingMember2024-12-310000080424us-gaap:UnderlyingOtherMemberus-gaap:NetInvestmentHedgingMember2024-06-300000080424us-gaap:ForeignExchangeContractMember2024-10-012024-12-310000080424us-gaap:ForeignExchangeContractMember2023-10-012023-12-310000080424us-gaap:ForeignExchangeContractMember2024-07-012024-12-310000080424us-gaap:ForeignExchangeContractMember2023-07-012023-12-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2024-10-012024-12-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2023-10-012023-12-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2024-07-012024-12-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2023-07-012023-12-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-10-012024-12-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-10-012023-12-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-07-012024-12-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-07-012023-12-310000080424us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300000080424us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300000080424us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300000080424us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-07-012024-12-310000080424us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-07-012024-12-310000080424us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-07-012024-12-310000080424us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000080424us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000080424us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000080424srt:MinimumMember2024-07-012024-12-310000080424srt:MaximumMember2024-07-012024-12-310000080424srt:MinimumMember2024-12-310000080424srt:MaximumMember2024-12-3100000804242024-07-012024-09-3000000804242023-10-012024-09-300000080424us-gaap:CostOfSalesMember2024-10-012024-12-310000080424us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012024-12-310000080424us-gaap:OtherNonoperatingIncomeExpenseMember2024-10-012024-12-310000080424us-gaap:CostOfSalesMember2024-07-012024-12-310000080424us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-12-310000080424us-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012024-12-310000080424us-gaap:EmployeeSeveranceMember2024-06-300000080424us-gaap:FacilityClosingMember2024-06-300000080424us-gaap:OtherRestructuringMember2024-06-300000080424us-gaap:EmployeeSeveranceMember2024-07-012024-09-300000080424us-gaap:FacilityClosingMember2024-07-012024-09-300000080424us-gaap:OtherRestructuringMember2024-07-012024-09-300000080424us-gaap:EmployeeSeveranceMember2024-10-012024-12-310000080424us-gaap:FacilityClosingMember2024-10-012024-12-310000080424us-gaap:OtherRestructuringMember2024-10-012024-12-310000080424us-gaap:EmployeeSeveranceMember2024-07-012024-12-310000080424us-gaap:FacilityClosingMember2024-07-012024-12-310000080424us-gaap:OtherRestructuringMember2024-07-012024-12-310000080424us-gaap:EmployeeSeveranceMember2024-12-310000080424us-gaap:FacilityClosingMember2024-12-310000080424us-gaap:OtherRestructuringMember2024-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark one)
xTrueQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended December 31, 2024

OR
oFalseTRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     

pglogoa21.jpg
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
OhioOH1-43431-0411980
(State of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
One Procter & Gamble PlazaCincinnatiOH
One Procter & Gamble Plaza, Cincinnati, Ohio
45202
(Address of principal executive offices)(Zip Code)
(513) 983-1100
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, without Par ValuePGNYSE
1.375% Notes due 2025PG25NYSE
0.110% Notes due 2026PG26DNYSE
3.250% EUR Notes due 2026PG26FNYSE
4.875% EUR Notes due May 2027PG27ANYSE
1.200% Notes due 2028PG28NYSE
3.150% EUR Notes due 2028PG28BNYSE
1.250% Notes due 2029PG29BNYSE
1.800% Notes due 2029PG29ANYSE
6.250% GBP Notes due January 2030PG30NYSE
0.350% Notes due 2030PG30CNYSE
0.230% Notes due 2031PG31ANYSE
3.250% EUR Notes due 2031PG31BNYSE
5.250% GBP Notes due January 2033PG33NYSE
3.200% EUR Notes due 2034PG34CNYSE
1.875% Notes due 2038PG38NYSE
0.900% Notes due 2041PG41NYSE
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
þAccelerated filer¨
Non-accelerated filer¨Smaller reporting company¨False
Emerging growth company¨False
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ False
There were 2,344,851,814 shares of Common Stock outstanding as of December 31, 2024.


FORM 10-Q TABLE OF CONTENTSPage
PART IItem 1.
Item 2.
Item 3.
Item 4.
PART IIItem 1.
Item 1A.
Item 2.
Item 5.
Item 6.

The Procter & Gamble Company 1
PART I. FINANCIAL INFORMATION 
Item 1.Financial Statements
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
Three Months Ended December 31Six Months Ended December 31
Amounts in millions except per share amounts2024 20232024 2023
NET SALES$21,882 $21,441 $43,619 $43,312 
Cost of products sold10,418 10,144 20,839 20,645 
Selling, general and administrative expense5,723 5,522 11,242 11,127 
Indefinite-lived intangible asset impairment charge— 1,341 — 1,341 
OPERATING INCOME5,741 4,433 11,538 10,200 
Interest expense(240)(248)(478)(472)
Interest income119 133 254 262 
Other non-operating income/(expense), net224 177 (330)309 
EARNINGS BEFORE INCOME TAXES5,845 4,496 10,985 10,299 
Income taxes1,187 1,003 2,339 2,250 
NET EARNINGS4,659 3,493 8,646 8,049 
Less: Net earnings attributable to noncontrolling interests29 25 56 60 
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE$4,630 $3,468 $8,589 $7,988 
NET EARNINGS PER COMMON SHARE (1)
Basic$1.94 $1.44 $3.59 $3.33 
Diluted$1.88 $1.40 $3.49 $3.23 
(1)Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Three Months Ended December 31Six Months Ended December 31
Amounts in millions2024202320242023
NET EARNINGS$4,659 $3,493 $8,646 $8,049 
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
Foreign currency translation(770)492 256 83 
Unrealized gains/(losses) on investment securities— (1)1 (2)
Unrealized gains/(losses) on defined benefit postretirement plans24 (75)3 (30)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX(747)416 260 51 
TOTAL COMPREHENSIVE INCOME3,912 3,909 8,906 8,100 
Less: Comprehensive income attributable to noncontrolling interests26 25 54 58 
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE$3,887 $3,884 $8,852 $8,041 

See accompanying Notes to Consolidated Financial Statements.
2 The Procter & Gamble Company
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
Amounts in millionsDecember 31, 2024June 30, 2024
Assets
CURRENT ASSETS
Cash and cash equivalents$10,230 $9,482 
Accounts receivable6,234 6,118 
INVENTORIES
Materials and supplies1,949 1,617 
Work in process879 929 
Finished goods4,192 4,470 
Total inventories7,020 7,016 
Prepaid expenses and other current assets2,158 2,095 
TOTAL CURRENT ASSETS25,642 24,709 
PROPERTY, PLANT AND EQUIPMENT, NET22,074 22,152 
GOODWILL39,898 40,303 
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET21,833 22,047 
OTHER NONCURRENT ASSETS13,192 13,158 
TOTAL ASSETS$122,639 $122,370 
Liabilities and Shareholders' Equity
CURRENT LIABILITIES
Accounts payable$14,495 $15,364 
Accrued and other liabilities9,879 11,073 
Debt due within one year9,424 7,191 
TOTAL CURRENT LIABILITIES33,797 33,627 
LONG-TERM DEBT25,263 25,269 
DEFERRED INCOME TAXES6,725 6,516 
OTHER NONCURRENT LIABILITIES5,411 6,398 
TOTAL LIABILITIES71,195 71,811 
SHAREHOLDERS’ EQUITY
Preferred stock788 798 
Common stock – shares issued –December 20244,009.2 
June 20244,009.2 4,009 4,009 
Additional paid-in capital68,283 67,684 
Reserve for ESOP debt retirement(707)(737)
Accumulated other comprehensive loss(11,637)(11,900)
Treasury stock(137,112)(133,379)
Retained earnings127,544 123,811 
Noncontrolling interest275 272 
TOTAL SHAREHOLDERS’ EQUITY51,443 50,559 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$122,639 $122,370 

See accompanying Notes to Consolidated Financial Statements.
The Procter & Gamble Company 3
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
Three Months Ended December 31, 2024
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE SEPTEMBER 30, 20242,355,042 $4,009 $791 $68,102 ($707)($10,893)($134,823)$125,361 $300 $52,141 
Net earnings4,630 29 4,659 
Other comprehensive income/(loss)(744)(3)(747)
Dividends and dividend equivalents
($1.0065 per share):
Common(2,375)(2,375)
Preferred(72)(72)
Treasury stock purchases(14,716)(2,520)(2,520)
Employee stock plans4,057 181 228 408 
Preferred stock conversions469 (3)— 3 — 
ESOP debt impacts— — — 
Noncontrolling interest, net— (51)(51)
BALANCE DECEMBER 31, 20242,344,852 $4,009 $788 $68,283 ($707)($11,637)($137,112)$127,544 $275 $51,443 
Six Months Ended December 31, 2024
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE JUNE 30, 20242,357,051 $4,009 $798 $67,684 ($737)($11,900)($133,379)$123,811 $272 $50,559 
Net earnings8,589 56 8,646 
Other comprehensive income/(loss)263 (3)260 
Dividends and dividend equivalents
($2.013 per share):
Common(4,754)(4,754)
Preferred(144)(144)
Treasury stock purchases(26,269)(4,462)(4,462)
Employee stock plans12,827 598 720 1,318 
Preferred stock conversions1,243 (10)1 9 — 
ESOP debt impacts30 41 71 
Noncontrolling interest, net— (51)(51)
BALANCE DECEMBER 31, 20242,344,852 $4,009 $788 $68,283 ($707)($11,637)($137,112)$127,544 $275 $51,443 

See accompanying Notes to Consolidated Financial Statements.
4 The Procter & Gamble Company
Three Months Ended December 31, 2023
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE SEPTEMBER 30, 20232,356,886 $4,009 $812 $66,822 ($782)($12,583)($131,029)$120,443 $321 $48,014 
Net earnings3,468 25 3,493 
Other comprehensive income/(loss)416 — 416 
Dividends and dividend equivalents
($0.9407 per share):
Common(2,225)(2,225)
Preferred(70)(70)
Treasury stock purchases(6,879)(1,008)(1,008)
Employee stock plans2,630 113 147 260 
Preferred stock conversions385 (3)— 3 — 
ESOP debt impacts— — — 
Noncontrolling interest, net— (52)(52)
BALANCE DECEMBER 31, 20232,353,021 $4,009 $809 $66,935 ($782)($12,167)($131,887)$121,617 $294 $48,829 
Six Months Ended December 31, 2023
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE JUNE 30, 20232,362,120 $4,009 $819 $66,556 ($821)($12,220)($129,736)$118,170 $288 $47,065 
Net earnings7,988 60 8,049 
Other comprehensive income/(loss)53 (2)51 
Dividends and dividend equivalents
($1.8814 per share):
Common(4,450)(4,450)
Preferred(140)(140)
Treasury stock purchases(16,722)(2,516)(2,516)
Employee stock plans6,351 378 356 734 
Preferred stock conversions1,273 (10)1 9 — 
ESOP debt impacts39 48 87 
Noncontrolling interest, net— (52)(52)
BALANCE DECEMBER 31, 20232,353,021 $4,009 $809 $66,935 ($782)($12,167)($131,887)$121,617 $294 $48,829 
See accompanying Notes to Consolidated Financial Statements.
The Procter & Gamble Company 5
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended December 31
Amounts in millions20242023
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD$9,482 $8,246 
OPERATING ACTIVITIES
Net earnings8,646 8,049 
Depreciation and amortization1,434 1,423 
Share-based compensation expense241 275 
Deferred income taxes221 (154)
Loss/(gain) on sale of assets787 (3)
Indefinite-lived intangible asset impairment charge— 1,341 
Change in accounts receivable(262)(839)
Change in inventories(170)(32)
Change in accounts payable and accrued and other liabilities(1,157)302 
Change in other operating assets and liabilities(748)(704)
Other135 346 
TOTAL OPERATING ACTIVITIES9,127 10,004 
INVESTING ACTIVITIES
Capital expenditures(1,918)(1,742)
Proceeds from asset sales47 8 
Acquisitions, net of cash acquired(6)— 
Other investing activity(153)(489)
TOTAL INVESTING ACTIVITIES(2,029)(2,224)
FINANCING ACTIVITIES
Dividends to shareholders(4,886)(4,578)
Additions to short-term debt with original maturities of more than three months5,905 2,798 
Reductions in short-term debt with original maturities of more than three months(571)(5,862)
Net additions/(reductions) to other short-term debt(2,705)3,740 
Additions to long-term debt995 254 
Reductions in long-term debt(1,478)(2,335)
Treasury stock purchases(4,449)(2,503)
Impact of stock options and other985 397 
TOTAL FINANCING ACTIVITIES(6,205)(8,087)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH(144)(49)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH748 (356)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD$10,230 $7,890 
See accompanying Notes to Consolidated Financial Statements.
6 The Procter & Gamble Company
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.
2. New Accounting Pronouncements and Policies
In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements.
In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures.
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
3. Segment Information
Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
•Beauty: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);
•Grooming: Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming);
•Health Care: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
•Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and
•Baby, Feminine & Family Care: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 7
Operating segments as a percentage of consolidated net sales are as follows:
% of Net sales by operating segment (1)
Three Months Ended December 31Six Months Ended December 31
2024202320242023
Fabric Care23 %23 %23 %23 %
Home Care12 %12 %12 %12 %
Baby Care9 %9 %9 %10 %
Family Care9 %9 %9 %8 %
Hair Care9 %9 %9 %9 %
Grooming8 %8 %8 %8 %
Oral Care9 %9 %8 %8 %
Personal Health Care6 %6 %7 %7 %
Feminine Care6 %6 %6 %6 %
Personal Care (2)
5 %5 %6 %5 %
Skin Care (2)
4 %4 %3 %4 %
Total100 %100 %100 %100 %
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
(2)Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.
The following is a summary of reportable segment results:
Three Months Ended December 31Six Months Ended December 31
Net SalesEarnings/(Loss) Before Income TaxesNet Earnings/(Loss)Net SalesEarnings/(Loss) Before Income TaxesNet Earnings/(Loss)
Beauty2024$3,848 $996 $780 $7,741 $2,063 $1,620 
20233,849 1,112 868 7,946 2,361 1,839 
Grooming20241,752 568 459 3,475 1,090 885 
20231,734 538 440 3,458 1,071 862 
Health Care20243,249 974 758 6,397 1,928 1,499 
20233,172 932 719 6,245 1,821 1,408 
Fabric & Home Care20247,575 1,989 1,567 15,285 4,066 3,188 
20237,415 2,018 1,577 15,061 4,049 3,146 
Baby, Feminine & Family Care20245,298 1,464 1,119 10,400 2,847 2,185 
20235,146 1,437 1,102 10,332 2,845 2,177 
Corporate2024159 (146)(24)322 (1,009)(731)
2023126 (1,541)(1,214)270 (1,849)(1,383)
Total Company2024$21,882 $5,845 $4,659 $43,619 $10,985 $8,646 
202321,441 4,496 3,493 43,312 10,299 8,049 
4. Goodwill and Intangible Assets
Goodwill is allocated by reportable segment as follows:
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
Goodwill at June 30, 2024$13,723 $12,633 $7,638 $1,810 $4,499 $40,303 
Acquisitions and divestitures— — — — — — 
Translation and other(139)(104)(107)(11)(44)(405)
Goodwill at December 31, 2024$13,584 $12,529 $7,531 $1,799 $4,456 $39,898 
Goodwill decreased from June 30, 2024, primarily due to currency translation.
Amounts in millions of dollars except per share amounts or as otherwise specified.
8 The Procter & Gamble Company
Identifiable intangible assets at December 31, 2024, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$8,965 $(6,684)
Intangible assets with indefinite lives19,552 — 
Total identifiable intangible assets$28,517 $(6,684)
Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended December 31, 2024 and 2023, was $80 and $84, respectively. For the six months ended December 31, 2024 and 2023, amortization expense was $163 and $171, respectively.
Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.
As previously disclosed, the carrying value of the Gillette indefinite-lived intangible asset was impaired during the fiscal year ended June 30, 2024. The impairment charge arose due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of a new restructuring program focused primarily in certain Enterprise Markets, including Argentina and Nigeria. Following the impairment charge, the carrying value of the Gillette indefinite-lived intangible asset was equivalent to the estimated fair value as of December 31, 2023.
Based on our impairment testing performed during the three months ended December 31, 2024, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of December 31, 2024, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion.
Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger a further impairment charge.
The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rates), discount rate and royalty rates.
Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rates represent the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rates utilized in our fair value estimates are consistent with the brand operating plans and approximate expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment.
The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.
The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.





Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 9

We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2024, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps Discount Rate-25 bps Growth Rates-50 bps Royalty Rate
Gillette indefinite-lived intangible asset(5)%(5)%(4)%
5. Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.
Net earnings per common share were calculated as follows:
CONSOLIDATED AMOUNTSThree Months Ended December 31Six Months Ended December 31
2024202320242023
Net earnings$4,659 $3,493 $8,646 $8,049 
Less: Net earnings attributable to noncontrolling interests29 25 56 60 
Net earnings attributable to P&G4,630 3,468 8,589 7,988 
Less: Preferred dividends72 70 144 140 
Net earnings attributable to P&G available to common shareholders (Basic)$4,558 $3,398 $8,445 $7,849 
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,351.9 2,358.0 2,354.1 2,359.0 
Add effect of dilutive securities:
Convertible preferred shares (1)
71.3 73.9 71.6 74.3 
Stock options and other unvested equity awards (2)
34.9 36.4 36.4 38.5 
Diluted weighted average common shares outstanding2,458.1 2,468.4 2,462.1 2,471.8 
NET EARNINGS PER COMMON SHARE
Basic$1.94 $1.44 $3.59 $3.33 
Diluted$1.88 $1.40 $3.49 $3.23 
(1)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
(2)Excludes approximately 8 million and 9 million for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.
6. Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:
Three Months Ended December 31Six Months Ended December 31
2024202320242023
Share-based compensation expense$136 $150 $241 $275 
Net periodic benefit cost for pension benefits26 52 63 109 
Net periodic benefit (credit) for other retiree benefits(180)(156)(360)(311)
Amounts in millions of dollars except per share amounts or as otherwise specified.
10 The Procter & Gamble Company
7. Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2024.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. Except for the impairment of the Gillette indefinite-lived intangible asset discussed in Note 4, there were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the six months ended December 31, 2024 or during the fiscal year ended June 30, 2024.
Cash equivalents were $8.7 billion and $8.0 billion as of December 31, 2024 and June 30, 2024, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.
The fair value of long-term debt was $27.3 billion and $27.7 billion as of December 31, 2024 and June 30, 2024, respectively. This includes the current portion of long-term debt instruments ($3.3 billion and $3.8 billion as of December 31, 2024 and June 30, 2024, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows:
Notional AmountFair Value AssetFair Value (Liability)
December 31, 2024June 30, 2024December 31, 2024June 30, 2024December 31, 2024June 30, 2024
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$2,914 $2,993 $— $— $(215)$(325)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts$13,054 $10,140 $545 $119 $— $(31)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS$15,968 $13,133 $545 $119 $(215)$(356)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$3,359 $3,192 $1 $1 $(40)$(23)
TOTAL DERIVATIVES AT FAIR VALUE$19,326 $16,325 $546 $120 $(255)$(379)
The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $2.7 billion as of December 31, 2024 and June 30, 2024. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $10.4 billion and $11.9 billion as of December 31, 2024 and June 30, 2024, respectively. The increase in notional balance of the derivative instruments designated as net investment hedges is primarily driven by the Company's decision to leverage favorable interest rate spreads in the foreign currency swap market.
Derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $33 and $307 as of
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 11
December 31, 2024 and June 30, 2024, respectively. The Company has not been required to post collateral as a result of these contractual features.
Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss) Recognized in OCI on Derivatives
Three Months Ended December 31Six Months Ended December 31
2024202320242023
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts$857 $(487)$356 $(202)
(1)    For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and $130 for the six months ended December 31, 2024 and 2023, respectively.
(2)    In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $215 and $(159) for the six months ended December 31, 2024 and 2023, respectively.
Amount of Gain/(Loss) Recognized in Earnings
Three Months Ended December 31Six Months Ended December 31
2024202320242023
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$34 $117 $110 $128 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$(174)$128 $(48)$57 
The gains on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&A).
8. Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:
Investment SecuritiesPostretirement Benefit PlansForeign Currency TranslationTotal AOCI
Balance at June 30, 2024, net of tax$10 $613 $(12,522)$(11,900)
Other comprehensive income/(loss), before tax:
    OCI before reclassifications1 38 (362)(323)
    Amounts reclassified to the Consolidated Statement of Earnings— (38)752 714 
Total other comprehensive income/(loss), before tax1 — 390 391 
    Tax effect— 3 (134)(131)
Total other comprehensive income/(loss), net of tax1 3 256 260 
Less: OCI attributable to noncontrolling interests, net of tax— 2 (5)(3)
Balance at December 31, 2024, net of tax$11 $614 $(12,262)$(11,637)
The below provides additional details on amounts reclassified from AOCI into the Consolidated Statement of Earnings:
•Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.
•Foreign currency translation amounts are reclassified from AOCI into Other non-operating income/(expense), net. These amounts relate to accumulated foreign currency translation losses recognized due to the substantial liquidation of operations in Argentina recorded in the period ended September 30, 2024.


Amounts in millions of dollars except per share amounts or as otherwise specified.
12 The Procter & Gamble Company
9. Commitments and Contingencies
Litigation
We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we do not anticipate over the next 12-month period any significant audit activity concluding related to uncertain tax positions for which we have existing accrued liabilities.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
10. Supplier Finance Programs
The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in Accounts payable was approximately $5.6 billion as of December 31, 2024 and June 30, 2024.
11. Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.
In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded approximately $0.8 billion after tax of incremental charges, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the program beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024, were approximately $1.2 billion after tax.
For the three months ended December 31, 2024, the Company incurred total before tax charges of $47 including $28 in Costs of products sold, $25 in SG&A and $(5) in Other non-operating income/(expense). For the six months ended December 31, 2024, the Company incurred charges of $933 including $69 in Costs of products sold, $79 in SG&A and $785 in Other non-operating income/(expense).
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 13
The following table presents restructuring activity for the six months ended December 31, 2024:
Separation CostsAsset-Related CostsOther CostsTotal
RESERVE JUNE 30, 2024$133 $— $32 $166 
Costs incurred for the three months ended September 30, 202416 30 839 886 
Costs incurred for the three months ended December 31, 202425 9 14 47 
Costs incurred for the six months ended December 31, 202441 39 853 933 
Costs paid/settled for the six months ended December 31, 2024(58)(39)(823)(921)
RESERVE DECEMBER 31, 2024$115 $— $62 $178 
Separation Costs
Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include accumulated foreign currency translation losses, asset removal and termination of contracts.
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management's Discussion and Analysis,” “Risk Factors” and "Notes 4 and 9 to the Consolidated Financial Statements." These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, sanctions or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war or terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such
Amounts in millions of dollars except per share amounts or as otherwise specified.
14 The Procter & Gamble Company
systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity and data protection, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our environmental sustainability priorities. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section titled "Economic Conditions and Uncertainties" and the section titled "Risk Factors" (Part II, Item 1A) of this Form 10-Q.
Purpose, Approach and Non-GAAP Measures
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying Notes.
The MD&A is organized in the following sections:
•Overview
•Summary of Results – Six Months Ended December 31, 2024
•Economic Conditions and Uncertainties
•Results of Operations – Three and Six Months Ended December 31, 2024
•Segment Results – Three and Six Months Ended December 31, 2024
•Liquidity and Capital Resources
•Measures Not Defined by U.S. GAAP
Throughout the MD&A we refer to measures used by management to evaluate performance, including unit volume growth, net sales, net earnings, diluted net earnings per common share (diluted EPS) and operating cash flow. We also refer to a number of financial measures that are not defined under U.S. GAAP, consisting of organic sales growth, Core earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures, details on the use and the derivation of these measures, as well as reconciliations to the most directly comparable U.S. GAAP measure.
Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and consumption in the MD&A are based on a combination of vendor-purchased traditional brick-and-mortar and online data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products in dollar terms on a constant currency basis relative to all product sales in the category. The Company measures quarter and fiscal year to date market share through the most recent period for which market share data is available, which typically reflects a lag time of one or two months as compared to the end of the reporting period. Management also uses unit volume growth to evaluate drivers of changes in net sales. Organic volume growth reflects year-over-year changes in unit volume excluding the impacts of acquisitions and divestitures and certain one-time items, if applicable, and is used to explain changes in organic sales. Certain columns and rows may not add due to rounding.
OVERVIEW
P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in about 180 countries and territories, primarily through mass merchandisers, e-commerce (including social commerce) channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to individual consumers. We have on-the-ground operations in about 70 countries.
Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands.
The Procter & Gamble Company 15
Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We believe we are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.
The table below lists our reportable segments, including the product categories and brand composition within each segment.
Reportable SegmentsProduct Categories (Sub-Categories)Major Brands
Beauty
Hair Care (Conditioners, Shampoos, Styling Aids, Treatments)
Head & Shoulders, Herbal Essences, Pantene, Rejoice
Personal Care (1) (Antiperspirants and Deodorants, Personal Cleansing)
Native, Old Spice, Safeguard, Secret
Skin Care (1) (Facial Moisturizers, Cleaners and Treatments)
Olay, SK-II
Grooming
Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming)
Braun, Gillette, Venus
Health Care
Oral Care (Toothbrushes, Toothpastes, Other Oral Care)
Crest, Oral-B
Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care)
Metamucil, Neurobion, Pepto-Bismol, Vicks
Fabric & Home Care
Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents)
Ariel, Downy, Gain, Tide
Home Care (Air Care, Dish Care, P&G Professional, Surface Care)
Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer
Baby, Feminine & Family Care
Baby Care (Baby Wipes, Taped Diapers and Pants)
Luvs, Pampers
Feminine Care (Adult Incontinence, Menstrual Care)
Always, Always Discreet, Tampax
Family Care (Paper Towels, Tissues, Toilet Paper)
Bounty, Charmin, Puffs
(1)    Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.
Throughout the MD&A, we reference business results by region, which are comprised of North America, Europe, Greater China, Latin America, Asia Pacific and India, Middle East and Africa (IMEA).
The following table provides the percentage of net sales and net earnings by reportable business segment (excluding Corporate) for the three and six months ended December 31, 2024:
Three Months Ended December 31, 2024Six Months Ended December 31, 2024
Net SalesNet EarningsNet SalesNet Earnings
Beauty18 %18 %18 %18 %
Grooming8 %10 %8 %9 %
Health Care15 %16 %15 %16 %
Fabric & Home Care35 %33 %35 %34 %
Baby, Feminine & Family Care24 %24 %24 %23 %
Total Company100 %100 %100 %100 %
RECENT DEVELOPMENTS
Limited Market Portfolio Restructuring
In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded incremental restructuring charges of approximately $0.8 billion after tax, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the program beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024, were approximately $1.2 billion after tax.
Consistent with our historical policies for ongoing restructuring-type activities, resulting charges were funded by and included

16 The Procter & Gamble Company
within Corporate for segment reporting. Restructuring charges above the normal ongoing level of restructuring costs are reported as non-core charges. For more details on the restructuring program, refer to Note 11 to the Consolidated Financial Statements.
SUMMARY OF RESULTS – Six Months Ended December 31, 2024
The following are highlights of results for the six months ended December 31, 2024, versus the six months ended December 31, 2023:
•Net sales increased 1% to $43.6 billion versus the prior year period. Net sales increased 2% in Health Care, 1% in Fabric & Home Care and Baby, Feminine & Family Care and decreased 3% in Beauty. Net sales in Grooming were unchanged. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, increased 2%. Organic sales increased 3% in Health Care, Fabric & Home Care and Grooming and increased 2% in Baby, Feminine & Family Care. Organic sales in Beauty were unchanged.
•Net earnings were $8.6 billion, an increase of $597 million, or 7%, versus the prior year period due to the non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset in the prior year, partially offset by higher restructuring charges in the current year of $0.8 billion after tax related to the substantial liquidation of operations in certain Enterprise Markets, including Argentina.
•Net earnings attributable to Procter & Gamble were $8.6 billion, an increase of $601 million, or 8%, versus the prior year period.
•Diluted EPS increased 8% to $3.49 due to the increase in net earnings. Core EPS, which excludes incremental restructuring charges and the prior year Gillette intangible asset impairment charge, increased 4% to $3.81.
•Operating cash flow was $9.1 billion. Adjusted free cash flow, which is defined as operating cash flow less capital expenditures and excluding payments for the transitional tax resulting from the U.S. Tax Act, was $7.8 billion. Adjusted free cash flow productivity, which is defined as adjusted free cash flow as a percentage of net earnings excluding a non-cash charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina, was 83%.
ECONOMIC CONDITIONS AND UNCERTAINTIES
Global Economic Conditions. Our products are sold in numerous countries worldwide, with more than half our sales generated outside the United States. Our largest international markets are Greater China, the United Kingdom, Canada, Japan and Germany and collectively comprised approximately 20% of our net sales in fiscal 2024. As a result, we are exposed to global macroeconomic factors, geopolitical tensions and government policies. We are exposed to market risks from operating in challenging environments due to economic, political and social instabilities, natural disasters, debt and credit issues, currency controls, foreign exchange and interest rate changes. These risks can negatively impact our net sales, net earnings and cash flows. For example, we are exposed to risks due to the ongoing war between Russia and Ukraine. Our Russia business accounted for less than 2% of consolidated net sales and net earnings in the fiscal year ended June 30, 2024 and less than 2% of net assets as of June 30, 2024.
Foreign Exchange. We have significant exposure to exchange rate fluctuations, both due to translation and transaction exposures. Translation exposures arise from measuring income statements of foreign subsidiaries with functional currencies other than the U.S. dollar. Transaction exposures involve impacts from 1) input costs that are denominated in currencies other than the local reporting currency and 2) revaluation of working capital balances denominated in currencies other than the functional currency. We have experienced significant foreign exchange impacts in the past due to the weakening of certain foreign currencies versus the U.S. dollar, which have negatively impacted net sales, net earnings and cash flows. In response to the devaluation of foreign currencies (including those deemed highly inflationary), any lags or inability (due to government restrictions) to implement price increases or the negative impacts of such actions on product consumption may lead to a decline in our net sales, net earnings and cash flows.
Commodities and Supply Chain. Our costs are subject to fluctuations due to changes in commodity and input material prices, transportation costs, inflationary impacts and productivity efforts. We have significant exposures to certain commodities and input materials, in particular certain oil-derived materials like resins and paper-based materials like pulp. Volatility in the market price of commodities and input materials directly affects our costs. Disruptions in manufacturing, supply and distribution operations can lead to increased costs. Legal or regulatory requirements and sustainability initiatives may result in increased costs. We strive to implement, achieve and sustain cost improvement plans, including supply chain optimization and general overhead and workforce optimization. Increased pricing in response to certain inflationary or cost increases may also offset portions of the cost impacts; however, such price increases may negatively impact product consumption. If we are unable to manage cost impacts through pricing actions and consistent productivity improvements, it may negatively impact our net sales, net earnings and cash flows.
Government Policies. We are exposed to changes in U.S. and foreign government legislative, regulatory or enforcement policies that can have a negative impact on net sales, net earnings and cash flows. These include tax policy changes (both U.S.

The Procter & Gamble Company 17
and foreign), including those resulting from the current work being led by the OECD/G20 Inclusive Framework focused on "Addressing the Challenges of the Digitalization of the Economy”. Government controls such as currency exchanges, pricing and import authorizations as well as government policies related to environmental and climate change matters and changes to international trade agreements can also impact our financial performance.
For additional information on risk factors that could impact our business results, please refer to Risk Factors in Part I, Item 1A of the Company's Form 10-K for the fiscal year ended June 30, 2024.
RESULTS OF OPERATIONS – Three Months Ended December 31, 2024
The following discussion provides a review of results for the three months ended December 31, 2024, versus the three months ended December 31, 2023.
Three Months Ended December 31
Amounts in millions, except per share amounts20242023% Chg
Net sales$21,882$21,4412%
Operating income5,7414,43330%
Earnings before income taxes5,8454,49630%
Net earnings4,6593,49333%
Net earnings attributable to Procter & Gamble4,6303,46834%
Diluted net earnings per common share1.881.4034%
Core net earnings per common share1.881.842%
Three Months Ended December 31
COMPARISONS AS A PERCENTAGE OF NET SALES20242023Basis Pt Chg
Gross margin52.4 %52.7 %(30)
Selling, general & administrative expense26.2 %25.8 %40 
Operating income26.2 %20.7 %550 
Earnings before income taxes26.7 %21.0 %570 
Net earnings21.3 %16.3 %500 
Net earnings attributable to Procter & Gamble21.2 %16.2 %500 
Net Sales
Net sales for the quarter increased 2% to $21.9 billion as unit volume and mix each increased 1%. Pricing and foreign exchange had a neutral impact on net sales. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 3% and organic volume increased 2%.
The following table summarizes key drivers of the change in net sales by reportable segment:
Net Sales Change Drivers 2024 vs. 2023 (Three Months Ended December 31) (1)
Volume with Acquisitions & DivestituresVolume Excluding Acquisitions & DivestituresForeign ExchangePriceMix
Other (2)
Net Sales Growth
Beauty(1)%— %(1)%2 %— %— %— %
Grooming2 %2 %(1)%1 %(1)%— %1 %
Health Care— %— %— %1 %2 %(1)%2 %
Fabric & Home Care1 %2 %— %— %1 %— %2 %
Baby, Feminine & Family Care4 %4 %— %(1)%— %— %3 %
Total Company1 %2 %— %— %1 %— %2 %
(1)Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.    
(2)Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin decreased 30 basis points to 52.4% of net sales for the quarter. The decrease in gross margin was due to:
•110 basis points of decline from unfavorable product mix,
•50 basis points of higher commodity costs,

18 The Procter & Gamble Company
•20 basis points of product and packaging investments,
•20 basis points of higher transportation services costs and
•10 basis points of unfavorable foreign exchange impacts.
These impacts were partially offset by:
•150 basis points of manufacturing productivity savings and
•30 basis points of increase due to higher pricing.
Total SG&A spending increased 4% to $5.7 billion versus the prior year period due to increased marketing spending and overhead costs. SG&A as a percentage of net sales increased 40 basis points to 26.2% due to an increase in marketing spending and overhead costs as a percentage of net sales. Marketing spending as a percentage of net sales increased 10 basis points as the increase in marketing spending was partially offset by the positive scale impacts of the net sales increase and productivity savings. Overhead costs as a percentage of net sales increased 40 basis points as wage inflation and foreign exchange were partially offset by the positive scale impacts of the net sales increase and productivity savings. Other operating expenses as a percentage of net sales was unchanged. Productivity-driven cost savings delivered 110 basis points of benefit to SG&A as a percentage of net sales.
Operating income increased $1.3 billion, or 30%, to $5.7 billion and operating margin increased 550 basis points to 26.2% versus the prior year period primarily due to the non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset in the prior year, as well as the increase in net sales, partially offset by the decrease in gross margin, the components of which are described above.
Non-Operating Expenses and Income
Interest expense was $240 million for the quarter, a decrease of $8 million versus the prior year period. Interest income was $119 million for the quarter, a decrease of $14 million versus the prior year period. Other non-operating income/(expense) was $224 million, which is an increase of $47 million versus the prior year period due to an increase in the net periodic benefit credit for postretirement benefits.
Income Taxes
The effective income tax rate for the three months ended December 31, 2024, was 20.3%, compared to 22.3% for the three months ended December 31, 2023. The decrease in the effective tax rate was primarily driven by favorable geographic mix impacts and higher excess tax benefits of share-based compensation.
Net Earnings
Net earnings increased $1.2 billion, or 33%, to $4.7 billion due primarily to the non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset in the prior year. Foreign exchange had a negative impact of approximately $45 million on net earnings for the quarter, including both transactional and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $1.2 billion, or 34%, to $4.6 billion for the quarter. Diluted EPS increased 34% to $1.88 versus the prior year period.
RESULTS OF OPERATIONS – Six Months Ended December 31, 2024
The following discussion provides a review of results for the six months ended December 31, 2024, versus the six months ended December 31, 2023.
Six Months Ended December 31
Amounts in millions, except per share amounts
2024
2023
% Chg
Net sales$43,619$43,3121%
Operating income11,53810,20013%
Earnings before income taxes10,98510,2997%
Net earnings8,6468,0497%
Net earnings attributable to Procter & Gamble8,5897,9888%
Diluted net earnings per common share3.493.238%
Core net earnings per common share3.813.664%

The Procter & Gamble Company 19
Six Months Ended December 31
COMPARISONS AS A PERCENTAGE OF NET SALES
2024
2023
Basis Pt Chg
Gross margin52.2 %52.3 %(10)
Selling, general & administrative expense25.8 %25.7 %10 
Operating income26.5 %23.6 %290 
Earnings before income taxes25.2 %23.8 %140 
Net earnings19.8 %18.6 %120 
Net earnings attributable to Procter & Gamble19.7 %18.4 %130 
Net Sales
Net sales for the period increased 1% to $43.6 billion as a 1% increase in both unit volume and higher pricing was partially offset by unfavorable foreign exchange of 1%. Mix was unchanged. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 2%.
The following table summarizes key drivers of the change in net sales by reportable segment:
Net Sales Change Drivers 2024 vs. 2023 (Six Months Ended December 31) (1)
Volume with Acquisitions & DivestituresVolume Excluding Acquisitions & DivestituresForeign ExchangePriceMix
Other (2)
Net Sales Growth
Beauty(1)%— %(1)%1 %(2)%— %(3)%
Grooming3 %4 %(2)%1 %(2)%— %— %
Health Care(1)%— %(1)%1 %3 %— %2 %
Fabric & Home Care1 %2 %(1)%— %1 %— %1 %
Baby, Feminine & Family Care1 %2 %— %— %— %— %1 %
Total Company1 %1 %(1)%1 %— %— %1 %
(1)Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.    
(2)Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin decreased 10 basis points to 52.2% of net sales for the period. The decrease in gross margin was due to:
•80 basis points of decline from unfavorable product mix,
•70 basis points of higher commodity costs,
•30 basis points of product and packaging investments,
•20 basis points of higher transportation services and other costs and
•10 basis points of unfavorable foreign exchange impacts.
These impacts were partially offset by:
•170 basis points of manufacturing productivity savings,
•20 basis points of increase due to higher pricing and
•10 basis points of increase from gain of manufacturing scale benefits.
Total SG&A spending increased 1% to $11.2 billion versus the prior year period due to increased marketing spending and overhead costs. SG&A as a percentage of net sales increased 10 basis points to 25.8% due to the increase in marketing spending and overhead spending as a percentage of sales. Marketing spending as a percentage of net sales increased 30 basis points as the increase in marketing spending was partially offset by the positive scale impacts of the net sales increase and productivity savings. Overhead costs as a percentage of net sales increased 20 basis points due to wage inflation, partially offset by the positive scale impacts of the net sales increase and productivity savings. Other operating expenses as a percentage of net sales decreased 40 basis points primarily driven by favorable foreign exchange impacts. Productivity-driven cost savings delivered 90 basis points of benefit to SG&A as a percentage of net sales.
Operating income increased $1.3 billion, or 13%, to $11.5 billion and operating margin increased 290 basis points to 26.5% versus the prior year period due primarily to the non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset in the prior year, as well as the increase in net sales, partially offset by the decrease in gross margin, the components of which are described above.



20 The Procter & Gamble Company
Non-Operating Expenses and Income
Interest expense was $478 million for the period, an increase of $6 million versus the prior year period. Interest income was $254 million for the period, a decrease of $8 million versus the prior year period. Other non-operating income/(expense) was $(330) million, which is a decrease of $639 million versus the prior year period primarily due to the non-cash charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina recorded in the period ended September 30, 2024.
Income Taxes
The effective income tax rate for the six months ended December 31, 2024, was 21.3%, compared to 21.8% for the six months ended December 31, 2023. The decrease in the effective tax rate was primarily driven by higher excess tax benefits of share-based compensation and favorable geographic mix impacts, partially offset by a 140 basis-point increase due primarily to the charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
Net Earnings
Net earnings increased $597 million, or 7%, to $8.6 billion, as the increase in operating income, the components of which are described above were partially offset by the non-cash charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina recorded in the period ended September 30, 2024. Foreign exchange had a positive impact of approximately $17 million on net earnings for the period, including both transactional and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $601 million, or 8%, to $8.6 billion for the period. Diluted EPS increased 8% to $3.49 versus the prior year period due to the increase in net earnings. Core EPS, which represents diluted EPS excluding charges for incremental restructuring and the impairment of the Gillette intangible asset, increased 4% to $3.81.
SEGMENT RESULTS – Three and Six Months Ended December 31, 2024
The following discussion provides a review of results by reportable business segment. Analysis of the results for the three and six months ended December 31, 2024, is provided based on a comparison to the three and six months ended December 31, 2023. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales, earnings before income taxes and net earnings by reportable business segment for the three and six months ended December 31, 2024, versus the comparable prior year period (dollar amounts in millions):
Three Months Ended December 31, 2024
Net Sales% Change Versus Year AgoEarnings/(Loss) Before Income Taxes% Change Versus Year AgoNet Earnings/(Loss)% Change Versus Year Ago
Beauty$3,848 — %$996 (10)%$780 (10)%
Grooming1,752 1 %568 6 %459 4 %
Health Care3,249 2 %974 5 %758 5 %
Fabric & Home Care7,575 2 %1,989 (1)%1,567 (1)%
Baby, Feminine & Family Care5,298 3 %1,464 2 %1,119 2 %
Corporate159 N/A(146)N/A(24)N/A
Total Company$21,882 2 %$5,845 30 %$4,659 33 %
Six Months Ended December 31, 2024
Net Sales% Change Versus Year AgoEarnings/(Loss) Before Income Taxes% Change Versus Year AgoNet Earnings/(Loss)% Change Versus Year Ago
Beauty$7,741 (3)%$2,063 (13)%$1,620 (12)%
Grooming3,475 — %1,090 2 %885 3 %
Health Care6,397 2 %1,928 6 %1,499 6 %
Fabric & Home Care15,285 1 %4,066 — %3,188 1 %
Baby, Feminine & Family Care10,400 1 %2,847 — %2,185 — %
Corporate322 N/A(1,009)N/A(731)N/A
Total Company$43,619 1 %$10,985 7 %$8,646 7 %






The Procter & Gamble Company 21
Beauty
Three months ended December 31, 2024, compared with three months ended December 31, 2023
Beauty net sales were unchanged at $3.8 billion as unit volume decline of 1% and unfavorable foreign exchange of 1% were offset by positive impacts of higher pricing of 2%. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 2% and organic volume was unchanged. Global market share of the Beauty segment was unchanged.
•Hair Care net sales decreased mid-single digits. Negative impacts of divestitures, unfavorable foreign exchange and a unit volume decrease were partially offset by positive impacts of favorable geographic and brand mix (due to growth of the premium Native brand). The volume decrease was driven by a decline in Greater China (due to market contraction in the retail channel where we have higher shares and distribution footprint changes), partially offset by growth in Latin America and Europe (due to market growth). Organic sales increased low single digits driven by high single-digit growth in Latin America and a low single-digit growth in North America, partially offset by a mid-single-digit decline in Greater China. Global market share of the Hair Care category decreased 0.7 points.
•Personal Care net sales increased double digits. Positive impacts of an increase in unit volume and higher pricing (primarily in North America) were partially offset by unfavorable foreign exchange. The volume increase was driven by growth in North America (due to innovation), Europe (due to distribution expansion and innovation), and Latin America (due to market growth). Organic sales increased double digits due to a low teens growth in North America and a more than 20% growth in Europe, partially offset by a mid-single-digit decline in Greater China. Global market share of the Personal Care category increased 0.8 points.
•Skin Care net sales decreased low single digits. Negative impacts of a decrease in unit volume were partially offset by favorable mix (due primarily to the growth of the super-premium SK-II brand, which has higher than category-average selling prices), higher pricing (primarily in Greater China) and a favorable foreign exchange impact. The volume decrease was driven by declines in all regions, led by North America (due to distribution losses) and Greater China (due to market contraction). Organic sales decreased mid-single digits due to a 20% decline in North America and a mid-single-digit decline in Asia Pacific, partially offset by a mid-single-digit growth in Greater China. Global market share of the Skin Care category decreased 0.7 points.
Net earnings decreased 10% to $780 million due to a 230 basis-point decline in net earnings margin. Net sales were unchanged. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net sales, partially offset by a lower effective tax rate. The gross margin decline was driven by negative product mix (due to the decline of premium brands) and higher commodity costs, partially offset by increased productivity savings and higher pricing. SG&A as a percentage of net sales increased due primarily to increases in marketing and overhead spending. The lower effective tax rate was driven by favorable geographic mix.
Six months ended December 31, 2024, compared with six months ended December 31, 2023
Beauty net sales decreased 3% to $7.7 billion, as unit volume decrease of 1%, negative impacts of unfavorable foreign exchange of 1% and unfavorable mix of 2% (due primarily to the decline of the super-premium SK-II brand, which has higher than segment-average selling prices) were partially offset by the positive impacts of higher pricing of 1%. Excluding the impact of acquisitions and divestitures and foreign exchange, organic volume and organic sales were unchanged. Global market share of the Beauty segment increased 0.1 points.
•Hair Care net sales decreased low single digits. Negative impacts of divestitures, declining unit volume and unfavorable foreign exchange were partially offset by positive impacts of favorable brand mix (due to growth of the premium Native brand) and higher pricing (primarily in Europe and Latin America). The decline in unit volume was driven by a decline in Greater China (due to market contraction and distribution footprint changes), partially offset by growth in North America (due to innovation) and Latin America (due to market growth). Organic sales increased low single digits due to a high single-digit growth in Latin America and a mid-single-digit growth in North America, partially offset by a high single-digit decline in Greater China. Global market share of the Hair Care category decreased 0.6 points.
•Personal Care net sales increased high single digits. Positive impacts of an increase in unit volume, higher pricing (primarily in North America) and favorable product mix (due to the growth of the premium brands) were partially offset by unfavorable foreign exchange. The volume increase was driven by growth in North America (due to innovation), Europe (due to distribution expansion and innovation), and Latin America (due to market growth), partially offset by a decline in Greater China (due to market contraction). Organic sales increased double digits due to a more than 20% growth in Europe and a double digit growth in North America, partially offset by a mid-single-digit decline in Greater China. Global market share of the Personal Care category increased 0.6 points.
•Skin Care net sales decreased mid-teens. Negative impacts of a decrease in unit volume and unfavorable product mix (due primarily to the decline of the super-premium SK-II brand, which has higher than category-average selling prices), were partially offset by higher pricing (primarily in Greater China and Asia Pacific). The volume decrease was driven by declines in all regions, led by North America (due to distribution losses) and Greater China (due to market contraction).

22 The Procter & Gamble Company
Organic sales decreased mid-teens due to 20% declines in North America and Asia Pacific and a double-digit decline in Greater China. Global market share of the Skin Care category decreased 0.6 points
Net earnings decreased 12% to $1.6 billion due to a decrease in net sales and a 220 basis-point decline in net earnings margin. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net sales, partially offset by a lower effective tax rate. The gross margin decline was driven by negative product mix (due to the decline of the super-premium SK-II brand) and higher commodities, partially offset by increased pricing and productivity savings. SG&A as a percentage of net sales increased due primarily to an increase in marketing and overhead spending. The lower effective tax rate was driven by favorable geographic mix.
Grooming
Three months ended December 31, 2024, compared with three months ended December 31, 2023
Grooming net sales increased 1% to $1.8 billion as the benefits of a 2% increase in unit volume and higher pricing of 1% (driven primarily by IMEA and Asia Pacific) were partially offset by unfavorable geographic mix of 1% and unfavorable foreign exchange of 1%. The volume increase was driven by growth in IMEA (due to increased distribution) and Europe (due to market growth). Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 2% driven by a low teens growth in IMEA and a double-digit growth in Asia Pacific. Global market share of the Grooming segment increased 0.3 points.
Net earnings increased 4% to $459 million due to an increase in net sales and an 80 basis-point increase in net earnings margin. Net earnings margin increased as an increase in gross margin and a decrease in SG&A as a percentage of net sales were partially offset by a higher effective tax rate. The gross margin improvement was primarily driven by increased productivity savings and increased pricing, partially offset by unfavorable geographic mix. SG&A as a percentage of net sales decreased due primarily to higher foreign exchange transactional charges in the prior year period. The higher effective tax rate was driven by unfavorable geographic mix.
Six months ended December 31, 2024, compared with six months ended December 31, 2023
Grooming net sales were unchanged at $3.5 billion driven by unit volume increase of 3% and higher pricing of 1% (driven primarily by Latin America and IMEA), offset by unfavorable geographic mix of 2% and unfavorable foreign exchange of 2%. The volume increase was driven by growth in IMEA (due to increased distribution), Latin America (due to market growth) and Europe (due to market growth). Excluding the impact of acquisitions and divestitures and foreign exchange, Grooming organic sales increased 3% due to high teens growth in IMEA, high single-digit growth in Asia Pacific and mid-single-digit growth in Latin America. Organic volume increased 4%. Global market share of the Grooming segment increased 0.6 points.
Net earnings increased 3% to $885 million due to a 60 basis-point increase in net earnings margin. Net earnings margin increased as a decrease in SG&A as a percentage of net sales was partially offset by a decrease in gross margin. The gross margin decrease was driven primarily by unfavorable geographic mix, partially offset by productivity savings and higher pricing. SG&A as a percentage of net sales decreased due to higher foreign exchange transactional charges in the prior year period and reduced marketing spending.
Health Care
Three months ended December 31, 2024, compared with three months ended December 31, 2023
Health Care net sales increased 2% to $3.2 billion driven by favorable product mix of 2% and higher pricing of 1%. Unit volume and foreign exchange were unchanged. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 3%. Global market share of the Health Care segment was unchanged.
•Oral Care net sales increased mid-single digits driven by the positive impacts of favorable product mix (due to growth of power brushes and premium paste, which have higher than category-average selling prices). Unit volume was unchanged as growth in North America (due to market growth and innovation) and Europe (due to distribution gains and innovation) was offset by declines in Greater China (due to market contraction and share losses) and IMEA (due to share losses). Organic sales increased low single digits driven by a high single-digit increase in Europe and a mid-single-digit increase in North America, partially offset by a mid-teens decrease in Greater China. Global market share of the Oral Care category increased 0.1 points.
•Personal Health Care net sales increased low single digits as higher pricing (driven by Europe and Latin America) and a unit volume increase were partially offset by negative impacts of product mix (due to the decline of respiratory products, which have higher than category-average selling prices) and unfavorable foreign exchange. The unit volume increase was primarily due to growth in Europe (due to innovation), partially offset by a decline in IMEA (due to increased competitive activity). Organic sales increased low single digits driven by a double-digit growth in Europe, partially offset by a low-single-digit decline in North America. Global market share of the Personal Health Care category decreased 0.1 points.
Net earnings increased 5% to $758 million due to net sales growth and a 60 basis-point increase in net earnings margin. Net earnings margin increased due to an increase in gross margin, partially offset by an increase in SG&A as a percentage of net sales. The gross margin increase was driven primarily by productivity savings and higher pricing, partially offset by

The Procter & Gamble Company 23
unfavorable product mix (due to a decline in respiratory products, which have higher than segment-average gross margins). SG&A as a percentage of net sales increased due to an increase in overhead spending, partially offset by the positive scale impacts of the net sales increase.
Six months ended December 31, 2024, compared with six months ended December 31, 2023
Health Care net sales increased 2% to $6.4 billion driven by favorable geographic and product mix of 3% and higher pricing of 1%, partially offset by unfavorable foreign exchange of 1% and a 1% decrease in unit volume. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 3% and organic volume was unchanged. Global market share of the Health Care segment was unchanged.
•Oral Care net sales increased low single digits due to the positive impacts of favorable product mix (due to growth of premium paste and power brushes, which have higher than category-average selling prices), partially offset by a decrease in unit volume. The unit volume decrease was due to a decline in Greater China (due to market contraction and share losses) and IMEA (due to share losses), partially offset by growth in North America (due to market growth and innovation) and Europe (due to distribution expansion and innovation). Organic sales also increased low single digits due to a high single-digit increase in Europe and a mid-single-digit increase in North America, partially offset by high teens decreases in Greater China and IMEA. Global market share of the Oral Care category increased 0.2 points.
•Personal Health Care net sales increased low single digits due to the positive impacts of higher pricing (driven by Latin America and Europe), favorable geographic mix and unit volume increase, partially offset by unfavorable foreign exchange. The increase in unit volume was driven by growth in North America (due to distribution gains), Europe (due to innovation), partially offset by a decline in IMEA (due to increased competitive activity). Organic sales increased low single digits due to mid-single-digit growth in both Europe and Latin America and low single-digit growth in North America, partially offset by a low single-digit decline in IMEA. Global market share of the Personal Health Care category decreased 0.1 points.
Net earnings increased 6% to $1.5 billion due to net sales growth and a 90 basis-point increase in net earnings margin. Net earnings margin increased due to an increase in gross margin, a decrease in SG&A as a percentage of net sales and a lower effective tax rate. The gross margin increase was driven by productivity savings and higher pricing. SG&A as a percentage of net sales decreased due to decreased marketing spending, higher foreign exchange transactional charges in the prior year period and the positive scale impacts of the net sales increase. The lower effective tax rate was driven by favorable geographic mix.
Fabric & Home Care
Three months ended December 31, 2024, compared with three months ended December 31, 2023
Fabric & Home Care net sales increased 2% to $7.6 billion driven by a unit volume increase of 1% and favorable mix of 1%. Excluding the impact of foreign exchange and acquisitions and divestitures, organic sales increased 3% and organic volume increased 2%. Global market share of the Fabric & Home Care segment increased 0.1 points.
•Fabric Care net sales increased low single digits driven by an increase in unit volume and a positive impact of favorable geographic mix, partially offset by unfavorable foreign exchange. The increase in unit volume was due to growth in North America (due to innovation) and Europe (due to innovation and increased marketing support), partially offset by declines in Latin America (due to share losses). Organic sales increased low single digits driven by a high single-digit growth in Asia Pacific, a mid-single-digit growth in Europe and a low single-digit growth in North America, partially offset by a high single-digit decline in Latin America. Global market share of the Fabric Care category increased 0.1 points.
•Home Care net sales increased mid-single digits driven by a unit volume increase and favorable premium product mix, partially offset by the impact of divestitures. The increase in volume was due to growth in North America (due to innovation) and Europe (due to market growth). Organic sales increased mid-single digits driven by a mid-single-digit growth in both North America and Europe. Global market share of the Home Care category increased 0.3 points.
Net earnings decreased 1% to $1.6 billion as the increase in net sales was more than offset by a 60 basis-point decline in net earnings margin. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net sales, partially offset by a lower effective tax rate. The gross margin decrease was driven by unfavorable product mix, partially offset by productivity savings. SG&A as a percentage of net sales increased due to an increase in marketing and overhead spending, partially offset by the positive scale effects of the net sales increase. The lower effective tax rate was driven by favorable geographic mix.
Six months ended December 31, 2024, compared with six months ended December 31, 2023
Fabric & Home Care net sales increased 1% to $15.3 billion driven by a unit volume increase of 1% and favorable product mix of 1%, partially offset by unfavorable foreign exchange of 1%. Excluding the impact of foreign exchange and acquisitions and divestitures, organic sales increased 3% and organic volume increased 2%. Global market share of the Fabric & Home Care segment increased 0.1 points.
•Fabric Care net sales were unchanged as the positive impact of favorable premium product mix was offset by the negative impacts of unfavorable foreign exchange. Unit volume was unchanged as growth in North America (due to market growth)

24 The Procter & Gamble Company
and Europe (due to innovation and increased marketing support) was offset by declines in Latin America and IMEA (both due to share losses). Organic sales increased low single digits driven by a mid-single-digit increase in Europe and North America, partially offset by a high single-digit decrease in Latin America. Global market share of the Fabric Care category decreased 0.1 points.
•Home Care net sales increased mid-single digits driven by a unit volume increase and favorable premium product mix, partially offset by the impact of unfavorable foreign exchange and divestitures. The increase in volume was due primarily to growth in North America (due to innovation) and Europe (due to market growth). Organic sales increased mid-single digits driven by mid-single-digit growth in North America and Europe. Global market share of the Home Care category increased 0.4 points.
Net earnings increased 1% to $3.2 billion due to the increase in net sales. Net earnings margin was unchanged as an increase in gross margin and a lower effective tax rate was fully offset by an increase in SG&A as a percentage of net sales. The gross margin increase was driven by increased productivity savings, partially offset by unfavorable product mix. SG&A as a percentage of net sales increased due to an increase in marketing and overhead spending, partially offset by the positive scale effects of the net sales increase and higher foreign exchange transactional charges in the prior year period. The lower effective tax rate was driven by favorable geographic mix.
Baby, Feminine & Family Care
Three months ended December 31, 2024, compared with three months ended December 31, 2023
Baby, Feminine & Family Care net sales increased 3% to $5.3 billion due to a 4% increase in unit volume, partially offset by lower pricing of 1%. Excluding the impacts of foreign exchange and acquisitions and divestitures, organic sales increased 4%. Global market share of the Baby, Feminine & Family Care segment was unchanged.
•Baby Care net sales decreased low single digits. Negative impacts of a decrease in unit volume, lower pricing (driven by merchandising investments in North America and Europe) and divestitures were partially offset by favorable geographic and product mix (due to a higher proportion of premium diapers, which have higher than category-average selling prices). The unit volume decline was driven by Europe and Asia Pacific (both due to market contraction). Organic sales decreased low single digits due to a double digit decline in Asia Pacific and a mid-single-digit decline in Europe, partially offset by a mid-single-digit growth in Latin America. Global market share of the Baby Care category was unchanged.
•Feminine Care net sales increased low single digits. Positive impacts of favorable geographic mix were partially offset by a decrease in unit volume. The unit volume decrease was primarily driven by declines in Greater China (due to share losses) and IMEA (due to increased pricing), partially offset by growth in North America (due to market growth). Organic sales increased low single digits driven by a mid-single-digit growth in North America, partially offset by a mid-single-digit decline in Greater China. Global market share of the Feminine Care category decreased 0.4 points.
•Net sales in Family Care, which is predominantly a North America business, increased double digits driven by an increase in unit volume (due to strong consumption offtake and retail inventory build), partially offset by lower pricing (due to investments). Organic sales increased double digits. North America market share of the Family Care category increased 0.3 points.
Net earnings increased 2% to $1.1 billion driven by the increase in net sales, partially offset by the 30 basis-point decline in net earnings margin. Net earnings margin decreased primarily due to a decline in gross margin, partially offset by a decline in SG&A as a percentage of net sales. Gross margin decreased primarily due to higher commodity costs and unfavorable mix, partially offset by increased productivity savings. SG&A as a percentage of net sales decreased due to a decrease in marketing spending, higher foreign exchange transactional charges in the prior year period and positive scale effects of the net sales increase.
Six months ended December 31, 2024, compared with six months ended December 31, 2023
Baby, Feminine & Family Care net sales increased 1% to $10.4 billion driven by a 1% increase in unit volume. Excluding the impacts of foreign exchange and acquisitions and divestitures, organic sales increased 2%. Global market share of the Baby, Feminine & Family Care segment decreased 0.1 points.
•Baby Care net sales decreased mid-single digits. Negative impacts of a decrease in unit volume, unfavorable foreign exchange and lower pricing (driven by merchandising investments in North America and Europe) were partially offset by favorable product mix (due to growth of premium diapers, which have higher than category-average selling prices). The unit volume decline was driven across most regions led by Europe and Asia Pacific (both due to market contraction) and IMEA (due to share losses). Organic sales decreased low single digits primarily driven by a double-digit decline in IMEA and a high single-digit decline in Europe. Global market share of the Baby Care category decreased 0.2 points.
•Feminine Care net sales increased low single digits. Positive impacts of favorable geographic mix and higher pricing (driven primarily by North America and IMEA) were partially offset by a decrease in unit volume and unfavorable foreign exchange. The unit volume decrease was primarily driven by declines in Greater China (due to share losses) and IMEA (due to increased pricing), partially offset by growth in North America (due to market growth). Organic sales increased low

The Procter & Gamble Company 25
single digits driven by a mid-single-digit growth in North America, partially offset by a mid-single-digit decline in Greater China. Global market share of the Feminine Care category decreased 0.4 points.
•Net sales in Family Care, which is predominantly a North America business, increased high single digits driven by an increase in unit volume (due to strong consumption offtake and retail inventory build), partially offset by lower pricing (due to investments). Organic sales also increased high single digits. North America market share of the Family Care category increased 0.1 points.
Net earnings were unchanged at $2.2 billion as the increase in net sales was offset by a 10 basis-point decrease in net earnings margin. Net earnings margin decreased primarily due to a decrease in gross margin, partially offset by a decrease in SG&A as a percentage of net sales. Gross margin decreased primarily due to higher commodity costs and unfavorable mix, partially offset by productivity savings. SG&A as a percentage of net sales decreased due to higher foreign exchange transactional charges in the prior year period and the positive scale impacts of the net sales increase, partially offset by an increase in overhead spending.
Corporate
Corporate includes certain operating and non-operating activities not allocated to specific business segments. These include but are not limited to incidental businesses managed at the corporate level, gains and losses related to certain divested brands or businesses, impacts from various financing and investing activities, impacts related to employee benefits, asset impairments and restructuring activities including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used within the reportable segments to U.S. GAAP. The most notable ongoing reconciling item is income taxes, which adjusts the blended statutory rates that are reflected in the reportable segments to the overall Company effective tax rate.
For the three months ended December 31, 2024, Corporate net sales increased $34 million to $159 million due to an increase in net sales of incidental businesses managed at the corporate level. Corporate net earnings increased $1.2 billion to a loss of $24 million for the quarter due primarily to the non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset in the prior year.
For the six months ended December 31, 2024, Corporate net sales increased $52 million to $322 million due to an increase in net sales of incidental businesses managed at the corporate level. Corporate net earnings increased $652 million to a loss of $731 million due primarily to the non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset in the prior year, partially offset by incremental restructuring charges in the current year, comprised primarily of accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
LIQUIDITY & CAPITAL RESOURCES
Operating Activities
Operating cash flow was $9.1 billion fiscal year to date, a decrease of $877 million versus the prior year period. Net earnings, adjusted for non-cash items (depreciation and amortization, share-based compensation expense, deferred income taxes and gain/loss on sale of assets), generated $11.3 billion of operating cash flow. Working capital and other impacts used $2.2 billion of cash in the period primarily driven by the payment of the transitional tax related to the U.S. Tax Act, the payment of prior fiscal year-end incentive compensation accruals and a reduction in postretirement benefit accruals. Days sales outstanding were flat. Days inventory on hand decreased by one day.
Investing Activities
Investing activities used $2.0 billion of cash fiscal year to date primarily driven by capital expenditures.
Financing Activities
Financing activities used $6.2 billion of net cash fiscal year to date, mainly due to dividends to shareholders and treasury stock purchases, partially offset by a net debt increase and the impact of stock options and other.
As of December 31, 2024, our current liabilities exceeded current assets by $8.2 billion. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings that have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient funding to meet short-term financing requirements.
MEASURES NOT DEFINED BY U.S. GAAP
In accordance with the SEC's Regulation S-K Item 10(e), the following provides definitions of the non-GAAP measures and the reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of period-to-period results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk

26 The Procter & Gamble Company
compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measures but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.
Organic sales growth. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing the achievement of management goals for at-risk compensation.
The following tables provide a numerical reconciliation of organic sales growth to reported net sales growth:
Three Months Ended December 31, 2024Net Sales GrowthForeign Exchange Impact
Acquisition & Divestiture Impact/Other (1)
Organic Sales Growth
Beauty— %1 %1 %2 %
Grooming1 %1 %— %2 %
Health Care2 %— %1 %3 %
Fabric & Home Care2 %— %1 %3 %
Baby, Feminine & Family Care3 %— %1 %4 %
Total Company2 %— %1 %3 %
(1)Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Six Months Ended December 31, 2024Net Sales GrowthForeign Exchange Impact
Acquisition & Divestiture Impact/Other (1)
Organic Sales Growth
Beauty(3)%1 %2 %— %
Grooming— %2 %1 %3 %
Health Care2 %1 %— %3 %
Fabric & Home Care1 %1 %1 %3 %
Baby, Feminine & Family Care1 %— %1 %2 %
Total Company1 %1 %— %2 %
(1)Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Adjusted free cash flow. Adjusted free cash flow is defined as operating cash flow less capital expenditures and excluding payments for the transitional tax resulting from the U.S. Tax Act. Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.
The following table provides a numerical reconciliation of adjusted free cash flow ($ millions):
Six Months Ended December 31, 2024
Operating Cash FlowCapital SpendingU.S. Tax Act PaymentsAdjusted Free Cash Flow
$9,127 $(1,918)$562 $7,771 
Adjusted free cash flow productivity. Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding a non-cash charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina. We view adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, in allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation.
The following table provides a numerical reconciliation of adjusted free cash flow productivity ($ millions):
Six Months Ended December 31, 2024
Adjusted Free Cash FlowNet Earnings
Adjustments to
Net Earnings (1)
Net Earnings
as Adjusted		Adjusted Free Cash
Flow Productivity
$7,771 $8,646 $752 $9,398 83 %
(1)Adjustments to Net earnings relate to a non-cash charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.


The Procter & Gamble Company 27
Core EPS. Core EPS is a measure of the Company's diluted EPS excluding items that are not judged by management to be part of the Company's sustainable results or trends. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time. This measure is also used in assessing the achievement of management goals for at-risk compensation. The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
•Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of approximately $250 - $500 million before tax. In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina. The adjustment to Core earnings includes the restructuring charges that exceed the normal, recurring level of restructuring charges.
•Intangible asset impairment: In the fiscal year ended June 30, 2024, the Company recognized a non-cash, after-tax impairment charge of $1.0 billion ($1.3 billion before tax) to adjust the carrying value of the Gillette intangible asset acquired as part of the Company's 2005 acquisition of The Gillette Company.
We do not view the above items to be part of our sustainable results, and their exclusion from core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Amounts in millions except per share amounts
As Reported
(GAAP) (1)
As Reported
(GAAP)		Incremental RestructuringIntangible ImpairmentCore
(Non-GAAP)
Cost of products sold$10,418$10,144 $(12)$— $10,132 
Selling, general and administrative expense5,7235,522 (8)— 5,515 
Operating income5,7414,433 19 1,341 5,793 
Income taxes1,1871,003 (20)315 1,299 
Net earnings attributable to P&G4,6303,468 39 1,026 4,533 
Core EPS
Diluted net earnings per common share (2)
$1.88$1.40 $0.02 $0.42 $1.84 
(1)For the three months ended December 31, 2024, there were no adjustments to or reconciling items for Core EPS.
(2)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE IN CURRENT YEAR REPORTED (GAAP) MEASURES VERSUS PRIOR YEAR NON-GAAP (CORE) MEASURES
Core net earnings attributable to P&G2 %
Core EPS2 %


28 The Procter & Gamble Company
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Six Months Ended December 31, 2024
Amounts in millions except per share amountsAs Reported (GAAP)Incremental RestructuringCore
(Non-GAAP)
Cost of products sold$20,839$20 $20,859 
Selling, general and administrative expense11,242(25)11,216 
Operating income11,5385 11,543 
Other non-operating income/(expense), net
(330)789 459 
Income taxes2,339(7)2,331 
Net earnings attributable to P&G8,589801 9,391 
Core EPS
Diluted net earnings per common share (1)
$3.49$0.33 $3.81 
(1)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE VERSUS YEAR AGO
Core net earnings attributable to P&G4 %
Core EPS4 %

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Six Months Ended December 31, 2023
Amounts in millions except per share amountsAs Reported (GAAP)Incremental RestructuringIntangible ImpairmentCore
(Non-GAAP)
Cost of products sold$20,645 $(12)$— $20,633 
Selling, general and administrative expense11,127 (8)— 11,119 
Operating income10,200 19 1,341 11,560 
Income taxes2,250 (20)315 2,545 
Net earnings attributable to P&G7,988 39 1,026 9,054 
Core EPS
Diluted net earnings per common share (1)
$3.23 $0.02 $0.42 $3.66 
(1)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

Item 3.
Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in the Company’s exposure to market risk since June 30, 2024. Additional information can be found in Note 9, Risk Management Activities and Fair Value Measurements, of the Company's Form 10-K for the fiscal year ended June 30, 2024.
Item 4.Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s Chairman of the Board, President and Chief Executive Officer, Jon R. Moeller, and the Company’s Chief Financial Officer, Andre Schulten, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report.
Messrs. Moeller and Schulten have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to our management, including Messrs. Moeller and Schulten, to allow their timely decisions regarding required disclosure.



The Procter & Gamble Company 29
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended December 31, 2024, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1.Legal Proceedings
The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and tax. In addition, SEC regulations require that we disclose certain environmental proceedings arising under Federal, State or local law when a governmental authority is a party and such proceeding involves potential monetary sanctions that the Company reasonably believes will exceed a certain threshold ($1 million or more).
There were no material changes during the quarter ended December 31, 2024, to our disclosure in Part I, Item 3, “Legal Proceedings” of our Form 10-K for the fiscal year ended June 30, 2024. There were no relevant matters to disclose under this Item for this period.
Item 1A.Risk Factors
For information on risk factors, please refer to "Risk Factors" in Part I, Item 1A of the Company's Form 10-K for the fiscal year ended June 30, 2024.
Item 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
ISSUER PURCHASES OF EQUITY SECURITIES
Period
Total Number of Shares Purchased (1)
Average Price Paid per Share (2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)
Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program
10/01/2024 - 10/31/20245,149,365 $169.925,149,365 
(3)
11/01/2024 - 11/30/20245,182,400 168.845,182,400 
(3)
12/01/2024 - 12/31/20244,371,303 171.57 4,371,303 
(3)
Total14,703,068 $170.0314,703,068 (3)
(1)All transactions are reported on a trade date basis and were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises.
(2)Average price paid per share for open market transactions excludes commission.
(3)In accordance with the repurchase program announced on July 30, 2024, the Company reaffirmed in its earnings release on January 22, 2025, that it expects to reduce outstanding shares through direct share repurchases at a value of $6 to $7 billion in fiscal year 2025, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and are expected to be financed by a combination of operating cash flows and issuance of debt.    
Item 5.Other Information
During the three months ended December 31, 2024, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as defined in Item 408 of Regulation S-K.

30 The Procter & Gamble Company
Item 6.Exhibits
101.SCH (1)
Inline XBRL Taxonomy Extension Schema Document
101.CAL (1)
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF (1)
Inline XBRL Taxonomy Definition Linkbase Document
101.LAB (1)
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE (1)
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
+Filed herewith
(1)
Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
THE PROCTER & GAMBLE COMPANY
January 22, 2025/s/ MATTHEW W. JANZARUK
Date(Matthew W. Janzaruk)
Senior Vice President - Chief Accounting Officer
(Principal Accounting Officer)

 EX-31.1 2 fy2425q2ond10-qexhibit311.htm RULE 13A-14(A)/15D-14(A) CERTIFICATION CHIEF EXECUTIVE OFFICER Document

EXHIBIT 31.1
Rule 13a-14(a)/15d-14(a) Certifications
I, Jon R. Moeller, certify that:
(1)I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ JON R. MOELLER
(Jon R. Moeller)
Chairman of the Board, President and Chief Executive Officer
January 22, 2025
Date



 EX-31.2 3 fy2425q2ond10-qexhibit312.htm RULE 13A-14(A)/15D-14(A) CERTIFICATION CHIEF FINANCIAL OFFICER Document

EXHIBIT 31.2
Rule 13a-14(a)/15d-14(a) Certifications
I, Andre Schulten, certify that:
(1)I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


/s/ ANDRE SCHULTEN
(Andre Schulten)
Chief Financial Officer
January 22, 2025
Date


 EX-32.1 4 fy2425q2ond10-qexhibit321.htm SECTION 1350 CERTIFICATIONS CHIEF EXECUTIVE OFFICER Document

EXHIBIT 32.1
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)The Quarterly Report on Form 10-Q of the Company for the quarterly period ended December 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ JON R. MOELLER
(Jon R. Moeller)
Chairman of the Board, President and Chief Executive Officer
January 22, 2025
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.


EX-32.2 5 fy2425q2ond10-qexhibit322.htm SECTION 1350 CERTIFICATIONS CHIEF FINANCIAL OFFICER Document

EXHIBIT 32.2
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)The Quarterly Report on Form 10-Q of the Company for the quarterly period ended December 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ ANDRE SCHULTEN
(Andre Schulten)
Chief Financial Officer
January 22, 2025
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.


EX-101.SCH 6 pg-20241231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Consolidated Statements of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952157 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - New Accounting Pronouncements and Policies link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Share-Based Compensation and Postretirement Benefits link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Risk Management Activities and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Accumulated Other Comprehensive Income/(Loss) link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Supplier Finance Programs link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Restructuring Program link:presentationLink link:calculationLink link:definitionLink 9955511 - Disclosure - New Accounting Pronouncements and Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9955512 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9955513 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9955514 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9955515 - Disclosure - Share-Based Compensation and Postretirement Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9955516 - Disclosure - Risk Management Activities and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9955517 - Disclosure - Accumulated Other Comprehensive Income/(Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 9955518 - Disclosure - Restructuring Program (Tables) link:presentationLink link:calculationLink link:definitionLink 9955519 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955520 - Disclosure - Segment Information - Percent Of Sales By Business Unit (Details) link:presentationLink link:calculationLink link:definitionLink 9955521 - Disclosure - Segment Information - Global Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9955524 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955525 - Disclosure - Goodwill and Intangible Assets - Fair Value Impacts (Details) link:presentationLink link:calculationLink link:definitionLink 9955526 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955527 - Disclosure - Share-Based Compensation and Postretirement Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - Risk Management Activities and Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9955530 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) link:presentationLink link:calculationLink link:definitionLink 9955531 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 9955532 - Disclosure - Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9955534 - Disclosure - Supplier Finance Programs (Details) link:presentationLink link:calculationLink link:definitionLink 9955535 - Disclosure - Restructuring Program - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955536 - Disclosure - Restructuring Program - Restructuring Activity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pg-20241231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 pg-20241231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 pg-20241231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Statistical Measurement [Domain] Statistical Measurement [Domain] Reductions in long-term debt Repayments of Long-Term Debt Cover [Abstract] CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Intangible Asset, Indefinite-Lived [Table] Intangible Asset, Indefinite-Lived [Table] Trading Symbol Trading Symbol Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair Value Hedging Fair Value Hedging [Member] TOTAL COMPREHENSIVE INCOME Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Dividends and dividend equivalents, common stock (in dollars per share) Common Stock, Dividends, Per Share, Declared Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Preferred stock conversions (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Change in accounts receivable Increase (Decrease) in Accounts Receivable Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Hedging Relationship [Domain] Hedging Relationship [Domain] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Total other comprehensive income/(loss), before tax Other Comprehensive Income (Loss), before Tax Award Timing Disclosures [Line Items] Net Investment Hedging Net Investment Hedging [Member] -25 bps Growth Rates 25 bps Decrease Long-Term Growth [Member] 25 bps Decrease Long-Term Growth [Member] Change in other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Amount of Gain/(Loss) Recognized in Earnings Derivative, Gain (Loss) on Derivative, Net Other Performance Measure, Amount Other Performance Measure, Amount Goodwill [Line Items] Goodwill [Line Items] Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding INVENTORIES Inventory, Net [Abstract] OTHER NONCURRENT ASSETS Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Gross Carrying Amount Finite-Lived Intangible Assets, Gross Treasury stock purchases (in shares) Treasury Stock, Shares, Acquired Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Operating Segments Operating Segments [Member] Selling, General and Administrative Expenses Selling, General and Administrative Expenses [Member] TOTAL OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] Treasury Stock Treasury Stock, Common [Member] Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] 5.250% GBP Notes due January 2033 5.250% GBP notes due January 2033 [Member] 5.250% GBP notes due January 2033 Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Equity Components [Axis] Equity Components [Axis] Award Timing Method Award Timing Method [Text Block] Asset-Related Costs Facility Closing [Member] Net periodic benefit cost (credit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Restructuring Type [Axis] Restructuring Type [Axis] Amount of gain (loss) excluded from effectiveness testing, which was recognized in earnings Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Adjustment to Compensation, Amount Adjustment to Compensation Amount Carrying amount of the underlying debt obligation Underlying Debt Obligation, Carrying Amount Underlying Debt Obligation, Carrying Amount Payables and Accruals [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Current portion of long-term debt instruments Long-Term Debt, Current Maturities Measured At Fair Value Long-Term Debt, Current Maturities Measured At Fair Value Intangible Assets with Indefinite Lives Indefinite-Lived Intangible Assets [Member] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Accrued and other liabilities Accrued Liabilities, Current Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Share-Based Compensation and Postretirement Benefits Compensation and Employee Benefit Plans [Text Block] Cost paid/settled Payments for Restructuring Other investing activity Payments for (Proceeds from) Investments Health Care Health Care Segment [Member] Health Care Segment [Member] Cash and cash equivalents CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents CURRENT ASSETS Assets, Current [Abstract] GOODWILL Beginning balance Ending balance Goodwill Consolidation Items [Axis] Consolidation Items [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Personal Health Care Personal Health Care [Member] Personal Health Care [Member] OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX Other Comprehensive Income (Loss), Net of Tax [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Schedule of Potential Impacts to Estimated Fair Values Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Entity Information [Line Items] Entity Information [Line Items] Stock options Share-Based Payment Arrangement, Option [Member] Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE Comprehensive Income (Loss), Net of Tax, Attributable to Parent Pension Benefits Pension Plan [Member] Materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Security Exchange Name Security Exchange Name Award Type Award Type [Axis] Less: OCI attributable to noncontrolling interests, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest PROPERTY, PLANT AND EQUIPMENT, NET Property, Plant and Equipment, Net Work in process Inventory, Work in Process, Net of Reserves TOTAL LIABILITIES Liabilities Noncontrolling interest Equity, Attributable to Noncontrolling Interest Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Expiration Date Trading Arrangement Expiration Date INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Subsegments [Axis] Subsegments [Axis] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Total Shareholder Return Amount Total Shareholder Return Amount Common stock, issued (in shares) Common Stock, Shares, Issued Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Concentration risk (in percent) Concentration Risk, Percentage EARNINGS BEFORE INCOME TAXES Earnings/(Loss) Before Income Taxes Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Personal Care Personal Care [Member] Personal Care Fair Value (Liability) Derivative Liability Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Diluted weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Unrealized gains/(losses) on investment securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Gain/(loss) recognized in AOCI Accumulated Other Comprehensive Income, Gain (Loss) Accumulated Other Comprehensive Income, Gain (Loss) Reserve for ESOP Debt Retirement Reserve for ESOP Debt Retirement [Member] Reserve for ESOP Debt Retirement [Member] Other Non-operating Income (Expense) Other Nonoperating Income (Expense) [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Baby Care Baby Care [Member] Baby Care [Member] Risk Management Activities and Fair Value Measurements Financial Instruments Disclosure [Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Interest expense Interest Expense, Nonoperating Deferred income taxes Deferred Income Tax Expense (Benefit) Schedule of Goodwill Schedule of Goodwill [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Selling, general and administrative expense Selling, General and Administrative Expense Debt due within one year Debt, Current Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Cost of Sales Cost of Sales [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus 1.250% Notes due 2029 1.250% Notes due 2029 [Member] 1.250% Notes due 2029 All Executive Categories All Executive Categories [Member] Stock options and other unvested equity awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Reserve for ESOP debt retirement Reserve For ESOP Debt Retirement Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for the ESOP debt retirement is also recorded. Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Noncontrolling interest, net Noncontrolling Interest, Period Increase (Decrease) Assets Assets [Abstract] Retirement Plan Type [Domain] Retirement Plan Type [Domain] TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX Other comprehensive income/(loss) Other Comprehensive Income (Loss), Net of Tax Grooming Grooming Segment [Member] Grooming Segment [Member] Document Type Document Type Derivative Contract [Domain] Derivative Contract [Domain] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] NET EARNINGS PER COMMON SHARE Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Defined Benefit Plan [Table] Defined Benefit Plan [Table] -50 bps Royalty Rate 50 bps Decrease Long-Term Royalty [Member] 50 bps Decrease Long-Term Royalty Gross Carrying Amount Indefinite-lived intangible asset Indefinite-Lived Intangible Assets (Excluding Goodwill) Maximum Maximum [Member] Intangible asset amortization Amortization of Intangible Assets Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Payment terms for suppliers (in days) Supplier Finance Program, Payment Timing, Period Number of countries with on the ground operations Number of Countries With On-The-Ground Operations Number of Countries with On The Ground Operations Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Accounting Policies [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Amount due to suppliers participating in SCF Supplier Finance Program, Obligation Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Postretirement Benefit Plans Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount All Award Types Award Type [Domain] Name Outstanding Recovery, Individual Name Employee stock plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Non-PEO NEO Non-PEO NEO [Member] Gillette Gillette [Member] Gillette [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Award Timing Predetermined Award Timing Predetermined [Flag] Feminine Care Feminine Care [Member] Feminine Care [Member] New Accounting Pronouncements and Policies New Accounting Pronouncements, Policy [Policy Text Block] Diluted (in dollars per share) Earnings Per Share, Diluted Class of Stock [Axis] Class of Stock [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Type of Restructuring [Domain] Type of Restructuring [Domain] Change in estimated fair value (in percent) Percent Change in Estimated Fair Value Percent Change in Estimated Fair Value Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Retirement Benefits [Abstract] Separation Costs Employee Severance [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Restructuring Program Restructuring and Related Activities Disclosure [Text Block] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense ESOP debt impacts ESOP Debt Impacts ESOP Debt Impacts NET EARNINGS NET EARNINGS Net earnings Net Earnings/(Loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income taxes Income Tax Expense (Benefit) Notional Amount Derivative, Notional Amount Corporate Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Fair Value Asset Derivative Asset 0.230% Notes due 2031 0.230% Notes due 2031 [Member] 0.230% Notes due 2031 Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Table Text Block] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Cash equivalents Cash Equivalents, at Carrying Value TOTAL INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities OPERATING INCOME Operating Income (Loss) AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Number of reportable segments Number of Reportable Segments TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Additional paid-in capital Additional Paid in Capital 6.250% GBP Notes due January 2030 6.250% GBP notes due January 2030 [Member] 6.250% GBP notes due January 2030 Hedging Designation [Axis] Hedging Designation [Axis] Restructuring charges Cost incurred Restructuring Charges Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Dividends to shareholders Payments of Dividends Interest income Investment Income, Interest Family Care Family Care [Member] Family Care [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Individual: Individual [Axis] Accumulated Other Comprehensive Income/(Loss) AOCI Attributable to Parent [Member] 3.250% EUR Notes due 2026 3.250% EUR Notes due 2026 [Member] 3.250% EUR Notes due 2026 Total inventories Inventory, Net Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Statement [Line Items] 3.250% EUR Notes due 2031 3.250% EUR Notes due 2031 [Member] 3.250% EUR Notes due 2031 Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Incremental restructuring charges incurred Restructuring and Related Cost, Incurred Cost Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Interest rate contracts Interest Rate Contract [Member] Fabric Care Fabric Care [Member] Fabric Care [member] Skin Care Skin Care [Member] Skin Care Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Segments [Axis] Segments [Axis] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Exercise Price Award Exercise Price Earnings Per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Preferred Less: Preferred dividends Dividends, Preferred Stock Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Axis] Subsegments [Domain] Subsegments [Domain] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] 0.900% Notes due 2041 0.900% Notes due 2041 [Member] 0.900% Notes due 2041 Segments [Domain] Segments [Domain] Tax effect Other Comprehensive Income (Loss), Tax Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Additions to short-term debt with original maturities of more than three months Proceeds from Short-Term Debt, Maturing in More than Three Months All Individuals All Individuals [Member] PEO PEO [Member] 3.150% EUR Notes due 2028 3.150% EURO Notes due 2028 [Member] 3.150% EURO Notes due 2028 Entities [Table] Entities [Table] Name Trading Arrangement, Individual Name Other non-operating income/(expense), net Other Nonoperating Income (Expense) Other Retiree Benefits Other Postretirement Benefits Plan [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET Intangible Assets, Net (Excluding Goodwill) Amount of Gain/(Loss) Recognized in OCI on Derivatives Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Dividends and dividend equivalents, preferred stock (in dollars per share) Preferred Stock, Dividends Per Share, Declared Treasury stock Treasury Stock, Common, Value Number of audits underway Number of Audits Typically Underway Number of Audits Typically Underway Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Percentage of fair value in excess of carrying value Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Local Phone Number Local Phone Number Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Reconciliation of Revenue from Segments to Consolidated Reconciliation of Revenue from Segments to Consolidated [Table Text Block] DEFERRED INCOME TAXES Deferred Income Tax Liabilities, Net Other Costs Other Restructuring [Member] +25 bps Discount Rate 25 bps Increase Discount Rate [Member] 25 bps Increase Discount Rate 4.875% EUR Notes due May 2027 4.875% EUR Notes due May 2027 [Member] 4.875% EUR Notes due May 2027 PEO Total Compensation Amount PEO Total Compensation Amount Unrealized gains/(losses) on defined benefit postretirement plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock Common Stock [Member] Measure: Measure [Axis] Employee stock plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Investment Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member] Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-Lived Intangible Assets [Axis] Segment Reporting [Abstract] Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key Impact of stock options and other Proceeds From Stock Options Exercised And Other Financing Activities The cash inflow associated with the amount received from holders exercising their stock options. Also includes, the net cash inflow (outflow) from other financing activities. 3.200% EUR Notes due 2034 3.200% EUR Notes due 2034 [Member] 3.200% EUR Notes due 2034 Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Other comprehensive income/(loss), before tax: Other Comprehensive Income (Loss), before Tax Period Change [Abstract] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Amounts reclassified to the Consolidated Statement of Earnings Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Change in accounts payable and accrued and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Segment Information Segment Reporting Disclosure [Text Block] Convertible preferred shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Oral Care Oral Care [Member] Oral Care [Member] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] New Accounting Pronouncements and Policies Accounting Standards Update and Change in Accounting Principle [Text Block] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Title Trading Arrangement, Individual Title Supplier Finance Program [Table] Supplier Finance Program [Table] Statement [Table] Statement [Table] Foreign Currency Translation Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Less: Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest CONSOLIDATED AMOUNTS Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Consolidation Items [Domain] Consolidation Items [Domain] City Area Code City Area Code CURRENT LIABILITIES Liabilities, Current [Abstract] Net additions/(reductions) to other short-term debt Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Number of taxable jurisdictions Number of Taxable Jurisdictions Number of Taxable Jurisdictions Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Other Other Noncash Expense Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Loss/(gain) on sale of assets Gain (Loss) on Disposition of Assets TOTAL CURRENT ASSETS Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Preferred Stock Preferred Stock [Member] Treasury stock purchases Payments for Repurchase of Common Stock Home Care Home Care [Member] Home Care [Member] LONG-TERM DEBT Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] NET EARNINGS PER COMMON SHARE Earnings Per Share [Abstract] Equity [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Translation and other Goodwill, Translation and Measurement Period Adjustments Class of Stock [Domain] Class of Stock [Domain] Change in inventories Increase (Decrease) in Inventories Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] TOTAL FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities 1.200% Notes due 2028 1.200% Notes due 2028 [Member] 1.200% Notes due 2028 Underlying Securities Award Underlying Securities Amount Amendment Flag Amendment Flag Fair value of long-term debt Long-Term Debt, Fair Value Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Depreciation and amortization Depreciation, Depletion and Amortization Fair Value as of Grant Date Award Grant Date Fair Value SHAREHOLDERS’ EQUITY Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Restatement Determination Date: Restatement Determination Date [Axis] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock Common Stock, Value, Issued 0.110% Notes due 2026 0.110% Notes due 2026 [Member] 0.110% Notes due 2026 Beauty Beauty Segment [Member] Beauty Segment Member OCI before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Indefinite-lived intangible asset impairment charge Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Indefinite-Lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] 1.800% Notes due 2029 1.800% Notes due 2029 [Member] 1.800% Notes due 2029 Preferred stock Preferred Stock, Value, Issued Acquisitions and divestitures Goodwill, Acquisitions and Divestitures Goodwill, Acquisitions and Divestitures Historical restructuring costs, before tax Historical Restructuring Costs Before Tax Historical Restructuring Costs Before Tax Basic (in dollars per share) Earnings Per Share, Basic Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Schedule of Goodwill [Table] Goodwill [Table] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Net earnings attributable to P&G available to common shareholders (Basic) Net Income (Loss) Available to Common Stockholders, Basic Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Intangible assets with determinable lives Finite-Lived Intangible Assets, Net [Abstract] TOTAL CURRENT LIABILITIES Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] TOTAL ASSETS Assets Underlying, Other Underlying, Other [Member] Cost of products sold Cost of Goods and Services Sold Supplier Finance Programs Supplier Finance Program [Text Block] Capital expenditures Payments to Acquire Property, Plant, and Equipment OTHER NONCURRENT LIABILITIES Other Liabilities, Noncurrent Supplier Finance Program [Line Items] Supplier Finance Program [Line Items] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Termination Date Trading Arrangement Termination Date NET SALES Net Sales Revenues 1.375% Notes due 2025 1.375% Notes due 2025 [Member] 1.375% Notes due 2025 Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Entity Address, State or Province Entity Address, City or Town Baby, Feminine & Family Care Baby, Feminine & Family Care Segment [Member] Baby, Feminine & Family Care Segment Additions to long-term debt Proceeds from Issuance of Long-Term Debt Potential Impacts to Estimated Fair Value [Domain] Potential Impacts to Estimated Fair Value [Domain] Potential Impacts to Estimated Fair Value [Domain] Grooming Grooming [Member] Grooming Share-based compensation expense Share-Based Payment Arrangement, Expense NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE Net Income (Loss) Attributable to Parent Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Underlying Asset Class [Domain] Underlying Asset Class [Domain] Preferred stock conversions Stock Issued During Period, Value, Conversion of Convertible Securities Accumulated Other Comprehensive Income/(Loss) Comprehensive Income (Loss) Note [Text Block] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Fabric & Home Care Fabric & Home Care Segment [Member] Fabric & Home Care Segment Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Document Fiscal Year Focus Document Fiscal Year Focus Noncontrolling Interest Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Product Concentration Risk Product Concentration Risk [Member] SHARES IN MILLIONS Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Treasury stock purchases Treasury Stock, Value, Acquired, Cost Method Foreign currency translation gain (loss) Restructuring Reserve, Foreign Currency Translation Gain (Loss) Intangible assets with indefinite lives Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Common Dividends, Common Stock Name Forgone Recovery, Individual Name Underlying Asset Class [Axis] Underlying Asset Class [Axis] Document Period End Date Document Period End Date 0.350% Notes due 2030 0.350% Notes due 2030 [Member] 0.350% Notes due 2030 Finished goods Inventory, Finished Goods, Net of Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Insider Trading Arrangements [Line Items] Compensation and Employee Benefit Plans Compensation and Employee Benefit Plans [Table Text Block] Compensation and Employee Benefit Plans [Table Text Block] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Reductions in short-term debt with original maturities of more than three months Repayments of Short-Term Debt, Maturing in More than Three Months PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Add effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Dividends and dividend equivalents: Payments of Dividends [Abstract] Adjustment to Compensation: Adjustment to Compensation [Axis] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Less: Net earnings attributable to noncontrolling interests Less: Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Foreign currency interest rate contracts Foreign Exchange Contract [Member] Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Basic weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Proceeds from asset sales Proceeds from Sale of Productive Assets TOTAL SHAREHOLDERS’ EQUITY Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] 1.875% Notes due 2038 1.875% Notes due 2038 [Member] 1.875% Notes due 2038 Name Awards Close in Time to MNPI Disclosures, Individual Name Revenue Benchmark Revenue Benchmark [Member] Hair Care Hair Care [Member] Hair Care [Member] Entity Filer Category Entity Filer Category Beginning balance Ending balance Restructuring Reserve Collateral already posted, aggregate fair value Collateral Already Posted, Aggregate Fair Value Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Company Selected Measure Name Company Selected Measure Name EX-101.PRE 10 pg-20241231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 pg-20241231_g1.jpg begin 644 pg-20241231_g1.jpg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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.4
Cover Page
 6 Months Ended
Dec. 31, 2024
shares
Entity Information [Line Items]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Dec. 31, 2024
Document Transition Report false
Entity Registrant Name PROCTER & GAMBLE CO
Entity Incorporation, State or Country Code OH
Entity File Number 1-434
Entity Tax Identification Number 31-0411980
Entity Address, Address Line One One Procter & Gamble Plaza
Entity Address, State or Province Cincinnati
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45202
City Area Code 513
Local Phone Number 983-1100
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 2,344,851,814
Entity Central Index Key 0000080424
Current Fiscal Year End Date --06-30
Document Fiscal Year Focus 2025
Document Fiscal Period Focus Q2
Amendment Flag false
Common Stock  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, without Par Value
Trading Symbol PG
Security Exchange Name NYSE
1.375% Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Notes due 2025
Trading Symbol PG25
Security Exchange Name NYSE
0.110% Notes due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 0.110% Notes due 2026
Trading Symbol PG26D
Security Exchange Name NYSE
3.250% EUR Notes due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 3.250% EUR Notes due 2026
Trading Symbol PG26F
Security Exchange Name NYSE
4.875% EUR Notes due May 2027  
Entity Information [Line Items]  
Title of 12(b) Security 4.875% EUR Notes due May 2027
Trading Symbol PG27A
Security Exchange Name NYSE
1.200% Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 1.200% Notes due 2028
Trading Symbol PG28
Security Exchange Name NYSE
3.150% EUR Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.150% EUR Notes due 2028
Trading Symbol PG28B
Security Exchange Name NYSE
1.250% Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 1.250% Notes due 2029
Trading Symbol PG29B
Security Exchange Name NYSE
1.800% Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 1.800% Notes due 2029
Trading Symbol PG29A
Security Exchange Name NYSE
6.250% GBP Notes due January 2030  
Entity Information [Line Items]  
Title of 12(b) Security 6.250% GBP Notes due January 2030
Trading Symbol PG30
Security Exchange Name NYSE
0.350% Notes due 2030  
Entity Information [Line Items]  
Title of 12(b) Security 0.350% Notes due 2030
Trading Symbol PG30C
Security Exchange Name NYSE
0.230% Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 0.230% Notes due 2031
Trading Symbol PG31A
Security Exchange Name NYSE
3.250% EUR Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 3.250% EUR Notes due 2031
Trading Symbol PG31B
Security Exchange Name NYSE
5.250% GBP Notes due January 2033  
Entity Information [Line Items]  
Title of 12(b) Security 5.250% GBP Notes due January 2033
Trading Symbol PG33
Security Exchange Name NYSE
3.200% EUR Notes due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 3.200% EUR Notes due 2034
Trading Symbol PG34C
Security Exchange Name NYSE
1.875% Notes due 2038  
Entity Information [Line Items]  
Title of 12(b) Security 1.875% Notes due 2038
Trading Symbol PG38
Security Exchange Name NYSE
0.900% Notes due 2041  
Entity Information [Line Items]  
Title of 12(b) Security 0.900% Notes due 2041
Trading Symbol PG41
Security Exchange Name NYSE
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Earnings - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
NET SALES $ 21,882 $ 21,441 $ 43,619 $ 43,312
Cost of products sold 10,418 10,144 20,839 20,645
Selling, general and administrative expense 5,723 5,522 11,242 11,127
Indefinite-lived intangible asset impairment charge 0 1,341 0 1,341
OPERATING INCOME 5,741 4,433 11,538 10,200
Interest expense (240) (248) (478) (472)
Interest income 119 133 254 262
Other non-operating income/(expense), net 224 177 (330) 309
EARNINGS BEFORE INCOME TAXES 5,845 4,496 10,985 10,299
Income taxes 1,187 1,003 2,339 2,250
NET EARNINGS 4,659 3,493 8,646 8,049
Less: Net earnings attributable to noncontrolling interests 29 25 56 60
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 4,630 $ 3,468 $ 8,589 $ 7,988
NET EARNINGS PER COMMON SHARE        
Basic (in dollars per share) [1] $ 1.94 $ 1.44 $ 3.59 $ 3.33
Diluted (in dollars per share) [1] $ 1.88 $ 1.40 $ 3.49 $ 3.23
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]        
NET EARNINGS $ 4,659 $ 3,493 $ 8,646 $ 8,049
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX        
Foreign currency translation (770) 492 256 83
Unrealized gains/(losses) on investment securities 0 (1) 1 (2)
Unrealized gains/(losses) on defined benefit postretirement plans 24 (75) 3 (30)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX (747) 416 260 51
TOTAL COMPREHENSIVE INCOME 3,912 3,909 8,906 8,100
Less: Comprehensive income attributable to noncontrolling interests 26 25 54 58
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,887 $ 3,884 $ 8,852 $ 8,041
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Jun. 30, 2024
CURRENT ASSETS    
Cash and cash equivalents $ 10,230 $ 9,482
Accounts receivable 6,234 6,118
INVENTORIES    
Materials and supplies 1,949 1,617
Work in process 879 929
Finished goods 4,192 4,470
Total inventories 7,020 7,016
Prepaid expenses and other current assets 2,158 2,095
TOTAL CURRENT ASSETS 25,642 24,709
PROPERTY, PLANT AND EQUIPMENT, NET 22,074 22,152
GOODWILL 39,898 40,303
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET 21,833 22,047
OTHER NONCURRENT ASSETS 13,192 13,158
TOTAL ASSETS 122,639 122,370
CURRENT LIABILITIES    
Accounts payable 14,495 15,364
Accrued and other liabilities 9,879 11,073
Debt due within one year 9,424 7,191
TOTAL CURRENT LIABILITIES 33,797 33,627
LONG-TERM DEBT 25,263 25,269
DEFERRED INCOME TAXES 6,725 6,516
OTHER NONCURRENT LIABILITIES 5,411 6,398
TOTAL LIABILITIES 71,195 71,811
SHAREHOLDERS’ EQUITY    
Preferred stock 788 798
Common stock 4,009 4,009
Additional paid-in capital 68,283 67,684
Reserve for ESOP debt retirement (707) (737)
Accumulated other comprehensive loss (11,637) (11,900)
Treasury stock (137,112) (133,379)
Retained earnings 127,544 123,811
Noncontrolling interest 275 272
TOTAL SHAREHOLDERS’ EQUITY 51,443 50,559
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 122,639 $ 122,370
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Balance Sheets (Parenthetical) - shares
shares in Millions
Dec. 31, 2024
Jun. 30, 2024
Statement of Financial Position [Abstract]    
Common stock, issued (in shares) 4,009.2 4,009.2
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Preferred Stock
Additional Paid-In Capital
Reserve for ESOP Debt Retirement
Accumulated Other Comprehensive Income/(Loss)
Treasury Stock
Retained Earnings
Noncontrolling Interest
Beginning balance (in shares) at Jun. 30, 2023   2,362,120              
Beginning balance at Jun. 30, 2023 $ 47,065 $ 4,009 $ 819 $ 66,556 $ (821) $ (12,220) $ (129,736) $ 118,170 $ 288
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 8,049             7,988 60
Other comprehensive income/(loss) 51         53     (2)
Dividends and dividend equivalents:                  
Common (4,450)             (4,450)  
Preferred (140)             (140)  
Treasury stock purchases (in shares)   (16,722)              
Treasury stock purchases (2,516)           (2,516)    
Employee stock plans (in shares)   6,351              
Employee stock plans 734     378     356    
Preferred stock conversions (in shares)   1,273              
Preferred stock conversions 0   (10) 1     9    
ESOP debt impacts 87       39     48  
Noncontrolling interest, net (52)               (52)
Ending balance (in shares) at Dec. 31, 2023   2,353,021              
Ending balance at Dec. 31, 2023 48,829 $ 4,009 809 66,935 (782) (12,167) (131,887) 121,617 294
Beginning balance (in shares) at Sep. 30, 2023   2,356,886              
Beginning balance at Sep. 30, 2023 48,014 $ 4,009 812 66,822 (782) (12,583) (131,029) 120,443 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 3,493             3,468 25
Other comprehensive income/(loss) 416         416      
Dividends and dividend equivalents:                  
Common (2,225)             (2,225)  
Preferred (70)             (70)  
Treasury stock purchases (in shares)   (6,879)              
Treasury stock purchases (1,008)           (1,008)    
Employee stock plans (in shares)   2,630              
Employee stock plans 260     113     147    
Preferred stock conversions (in shares)   385              
Preferred stock conversions 0   (3)       3    
Noncontrolling interest, net (52)               (52)
Ending balance (in shares) at Dec. 31, 2023   2,353,021              
Ending balance at Dec. 31, 2023 48,829 $ 4,009 809 66,935 (782) (12,167) (131,887) 121,617 294
Beginning balance (in shares) at Jun. 30, 2024   2,357,051              
Beginning balance at Jun. 30, 2024 50,559 $ 4,009 798 67,684 (737) (11,900) (133,379) 123,811 272
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 8,646             8,589 56
Other comprehensive income/(loss) 260         263     (3)
Dividends and dividend equivalents:                  
Common (4,754)             (4,754)  
Preferred (144)             (144)  
Treasury stock purchases (in shares)   (26,269)              
Treasury stock purchases (4,462)           (4,462)    
Employee stock plans (in shares)   12,827              
Employee stock plans 1,318     598     720    
Preferred stock conversions (in shares)   1,243              
Preferred stock conversions 0   (10) 1     9    
ESOP debt impacts 71       30     41  
Noncontrolling interest, net (51)               (51)
Ending balance (in shares) at Dec. 31, 2024   2,344,852              
Ending balance at Dec. 31, 2024 51,443 $ 4,009 788 68,283 (707) (11,637) (137,112) 127,544 275
Beginning balance (in shares) at Sep. 30, 2024   2,355,042              
Beginning balance at Sep. 30, 2024 52,141 $ 4,009 791 68,102 (707) (10,893) (134,823) 125,361 300
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 4,659             4,630 29
Other comprehensive income/(loss) (747)         (744)     (3)
Dividends and dividend equivalents:                  
Common (2,375)             (2,375)  
Preferred (72)             (72)  
Treasury stock purchases (in shares)   (14,716)              
Treasury stock purchases (2,520)           (2,520)    
Employee stock plans (in shares)   4,057              
Employee stock plans 408     181     228    
Preferred stock conversions (in shares)   469              
Preferred stock conversions 0   (3)       3    
Noncontrolling interest, net (51)               (51)
Ending balance (in shares) at Dec. 31, 2024   2,344,852              
Ending balance at Dec. 31, 2024 $ 51,443 $ 4,009 $ 788 $ 68,283 $ (707) $ (11,637) $ (137,112) $ 127,544 $ 275
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]        
Dividends and dividend equivalents, common stock (in dollars per share) $ 1.0065 $ 0.9407 $ 2.013 $ 1.8814
Dividends and dividend equivalents, preferred stock (in dollars per share) $ 1.0065 $ 0.9407 $ 2.013 $ 1.8814
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statement of Cash Flows [Abstract]    
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD $ 9,482 $ 8,246
OPERATING ACTIVITIES    
Net earnings 8,646 8,049
Depreciation and amortization 1,434 1,423
Share-based compensation expense 241 275
Deferred income taxes 221 (154)
Loss/(gain) on sale of assets 787 (3)
Indefinite-lived intangible asset impairment charge 0 1,341
Change in accounts receivable (262) (839)
Change in inventories (170) (32)
Change in accounts payable and accrued and other liabilities (1,157) 302
Change in other operating assets and liabilities (748) (704)
Other 135 346
TOTAL OPERATING ACTIVITIES 9,127 10,004
INVESTING ACTIVITIES    
Capital expenditures (1,918) (1,742)
Proceeds from asset sales 47 8
Acquisitions, net of cash acquired (6) 0
Other investing activity (153) (489)
TOTAL INVESTING ACTIVITIES (2,029) (2,224)
FINANCING ACTIVITIES    
Dividends to shareholders (4,886) (4,578)
Additions to short-term debt with original maturities of more than three months 5,905 2,798
Reductions in short-term debt with original maturities of more than three months (571) (5,862)
Net additions/(reductions) to other short-term debt (2,705) 3,740
Additions to long-term debt 995 254
Reductions in long-term debt (1,478) (2,335)
Treasury stock purchases (4,449) (2,503)
Impact of stock options and other 985 397
TOTAL FINANCING ACTIVITIES (6,205) (8,087)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH (144) (49)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 748 (356)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD $ 10,230 $ 7,890
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.4
Basis of Presentation
 6 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of PresentationThe accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.24.4
New Accounting Pronouncements and Policies
 6 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
New Accounting Pronouncements and Policies New Accounting Pronouncements and Policies
In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements.
In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures.
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information
 6 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
•Beauty: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);
•Grooming: Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming);
•Health Care: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
•Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and
•Baby, Feminine & Family Care: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).
Operating segments as a percentage of consolidated net sales are as follows:
% of Net sales by operating segment (1)
Three Months Ended December 31Six Months Ended December 31
2024202320242023
Fabric Care23 %23 %23 %23 %
Home Care12 %12 %12 %12 %
Baby Care9 %9 %9 %10 %
Family Care9 %9 %9 %8 %
Hair Care9 %9 %9 %9 %
Grooming8 %8 %8 %8 %
Oral Care9 %9 %8 %8 %
Personal Health Care6 %6 %7 %7 %
Feminine Care6 %6 %6 %6 %
Personal Care (2)
5 %5 %6 %5 %
Skin Care (2)
4 %4 %3 %4 %
Total100 %100 %100 %100 %
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
(2)Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.
The following is a summary of reportable segment results:
Three Months Ended December 31Six Months Ended December 31
Net SalesEarnings/(Loss) Before Income TaxesNet Earnings/(Loss)Net SalesEarnings/(Loss) Before Income TaxesNet Earnings/(Loss)
Beauty2024$3,848 $996 $780 $7,741 $2,063 $1,620 
20233,849 1,112 868 7,946 2,361 1,839 
Grooming20241,752 568 459 3,475 1,090 885 
20231,734 538 440 3,458 1,071 862 
Health Care20243,249 974 758 6,397 1,928 1,499 
20233,172 932 719 6,245 1,821 1,408 
Fabric & Home Care20247,575 1,989 1,567 15,285 4,066 3,188 
20237,415 2,018 1,577 15,061 4,049 3,146 
Baby, Feminine & Family Care20245,298 1,464 1,119 10,400 2,847 2,185 
20235,146 1,437 1,102 10,332 2,845 2,177 
Corporate2024159 (146)(24)322 (1,009)(731)
2023126 (1,541)(1,214)270 (1,849)(1,383)
Total Company2024$21,882 $5,845 $4,659 $43,619 $10,985 $8,646 
202321,441 4,496 3,493 43,312 10,299 8,049 
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.24.4
Goodwill and Intangible Assets
 6 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill is allocated by reportable segment as follows:
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
Goodwill at June 30, 2024$13,723 $12,633 $7,638 $1,810 $4,499 $40,303 
Acquisitions and divestitures— — — — — — 
Translation and other(139)(104)(107)(11)(44)(405)
Goodwill at December 31, 2024$13,584 $12,529 $7,531 $1,799 $4,456 $39,898 
Goodwill decreased from June 30, 2024, primarily due to currency translation.
Identifiable intangible assets at December 31, 2024, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$8,965 $(6,684)
Intangible assets with indefinite lives19,552 — 
Total identifiable intangible assets$28,517 $(6,684)
Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended December 31, 2024 and 2023, was $80 and $84, respectively. For the six months ended December 31, 2024 and 2023, amortization expense was $163 and $171, respectively.
Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.
As previously disclosed, the carrying value of the Gillette indefinite-lived intangible asset was impaired during the fiscal year ended June 30, 2024. The impairment charge arose due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of a new restructuring program focused primarily in certain Enterprise Markets, including Argentina and Nigeria. Following the impairment charge, the carrying value of the Gillette indefinite-lived intangible asset was equivalent to the estimated fair value as of December 31, 2023.
Based on our impairment testing performed during the three months ended December 31, 2024, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of December 31, 2024, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion.
Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger a further impairment charge.
The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rates), discount rate and royalty rates.
Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rates represent the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rates utilized in our fair value estimates are consistent with the brand operating plans and approximate expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment.
The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.
The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.
We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2024, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps Discount Rate-25 bps Growth Rates-50 bps Royalty Rate
Gillette indefinite-lived intangible asset(5)%(5)%(4)%
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.4
Earnings Per Share
 6 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.
Net earnings per common share were calculated as follows:
CONSOLIDATED AMOUNTSThree Months Ended December 31Six Months Ended December 31
2024202320242023
Net earnings$4,659 $3,493 $8,646 $8,049 
Less: Net earnings attributable to noncontrolling interests29 25 56 60 
Net earnings attributable to P&G4,630 3,468 8,589 7,988 
Less: Preferred dividends72 70 144 140 
Net earnings attributable to P&G available to common shareholders (Basic)$4,558 $3,398 $8,445 $7,849 
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,351.9 2,358.0 2,354.1 2,359.0 
Add effect of dilutive securities:
Convertible preferred shares (1)
71.3 73.9 71.6 74.3 
Stock options and other unvested equity awards (2)
34.9 36.4 36.4 38.5 
Diluted weighted average common shares outstanding2,458.1 2,468.4 2,462.1 2,471.8 
NET EARNINGS PER COMMON SHARE
Basic$1.94 $1.44 $3.59 $3.33 
Diluted$1.88 $1.40 $3.49 $3.23 
(1)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
(2)Excludes approximately 8 million and 9 million for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.24.4
Share-Based Compensation and Postretirement Benefits
 6 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Share-Based Compensation and Postretirement Benefits Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:
Three Months Ended December 31Six Months Ended December 31
2024202320242023
Share-based compensation expense$136 $150 $241 $275 
Net periodic benefit cost for pension benefits26 52 63 109 
Net periodic benefit (credit) for other retiree benefits(180)(156)(360)(311)
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.4
Risk Management Activities and Fair Value Measurements
 6 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Risk Management Activities and Fair Value Measurements Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2024.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. Except for the impairment of the Gillette indefinite-lived intangible asset discussed in Note 4, there were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the six months ended December 31, 2024 or during the fiscal year ended June 30, 2024.
Cash equivalents were $8.7 billion and $8.0 billion as of December 31, 2024 and June 30, 2024, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.
The fair value of long-term debt was $27.3 billion and $27.7 billion as of December 31, 2024 and June 30, 2024, respectively. This includes the current portion of long-term debt instruments ($3.3 billion and $3.8 billion as of December 31, 2024 and June 30, 2024, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows:
Notional AmountFair Value AssetFair Value (Liability)
December 31, 2024June 30, 2024December 31, 2024June 30, 2024December 31, 2024June 30, 2024
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$2,914 $2,993 $— $— $(215)$(325)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts$13,054 $10,140 $545 $119 $— $(31)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS$15,968 $13,133 $545 $119 $(215)$(356)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$3,359 $3,192 $1 $1 $(40)$(23)
TOTAL DERIVATIVES AT FAIR VALUE$19,326 $16,325 $546 $120 $(255)$(379)
The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $2.7 billion as of December 31, 2024 and June 30, 2024. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $10.4 billion and $11.9 billion as of December 31, 2024 and June 30, 2024, respectively. The increase in notional balance of the derivative instruments designated as net investment hedges is primarily driven by the Company's decision to leverage favorable interest rate spreads in the foreign currency swap market.
Derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $33 and $307 as of
December 31, 2024 and June 30, 2024, respectively. The Company has not been required to post collateral as a result of these contractual features.
Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss) Recognized in OCI on Derivatives
Three Months Ended December 31Six Months Ended December 31
2024202320242023
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts$857 $(487)$356 $(202)
(1)    For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and $130 for the six months ended December 31, 2024 and 2023, respectively.
(2)    In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $215 and $(159) for the six months ended December 31, 2024 and 2023, respectively.
Amount of Gain/(Loss) Recognized in Earnings
Three Months Ended December 31Six Months Ended December 31
2024202320242023
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$34 $117 $110 $128 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$(174)$128 $(48)$57 
The gains on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&A).
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.24.4
Accumulated Other Comprehensive Income/(Loss)
 6 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Accumulated Other Comprehensive Income/(Loss) Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:
Investment SecuritiesPostretirement Benefit PlansForeign Currency TranslationTotal AOCI
Balance at June 30, 2024, net of tax$10 $613 $(12,522)$(11,900)
Other comprehensive income/(loss), before tax:
    OCI before reclassifications1 38 (362)(323)
    Amounts reclassified to the Consolidated Statement of Earnings— (38)752 714 
Total other comprehensive income/(loss), before tax1 — 390 391 
    Tax effect— 3 (134)(131)
Total other comprehensive income/(loss), net of tax1 3 256 260 
Less: OCI attributable to noncontrolling interests, net of tax— 2 (5)(3)
Balance at December 31, 2024, net of tax$11 $614 $(12,262)$(11,637)
The below provides additional details on amounts reclassified from AOCI into the Consolidated Statement of Earnings:
•Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.
•Foreign currency translation amounts are reclassified from AOCI into Other non-operating income/(expense), net. These amounts relate to accumulated foreign currency translation losses recognized due to the substantial liquidation of operations in Argentina recorded in the period ended September 30, 2024.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.24.4
Commitments and Contingencies
 6 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation
We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we do not anticipate over the next 12-month period any significant audit activity concluding related to uncertain tax positions for which we have existing accrued liabilities.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.4
Supplier Finance Programs
 6 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Supplier Finance Programs Supplier Finance Programs
The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in Accounts payable was approximately $5.6 billion as of December 31, 2024 and June 30, 2024.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.24.4
Restructuring Program
 6 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Program Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.
In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded approximately $0.8 billion after tax of incremental charges, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the program beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024, were approximately $1.2 billion after tax.
For the three months ended December 31, 2024, the Company incurred total before tax charges of $47 including $28 in Costs of products sold, $25 in SG&A and $(5) in Other non-operating income/(expense). For the six months ended December 31, 2024, the Company incurred charges of $933 including $69 in Costs of products sold, $79 in SG&A and $785 in Other non-operating income/(expense).
The following table presents restructuring activity for the six months ended December 31, 2024:
Separation CostsAsset-Related CostsOther CostsTotal
RESERVE JUNE 30, 2024$133 $— $32 $166 
Costs incurred for the three months ended September 30, 202416 30 839 886 
Costs incurred for the three months ended December 31, 202425 9 14 47 
Costs incurred for the six months ended December 31, 202441 39 853 933 
Costs paid/settled for the six months ended December 31, 2024(58)(39)(823)(921)
RESERVE DECEMBER 31, 2024$115 $— $62 $178 
Separation Costs
Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include accumulated foreign currency translation losses, asset removal and termination of contracts.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.4
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure        
Net Income (Loss) Attributable to Parent $ 4,630 $ 3,468 $ 8,589 $ 7,988
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.4
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.24.4
New Accounting Pronouncements and Policies (Policies)
 6 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
New Accounting Pronouncements and Policies New Accounting Pronouncements and Policies
In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements.
In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures.
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information (Tables)
 6 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Operating segments as a percentage of consolidated net sales are as follows:
% of Net sales by operating segment (1)
Three Months Ended December 31Six Months Ended December 31
2024202320242023
Fabric Care23 %23 %23 %23 %
Home Care12 %12 %12 %12 %
Baby Care9 %9 %9 %10 %
Family Care9 %9 %9 %8 %
Hair Care9 %9 %9 %9 %
Grooming8 %8 %8 %8 %
Oral Care9 %9 %8 %8 %
Personal Health Care6 %6 %7 %7 %
Feminine Care6 %6 %6 %6 %
Personal Care (2)
5 %5 %6 %5 %
Skin Care (2)
4 %4 %3 %4 %
Total100 %100 %100 %100 %
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
(2)Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.
Reconciliation of Revenue from Segments to Consolidated
The following is a summary of reportable segment results:
Three Months Ended December 31Six Months Ended December 31
Net SalesEarnings/(Loss) Before Income TaxesNet Earnings/(Loss)Net SalesEarnings/(Loss) Before Income TaxesNet Earnings/(Loss)
Beauty2024$3,848 $996 $780 $7,741 $2,063 $1,620 
20233,849 1,112 868 7,946 2,361 1,839 
Grooming20241,752 568 459 3,475 1,090 885 
20231,734 538 440 3,458 1,071 862 
Health Care20243,249 974 758 6,397 1,928 1,499 
20233,172 932 719 6,245 1,821 1,408 
Fabric & Home Care20247,575 1,989 1,567 15,285 4,066 3,188 
20237,415 2,018 1,577 15,061 4,049 3,146 
Baby, Feminine & Family Care20245,298 1,464 1,119 10,400 2,847 2,185 
20235,146 1,437 1,102 10,332 2,845 2,177 
Corporate2024159 (146)(24)322 (1,009)(731)
2023126 (1,541)(1,214)270 (1,849)(1,383)
Total Company2024$21,882 $5,845 $4,659 $43,619 $10,985 $8,646 
202321,441 4,496 3,493 43,312 10,299 8,049 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.4
Goodwill and Intangible Assets (Tables)
 6 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Goodwill is allocated by reportable segment as follows:
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
Goodwill at June 30, 2024$13,723 $12,633 $7,638 $1,810 $4,499 $40,303 
Acquisitions and divestitures— — — — — — 
Translation and other(139)(104)(107)(11)(44)(405)
Goodwill at December 31, 2024$13,584 $12,529 $7,531 $1,799 $4,456 $39,898 
Schedule of Finite-Lived Intangible Assets
Identifiable intangible assets at December 31, 2024, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$8,965 $(6,684)
Intangible assets with indefinite lives19,552 — 
Total identifiable intangible assets$28,517 $(6,684)
Schedule of Indefinite-Lived Intangible Assets
Identifiable intangible assets at December 31, 2024, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$8,965 $(6,684)
Intangible assets with indefinite lives19,552 — 
Total identifiable intangible assets$28,517 $(6,684)
Schedule of Potential Impacts to Estimated Fair Values The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps Discount Rate-25 bps Growth Rates-50 bps Royalty Rate
Gillette indefinite-lived intangible asset(5)%(5)%(4)%
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.4
Earnings Per Share (Tables)
 6 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
Net earnings per common share were calculated as follows:
CONSOLIDATED AMOUNTSThree Months Ended December 31Six Months Ended December 31
2024202320242023
Net earnings$4,659 $3,493 $8,646 $8,049 
Less: Net earnings attributable to noncontrolling interests29 25 56 60 
Net earnings attributable to P&G4,630 3,468 8,589 7,988 
Less: Preferred dividends72 70 144 140 
Net earnings attributable to P&G available to common shareholders (Basic)$4,558 $3,398 $8,445 $7,849 
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,351.9 2,358.0 2,354.1 2,359.0 
Add effect of dilutive securities:
Convertible preferred shares (1)
71.3 73.9 71.6 74.3 
Stock options and other unvested equity awards (2)
34.9 36.4 36.4 38.5 
Diluted weighted average common shares outstanding2,458.1 2,468.4 2,462.1 2,471.8 
NET EARNINGS PER COMMON SHARE
Basic$1.94 $1.44 $3.59 $3.33 
Diluted$1.88 $1.40 $3.49 $3.23 
(1)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
(2)Excludes approximately 8 million and 9 million for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.4
Share-Based Compensation and Postretirement Benefits (Tables)
 6 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Compensation and Employee Benefit Plans
The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:
Three Months Ended December 31Six Months Ended December 31
2024202320242023
Share-based compensation expense$136 $150 $241 $275 
Net periodic benefit cost for pension benefits26 52 63 109 
Net periodic benefit (credit) for other retiree benefits(180)(156)(360)(311)
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.4
Risk Management Activities and Fair Value Measurements (Tables)
 6 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows:
Notional AmountFair Value AssetFair Value (Liability)
December 31, 2024June 30, 2024December 31, 2024June 30, 2024December 31, 2024June 30, 2024
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$2,914 $2,993 $— $— $(215)$(325)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts$13,054 $10,140 $545 $119 $— $(31)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS$15,968 $13,133 $545 $119 $(215)$(356)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$3,359 $3,192 $1 $1 $(40)$(23)
TOTAL DERIVATIVES AT FAIR VALUE$19,326 $16,325 $546 $120 $(255)$(379)
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)
Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss) Recognized in OCI on Derivatives
Three Months Ended December 31Six Months Ended December 31
2024202320242023
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts$857 $(487)$356 $(202)
(1)    For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and $130 for the six months ended December 31, 2024 and 2023, respectively.
(2)    In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $215 and $(159) for the six months ended December 31, 2024 and 2023, respectively.
Derivative Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Earnings
Three Months Ended December 31Six Months Ended December 31
2024202320242023
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$34 $117 $110 $128 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$(174)$128 $(48)$57 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.4
Accumulated Other Comprehensive Income/(Loss) (Tables)
 6 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:
Investment SecuritiesPostretirement Benefit PlansForeign Currency TranslationTotal AOCI
Balance at June 30, 2024, net of tax$10 $613 $(12,522)$(11,900)
Other comprehensive income/(loss), before tax:
    OCI before reclassifications1 38 (362)(323)
    Amounts reclassified to the Consolidated Statement of Earnings— (38)752 714 
Total other comprehensive income/(loss), before tax1 — 390 391 
    Tax effect— 3 (134)(131)
Total other comprehensive income/(loss), net of tax1 3 256 260 
Less: OCI attributable to noncontrolling interests, net of tax— 2 (5)(3)
Balance at December 31, 2024, net of tax$11 $614 $(12,262)$(11,637)
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.4
Restructuring Program (Tables)
 6 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve by Type of Cost
The following table presents restructuring activity for the six months ended December 31, 2024:
Separation CostsAsset-Related CostsOther CostsTotal
RESERVE JUNE 30, 2024$133 $— $32 $166 
Costs incurred for the three months ended September 30, 202416 30 839 886 
Costs incurred for the three months ended December 31, 202425 9 14 47 
Costs incurred for the six months ended December 31, 202441 39 853 933 
Costs paid/settled for the six months ended December 31, 2024(58)(39)(823)(921)
RESERVE DECEMBER 31, 2024$115 $— $62 $178 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information - Additional Information (Details)
 6 Months Ended
Dec. 31, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 5
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information - Percent Of Sales By Business Unit (Details) - Revenue Benchmark - Product Concentration Risk - Operating Segments
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 100.00% 100.00% 100.00% 100.00%
Fabric & Home Care | Fabric Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 23.00% 23.00% 23.00% 23.00%
Fabric & Home Care | Home Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 12.00% 12.00% 12.00% 12.00%
Baby, Feminine & Family Care | Baby Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 9.00% 10.00%
Baby, Feminine & Family Care | Family Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 9.00% 8.00%
Baby, Feminine & Family Care | Feminine Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 6.00% 6.00% 6.00% 6.00%
Beauty | Hair Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 9.00% 9.00%
Beauty | Personal Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 5.00% 5.00% 6.00% 5.00%
Beauty | Skin Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 4.00% 4.00% 3.00% 4.00%
Grooming | Grooming        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 8.00% 8.00% 8.00% 8.00%
Health Care | Oral Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 8.00% 8.00%
Health Care | Personal Health Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 6.00% 6.00% 7.00% 7.00%
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information - Global Segment Results (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]        
Net Sales $ 21,882 $ 21,441 $ 43,619 $ 43,312
Earnings/(Loss) Before Income Taxes 5,845 4,496 10,985 10,299
Net Earnings/(Loss) 4,659 3,493 8,646 8,049
Corporate        
Segment Reporting Information [Line Items]        
Net Sales 159 126 322 270
Earnings/(Loss) Before Income Taxes (146) (1,541) (1,009) (1,849)
Net Earnings/(Loss) (24) (1,214) (731) (1,383)
Beauty | Operating Segments        
Segment Reporting Information [Line Items]        
Net Sales 3,848 3,849 7,741 7,946
Earnings/(Loss) Before Income Taxes 996 1,112 2,063 2,361
Net Earnings/(Loss) 780 868 1,620 1,839
Grooming | Operating Segments        
Segment Reporting Information [Line Items]        
Net Sales 1,752 1,734 3,475 3,458
Earnings/(Loss) Before Income Taxes 568 538 1,090 1,071
Net Earnings/(Loss) 459 440 885 862
Health Care | Operating Segments        
Segment Reporting Information [Line Items]        
Net Sales 3,249 3,172 6,397 6,245
Earnings/(Loss) Before Income Taxes 974 932 1,928 1,821
Net Earnings/(Loss) 758 719 1,499 1,408
Fabric & Home Care | Operating Segments        
Segment Reporting Information [Line Items]        
Net Sales 7,575 7,415 15,285 15,061
Earnings/(Loss) Before Income Taxes 1,989 2,018 4,066 4,049
Net Earnings/(Loss) 1,567 1,577 3,188 3,146
Baby, Feminine & Family Care | Operating Segments        
Segment Reporting Information [Line Items]        
Net Sales 5,298 5,146 10,400 10,332
Earnings/(Loss) Before Income Taxes 1,464 1,437 2,847 2,845
Net Earnings/(Loss) $ 1,119 $ 1,102 $ 2,185 $ 2,177
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.4
Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details)
$ in Millions
 6 Months Ended
Dec. 31, 2024
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 40,303
Acquisitions and divestitures 0
Translation and other (405)
Ending balance 39,898
Beauty  
Goodwill [Roll Forward]  
Beginning balance 13,723
Acquisitions and divestitures 0
Translation and other (139)
Ending balance 13,584
Grooming  
Goodwill [Roll Forward]  
Beginning balance 12,633
Acquisitions and divestitures 0
Translation and other (104)
Ending balance 12,529
Health Care  
Goodwill [Roll Forward]  
Beginning balance 7,638
Acquisitions and divestitures 0
Translation and other (107)
Ending balance 7,531
Fabric & Home Care  
Goodwill [Roll Forward]  
Beginning balance 1,810
Acquisitions and divestitures 0
Translation and other (11)
Ending balance 1,799
Baby, Feminine & Family Care  
Goodwill [Roll Forward]  
Beginning balance 4,499
Acquisitions and divestitures 0
Translation and other (44)
Ending balance $ 4,456
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.24.4
Goodwill and Intangible Assets - Intangible Assets (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Intangible assets with determinable lives  
Gross Carrying Amount $ 8,965
Accumulated Amortization (6,684)
Intangible assets with indefinite lives  
Gross Carrying Amount 19,552
Gross Carrying Amount $ 28,517
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.4
Goodwill and Intangible Assets - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]        
Intangible asset amortization $ 80 $ 84 $ 163 $ 171
Indefinite-Lived Intangible Assets [Line Items]        
Indefinite-lived intangible asset $ 19,552   $ 19,552  
Percentage of fair value in excess of carrying value 10.00%   10.00%  
Gillette        
Indefinite-Lived Intangible Assets [Line Items]        
Indefinite-lived intangible asset $ 12,800   $ 12,800  
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.4
Goodwill and Intangible Assets - Fair Value Impacts (Details) - Intangible Assets with Indefinite Lives - Gillette
Dec. 31, 2024
+25 bps Discount Rate  
Indefinite-Lived Intangible Assets [Line Items]  
Change in estimated fair value (in percent) (0.05)
-25 bps Growth Rates  
Indefinite-Lived Intangible Assets [Line Items]  
Change in estimated fair value (in percent) (0.05)
-50 bps Royalty Rate  
Indefinite-Lived Intangible Assets [Line Items]  
Change in estimated fair value (in percent) (0.04)
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.4
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
CONSOLIDATED AMOUNTS        
Net earnings $ 4,659 $ 3,493 $ 8,646 $ 8,049
Less: Net earnings attributable to noncontrolling interests 29 25 56 60
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE 4,630 3,468 8,589 7,988
Less: Preferred dividends 72 70 144 140
Net earnings attributable to P&G available to common shareholders (Basic) $ 4,558 $ 3,398 $ 8,445 $ 7,849
SHARES IN MILLIONS        
Basic weighted average common shares outstanding (in shares) 2,351.9 2,358.0 2,354.1 2,359.0
Add effect of dilutive securities:        
Convertible preferred shares (in shares) 71.3 73.9 71.6 74.3
Stock options and other unvested equity awards (in shares) 34.9 36.4 36.4 38.5
Diluted weighted average common shares outstanding (in shares) 2,458.1 2,468.4 2,462.1 2,471.8
NET EARNINGS PER COMMON SHARE        
Basic (in dollars per share) [1] $ 1.94 $ 1.44 $ 3.59 $ 3.33
Diluted (in dollars per share) [1] $ 1.88 $ 1.40 $ 3.49 $ 3.23
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 8.0 9.0 4.0 5.0
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.4
Share-Based Compensation and Postretirement Benefits (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Retirement Benefits [Abstract]        
Share-based compensation expense $ 136 $ 150 $ 241 $ 275
Pension Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Net periodic benefit cost (credit) 26 52 63 109
Other Retiree Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Net periodic benefit cost (credit) $ (180) $ (156) $ (360) $ (311)
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.24.4
Risk Management Activities and Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Cash equivalents $ 8,700 $ 8,000
Fair value of long-term debt 27,300 27,700
Current portion of long-term debt instruments $ 3,300 $ 3,800
Derivative Asset, Statement of Financial Position [Extensible Enumeration] OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Accrued and other liabilities, OTHER NONCURRENT LIABILITIES Accrued and other liabilities, OTHER NONCURRENT LIABILITIES
Collateral already posted, aggregate fair value $ 33 $ 307
Fair Value Hedging | Underlying, Other    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Carrying amount of the underlying debt obligation 2,700 2,700
Net Investment Hedging | Underlying, Other    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Carrying amount of the underlying debt obligation $ 10,400 $ 11,900
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.24.4
Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount $ 19,326 $ 16,325
Fair Value Asset 546 120
Fair Value (Liability) (255) (379)
Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 15,968 13,133
Fair Value Asset 545 119
Fair Value (Liability) (215) (356)
Interest rate contracts | Fair Value Hedging    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 2,914 2,993
Fair Value Asset 0 0
Fair Value (Liability) (215) (325)
Foreign currency interest rate contracts | Not Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 3,359 3,192
Fair Value Asset 1 1
Fair Value (Liability) (40) (23)
Foreign currency interest rate contracts | Net Investment Hedging    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 13,054 10,140
Fair Value Asset 545 119
Fair Value (Liability) $ 0 $ (31)
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.24.4
Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of gain (loss) excluded from effectiveness testing, which was recognized in earnings $ 57 $ 62 $ 107 $ 130
Gain/(loss) recognized in AOCI 825 (504) 215 (159)
Foreign currency interest rate contracts        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Gain/(Loss) Recognized in OCI on Derivatives $ 857 $ (487) $ 356 $ (202)
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.24.4
Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Interest rate contracts | Fair Value Hedging        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings $ 34 $ 117 $ 110 $ 128
Foreign currency interest rate contracts | Not Designated as Hedging Instrument        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings $ (174) $ 128 $ (48) $ 57
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.24.4
Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance $ 52,141 $ 48,014 $ 50,559 $ 47,065
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     (323)  
Amounts reclassified to the Consolidated Statement of Earnings     714  
Total other comprehensive income/(loss), before tax     391  
Tax effect     (131)  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX (747) 416 260 51
Less: OCI attributable to noncontrolling interests, net of tax     (3)  
Ending balance 51,443 48,829 51,443 48,829
Accumulated Other Comprehensive Income/(Loss)        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance (10,893) (12,583) (11,900) (12,220)
Other comprehensive income/(loss), before tax:        
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX (744) 416 263 53
Ending balance (11,637) $ (12,167) (11,637) $ (12,167)
Investment Securities        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     10  
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     1  
Amounts reclassified to the Consolidated Statement of Earnings     0  
Total other comprehensive income/(loss), before tax     1  
Tax effect     0  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX     1  
Less: OCI attributable to noncontrolling interests, net of tax     0  
Ending balance 11   11  
Postretirement Benefit Plans        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     613  
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     38  
Amounts reclassified to the Consolidated Statement of Earnings     (38)  
Total other comprehensive income/(loss), before tax     0  
Tax effect     3  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX     3  
Less: OCI attributable to noncontrolling interests, net of tax     2  
Ending balance 614   614  
Foreign Currency Translation        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     (12,522)  
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     (362)  
Amounts reclassified to the Consolidated Statement of Earnings     752  
Total other comprehensive income/(loss), before tax     390  
Tax effect     (134)  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX     256  
Less: OCI attributable to noncontrolling interests, net of tax     (5)  
Ending balance $ (12,262)   $ (12,262)  
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.24.4
Commitments and Contingencies (Details)
 6 Months Ended
Dec. 31, 2024
country
audit
taxable_jurisdiction
Loss Contingencies [Line Items]  
Number of countries with on the ground operations | country 70
Number of taxable jurisdictions | taxable_jurisdiction 150
Minimum  
Loss Contingencies [Line Items]  
Number of audits underway 30
Maximum  
Loss Contingencies [Line Items]  
Number of audits underway 40
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.24.4
Supplier Finance Programs (Details) - USD ($)
$ in Billions
Dec. 31, 2024
Jun. 30, 2024
Supplier Finance Program [Line Items]    
Amount due to suppliers participating in SCF $ 5.6 $ 5.6
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable
Minimum    
Supplier Finance Program [Line Items]    
Payment terms for suppliers (in days) 60 days  
Maximum    
Supplier Finance Program [Line Items]    
Payment terms for suppliers (in days) 180 days  
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.24.4
Restructuring Program - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2024
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]        
Foreign currency translation gain (loss)   $ (800)    
Incremental restructuring charges incurred       $ 1,200
Restructuring charges $ 47 $ 886 $ 933  
Selling, General and Administrative Expenses        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 25   79  
Cost of Sales        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 28   69  
Other Non-operating Income (Expense)        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (5)   785  
Minimum        
Restructuring Cost and Reserve [Line Items]        
Historical restructuring costs, before tax 250   250  
Maximum        
Restructuring Cost and Reserve [Line Items]        
Historical restructuring costs, before tax $ 500   $ 500  
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.24.4
Restructuring Program - Restructuring Activity (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2024
Restructuring Reserve [Roll Forward]      
Beginning balance   $ 166 $ 166
Cost incurred $ 47 886 933
Cost paid/settled     (921)
Ending balance 178   178
Separation Costs      
Restructuring Reserve [Roll Forward]      
Beginning balance   133 133
Cost incurred 25 16 41
Cost paid/settled     (58)
Ending balance 115   115
Asset-Related Costs      
Restructuring Reserve [Roll Forward]      
Beginning balance   0 0
Cost incurred 9 30 39
Cost paid/settled     (39)
Ending balance 0   0
Other Costs      
Restructuring Reserve [Roll Forward]      
Beginning balance   32 32
Cost incurred 14 $ 839 853
Cost paid/settled     (823)
Ending balance $ 62   $ 62
EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

W??\Z.R[D(CGF"U);5RTZMV1UY413L&>&H MRX_'^QZ"H1=U!WMW1^K7;^K7?W/]%@W*_U+#X_;_K^'/UW#0U'#PYAK>26,! M$)(%]<&87!H)GZA592Y)<\85?&&BQ(.U/.[G,46H6OK2CFE0*/E$\6J/ J4/ M@*Q:F@?4S@ ;EROK\LFZ!%Y#4EB5C* Q""([,''=+B3EBTS%-#9JFSQG**$O MK*NU(A7O1_D$]_*RI$$R)1JT;9E=;Z7^S).2TK&FI%(5K14-4I&AR#]J2,DM M?9.V3N,<9@5%^^Q"@CM4L?V@7:5472=_*,'PBT5:5#."B^#>*K?KTYL*S[W# MT[98Z/"^]NDD;ZC5HS'X@GEMX>[EOWD%I_1U^+![$H4_'&)5Y\7\EZ%:NRE7 M@\-6C8+-:3-(SZKY<2]>3>&?F5IS^A0*7)&J?SZ@1JZJR;;:&%FX:7(I#87,(,2;@[VD 8R+4?.OT@[ 4TL2V?)$/RWW6ZK4J)++5" M>=;V/:_;SADOG,&E79O)P:6H=,8+G$E059XS^7R-F=A=.1UGOS#GZXTV"^W! M94,.Q?7H>&W#']PW*FC,1A/ED(\FLDX MO7(\8Q!FF&B#P(AL\0:SS "1&=\;3.>@T@@>C_?HGZWOY,N2*;P1V9\\U9LK M)W8@Q16K,CT7NZ_8^!,9O$1DROYA5_-&G@-)I;3(&V&R(.=%3=E3$X^B#!15@6F4(8@4O#6_!-5,\ 5:D M<,NS2O\8\-J!]U5,J>IQ#UT2="+RG&I%V=#LD'X)RY(J8P0/3,%*9%3&Z@)N M[J>+^[OQ[?!A= O#R?VWZ<,"'C82\20'@$X0\R4A!QU8\*>W-\T)FU]P-#HQ M[P.$K6[4)QJTPGY -&YUPZZE7MB'.U1DUXD(TUKR9:5-/H,64(@B(?V2G*!] MX(4F#Y56X/?!CR#J0M=['V'VD>7EIR_&E, SAG1C4A_%?>BU^G'<&#&CSH)2 MDH>!YTPI.\GE; MX]E^\?AD-B)+42HXLREP;D,31;$-3="/ M;4C","+::\44FL77X7RT@/$4)N.[NS$=79,\.]NTS-%N45(//M&B@)JXTI1@ M)EA^*X@Z;M_2V/4L#=V.I7V:#],4<+6B9FOR-3492>T6%":5Y)JCR1E1D!K- MC4?E(42-KK/..?0Z;@"]@+30J N]D*8++9)'$*7IX.0/#4>TBD3CJ%^/2?S8IB.'F T MG$_'TR\+F(WF5!.3R?VTCG83X ] ,0LM"0T)W#J#W2 XF&0VX[CF\>QF6/-0 M!9BH# L09.S67'$4VA>12U@!2Z32K"@XG)@K23)%Q3*88RDD'4@!Y@J#CO?K M[\0G@2((*ZZHMN&9TA#0EN-O58$0>'6W=6TH1T])5J6DA)6E%$^5WK^&.MUPJLJ"USSMGSRV[')[@1R_P%762 M_X=. 7R1 NHDQ8Y38(D)JQ1:G?B$,N'*I"Y/;%.F59KNY7;4'M?T+J*>0CMT M)K3-Y4$)/7D>J>BW+*M(1C:[3<48659HOB\;][7KHWUTR^G@N#>M7PK_L]5MKPN2:D\T9KDC4&ULA57;;M- $/V5D4&HD:"^)6X) MB:6F+8*'HJ@I\(!X6-OC>%5[U^QNFO3OF5TG;BJ2\#*>OM0E8XHZ;VHR!(_(9QX:43 MMS=7Z42N3,T%SA7H5=,P]3S#6JZG7NCM-N[YLC)VPT\G+5OB LWW=JYHY?UWM/!>I))^6@77XNI%UA"6&-N+ *CSQ-> M8UU;(*+Q9XOI]4]:PWU]A_[9^4Z^9$SCM:Q_\L)44^_2@P)+MJK-O5Q_P:T_ M(XN7RUH[">ON;A)YD*^TD[>\BQO&&& MI1,EUZ#L;4*SBG/561,Y+FQ2%D;1*2<[DRXJIO##C/PJX%HVE&O-NG") N92 M&X6&*Z0T&)BAP)(;#6;G$(?O(0JBX0F\N(]'[/#B(WCW!]S]=951'*A^?A]R MN,,;'L:S/376+F&5LDG7J &MFMAD"7(%;6X*Z+,%5&^3PDW M5D='K7U=3-F6(&\H.D:/X:%2Q'N_/("2BTV&BA(,"[XY?FB3;T6\IRW^1^HM MA'%BY2@@&0U#*R]&\(U&88N*RX+G/Y8K++@9.'MI*N+&ULM5A;;^(X%/XK%C,:@81*+H1" MIT5*6Z9EU=(*F.[#:A], M;H3\IA( 39ZRE*NS1J+U^J3345$"&55'8@T&I?78OAZ+JF M*YB!_KJ^EWC7J5!BE@%73' B87G6"-V3\YZ9;R<\,-BHVI@83Q9"?#,WX_BL MX1A"D$*D#0+%RR-<0)H:(*3Q3XG9J$R:A?7Q"_H7ZSOZLJ *+D3Z)XMUBHVUU#Z$QB\2*3*_I)-.==ID"A76F3E8F20,5Y Z463$8XBWUW>0?.6!]^+!N7<0\!*B(^*[;>(Y7O< GE]%Q+=X_EX\ MR1ZIJ14RYDK+O/#81.,:XA7CJWJ0+IF*4F$"0_X*%S@=R^SO75$IC'9W&S6M M=Z+6-(*S!O:6 OD(C>&G#V[/^7S I6[E4O<0^G"&K1SG*1"Q)+O=V\7X,.8\ M <*%Z2R:$IJ)_"5(2U,RCZ9DE+&W9)SRB.$D5HMFKB#&!R0I(XIQXXK:1D44 M51"-(%N K')KT?_(.1#?*9ZT"<6XX_2E2%%=U F9O# *+:-Z_89*P=:#Y@VC M"Y8R_=S:86S+T,^_'TW'#^%\_#":D?&$? G'4_(0WGP=D>O1Y=5X978_O<0[7@'6@B:0:2(0=8PI+D8_$:P_<;G$=^'C]]*'ON=[GK5'37M_8GHSF>,&;^>UH,M]C'Q4/]8RC DD)/'K&7.TCY/IM)S",7*?M=AT< M!-W W+J#;5*^VR+SNWEXL\7HB2A+.*S7@RFT^_&H(S Q6T![U^ M8MO>3N[F[\#_SM>Z=W[;#P;VZ@X\8[+\:W8=:]/S=SD5SNLI MQA6#MN_US*"'@\ Z8&\]QX($I0/'@]:!=@^J=@_>W>X3K/DQ?\3,67DW"H9] MB9T71E&>Y2EF,R9W.L'2O1 9:D]B/KA6'"*1F281:K?,'^9P#KAA *+I$UGA MUJ"0!A1*952!$Y'+/YB;"R_ZI\B\T0";'V/ZHU,9NQI_TO;UOCCUT8_TFE-[(JF MU_H_'=(K2W'B_E"(CL%R"W4AQ4(IHA$.4-MDD+$K(!G,BMX(.5'*<@,CFW4VCPT Z?;^EUUL<<'(PK[J>&'I:3F!H/6+RB2 ^+>J\2]=U!8 M=^_?VE;X#JCU0=#=V\_WB.JH[._?+:4_L6'R[=[$/;:_COWH]G_U+J'I'G=; M);159G.#8KYU>')EOJ5R9;VL* M2USJ'!WC-UD6Q]#B1HNU/?HMA,:#I!TF>'(':2;@^Z40^N7&&*C^%S#\#U!+ M P04 " *@C9:QSQ4^:@# >" &0 'AL+W=OA9!>PO4#7K_,///,B\>,#TI_,R6BA<=*2#,)2FOWHR@R>8D5 M,]=JCY).MDI7S-)2[R*SU\@*KU2)*(WC050Q+H/IV.\M]72L:BNXQ*4&4U<5 MTT]S%.HP"9+@N/&5[TKK-J+I>,]VN$+[QWZI:16=4 I>H31<2="XG02S9#3O M.7DO\"?'@SF;@_-DH]0WM[@O)D'L"*' W#H$1I\'7* 0#HAH?&\Q@Y-)IW@^ M/Z+_ZGTG7S;,X$*)OWAARTDP#*# +:N%_:H.OV'K3]_AY4H8/\*AD>V3<%X; MJZI6F1A47#9?]MC&X4QA&+^AD+8*J>?=&/(L/S#+IF.M#J"=-*&YB7?5:Q,Y M+EU25E;3*2<].YWE>5W5@EDLX(LM4<-"593>TL7] >%>YJK"J/-)&1-"9\TV M DTXCBS9=@A1WMJ9-W;2-^P,X+.2MC1P)PLL7NI'Q/E$/#T2GZ<7 3]@?@U9 MTH4T3GL7\+)3(#*/E[V!=_>]YO8)_IYMC-54*_^\YF,#T7L=PMV?D=FS'"O4N&<2W%PCV3@1[E]"G*[J/12T0U!9^+FO09.TU1RZ;6I<(UF4: M-N[6@O=&6@-D"O*2R1T:X/(%#>5IY"]H\+9XA"\>9JWFF[H!M@J66N66=*Y8 MM;^%CZQR^YW9E\5]V'6JHBZXW'F;&G/!C.%;GC-WF0U0?_&!(&G8/'F[2A+' M$?G^@,92W["PPKS6W')BNU245K1]BL_QN&!+(A=+(!6>AD:1;"K%*UR]2S M*.6&@NVBN" -)7CA\[6R]/&Q(-YW3$N*M8&K=\,T26\);!C"33^%FZ371N!_ M$WQ.FX@=H;+W,?T26-,N;K?4C9^/*"A9+W1C$OZ\F;-@D_^0]@>0#F+XA,8T MX?JQTJ0B &FU$L)5%)=4=E0CY@74D50*G;Z+9GB>;NHV6&V(V+'C_)CRQ*>\ MUZ8\'9Q2/LANPM=N?W36LRO4._\R&7*T[]/NZ?&;-3W_6;QY.3\SO>-4 M# *WI!I?W_0#T,UKU"RLVOL78*,LO2=^6M(#CMH)T/E6*7M<. .GOP33?P%0 M2P,$% @ "H(V6JX,1[T! P # < !D !X;"]W;W)K&ULE551;]HP$/XKIVR:6FEK2 (TM( $+=,VJ5L%;?J7SA -/.2BT",O,Z8\\WV=9)@S M?2)++.AD)57.#&W5VM>E0I8ZIUSX8:?3]W/&"V\\=+IK-1[*R@A>X+4"7>4Y M4X]3%'(S\@)OJYCS=6:LPA\/2[;&!9K;\EK1SF]14IYCH;DL0.%JY$V"LVG7 MVCN#.XX;_4P&F\E2RE]V\SD=>1U+" 4FQB(P^MSC!0IA@8C&[P;3:T-:Q^?R M%OVCRYUR63*-%U)\YZG)1E[L08HK5@DSEYM/V.33LWB)%-JML*EM>QT/DDH; MF3?.Q"#G1?UE#TT=GCG$+SF$C4/H>->!',M+9MAXJ.0&E+4F-"NX5)TWD>.% MO92%473*R<^,YZB-JA)3*5ZLX5K)M6(Y'-VPI4!]//0-Q;"6?M+@36N\\ 6\ M/ES)PF0:9D6*Z:Z_3]Q:@N&6X#0\"'B)R0E$P7L(.V'W %[4)APYO.B_$F9% M"G,4S& *$_M N.&HX<=D25;T8G[NJT =H+L_@.VB,UVR!$<>M8E&=8_>^-V; MH-\Y/T"_V]+O'D(?+Z@KTTH@R!7LIC*O8\'R$6X>2V=P(;79E\#!$/L3N,D0 M5E)0#]M8QCX/<*>%T=2<.S6MZ_A(]@H,^6G^ 'G]*M"^"J [Q7R)JKW7,UA@ MR11SC6I9:YAHC>;#]FYJW3="4XU\(PT3,)\M9O.[&7RY_3J#J%.CP5L(HHC6 M=V_B, C/28I"J^SW&V=>))52A+NE:#*%N$N2&)F&Y18WZ),,<32 .'X-U%_Y M0MB# 01=Z)Z^!//OHD$W $NE%\& TJUQ2L93GRIGQ.NPCGKQ,1Q% UKB,*)U M$ ;';7DO9Q>SJ^EL_F1/U0QZ.R7NNQ*?QK#OE?O/)E2.:NWFL(9$5H6IAU6K M;4?]I)YP3^;U?^**J34O- ADAE[SIDSDYDDO50/N@8PZ+'A M0J>X-J9=$J*+&AJJ;V0+PMXS#?VZVR'AE92M: T$P* MI."0XM5DN9ZY>!_P@T&OSVSD*LFE?'#.79GBR D"#H5Q#-2^CG +G#LB*^// MP(G'E YX;I_8O_C:;2TYU7 K^4]6FCK%'S$JX4 [;G:R_PI#/7/'5TBN_1/U M(78^QZCHM)'- +8*&B;"FSX.?3@#Q/$+@'@ Q%YW2.15;JBA6:)DCY2+MFS. M\*5ZM!7'A/LH>Z/L+;,XD^VALBTVZ$Z$#^PZ]1ZMRI(YD_)G%V\V8"CC^FU" MC,WM&$@QY%F'//$+>1;H7@I3:_19E% ^QQ.K>10>GX2OXZN$&RANT'3R#L51 M/$,ZE'&%=SHV9.IYI_]IR Y:J0P3%?JURK51=GQ^7RH[L,TNL[F56NJ6%I!B MNS,:U!%P]OK59!%]NJ)U-FJ=76//OG5-#@K)@UT/IY;F'$ZMT)?$!KJYIW/K M>LSF"3F>*R!GH]2 JOS":%3(3I@P5>/IN).K,(K_PL-"WU-5,:$1AX.%1CK2\_+9DJ4T M/^,KEJDSCURD5*I=L?#RE6!T7C1*$R_T_:&7TCCK3<;%L5LQ&?.U3.*,W0J4 MK].4BM\R7A%%^R>R>^K6Z'VO)HRCU.6Y3'/D&"/ M5[V/P26)1KI!$?%GS%[RK6VD4WG@_$GO?)E?]7Q]1RQA,ZD15/UX9M_%;177U,WW-[>T&^*Y%4R#S1GUSSY*Y[+Y57OO(?F[)&N$WG'7SZS*J&! MYLUXDA?_HYH5\UZ'>]PJ!J4*3NE;D7'8>II).QX"](Z&A%TQM%[Q>M57_%F1XH]U*H ML[%J)R?W;*'*+M&7K!QTNGB_HULF9OKHMT=T3Q.6H^DKFJYSU3;/T?2:7.2+9G,T;VF-W^Z&CO:[)<-.3 MT] )Q&QVAJ+@/0K]L-]P/]?=FT=-Z?R_JY.CKVYU1E0/JZC@17N&U1U;<5%4 M>GN _?V'"D=?)$OS?YHJ7[+[S6PMG9?YBL[854]I8\[$,^M-WOP6#/T/3=T. M"<.0, ($LPK4KPO4=]$G]G,I]'/Y-L[0JGSPWS55I00&I9+H7T#/DV#L/6_W M]?X0O#^$.$.L; =UM@-GMC?T0<0S](:FJP_H,T\9NJ:"H9^H.J'WFE)V4@\= MB) P# DC0#"K-,.Z-,,3*L40LD"0, P)(T PJT"CND C:*48_?H ^V?Z]XHE M%IVB<*'V/ M;IBR;'HTEAIR0],X>=VHB YI51$W_M!1"DK#H#0"1;,+%9I"A2?4D@H.529( M&@:E$2B:72;C)P.G&SI*3Z*F1]N_V-633F&X6QAI#FNQ+X%Q:X';KG60DZV] MQMYP7N#@D0I)PZ T D6S2V6L9C XI:" 6DY0&@:E$2B:729C.P.G:3I*4(;= M!*53&.X61EK"SEL4Q;BZP&WKNBC*YF2KIC@OI.DI3+AH?[^&NIG0*P]W"R-XP>P+$F+[0;?JF MC*[EJWY!0F/1JAINR*'#$92&06D$BF:7PWC0,#BA:H2@#A24AD%I!(IFE\DX MT-!IG8Y1C8JX[R^1;F&X6QC9&V;G;ZQ=Z+9VM6K<,I'SC";MR@$Z,0A*PZ T M D6S2V+L9M@_I7* 6DU0&@:E$2B:729C-4/WM.8QRC%H?(@'N\K1*0RWA.W^ MO;&79N=O/%SH]G"UI'IT_ MT6:S,6?0>4)0&@:E$2B:O5+,N,;(/Z%L1*!N$I2&06D$BF:7R;C)R#VC>81L M5,3V=Y=5IW<*P]W"R-XP.W]CTR*W3?O,:"*7FW>CWX3#I[A)!X])T%E!4!J! MHMDUV5IE>M)EIK#K3&$7FL*N-#V%G8R,G8S %YMM &]YP= O#+6&_2,>^ M,#M_X],BMT^SI:-^S;%UN+$+0*<"06D8E$:@:'9YC(V,3KD$-0*UEZ T#$HC M4#2[3,9>1N +4:/&=:&_S*YT"\,M82/?^K>[FOW05F7O>%N?]*1,+(IOJ7(T MX^M,EI]AU$?K[[4^%E\I[1R?!I?70<-Q'%R2\FLL@R\_#OM*Q2+.N!2\K387#(Z9T('J/./G,O-CKY _=7;Y#]02P,$ M% @ "H(V6KW[C!JB!@ 12X !D !X;"]W;W)K&ULM5K;;MLX$/T5PEL4+=!6(JEKZAAH+*4MT.X6R7;W8;$/C,W$0G5Q M)29I@/WXI2ZQ+'*D)@W]DECRF4,=CCR<(W%^6Y3?J@WG OW(TKPZGFV$V!Y9 M5K7:\(Q5;XHMS^4WET69,2$/RRNKVI:/8.'\74JP,:Q%\)OZWV/J-:RD51?*L//JZ/9W9]13SE*U%3 M,/GOAB]YFM9,\CJ^=Z2SW9AUX/[G>_;31KP4<\$JOBS2OY.UV!S/@AE:\TMV MG8JSXO8#[P2Y-=^J2*OF+[IML7XX0ZOK2A19%RRO($OR]C_[T4W$7H#D@0-( M%T#4 &7O3U["2'W$W)")@DCOGJ#*'Z%B$T!WD.*&G:-=! MV X#A2J&4"0,8>W>3KOWT_PJ^B&MGB[#KOE/J32I=%*6L,$QS2-QGZV$IBDBPR218;(AO,?[";_^" I3XPF2"39)%) MLM@0V2!!X2Y!X:^7^E O/MKO'\ 0M=3I&$J4!2/6,<2WX1\_MOLVU#Y$D>]8 M]R_F-5;KU1)$N=H:!\)L6UWD0%@P5O_P7B>.3=3ZCF4P?-TK#A4#("S7=54Q M /,I5@5#9#2@(X))+YA,"C[A[%KO\N=E#) R=0RP2("M4J MH:-\7ZV>,80*]TKQ4&7?_..#=/]8;\=#M;%? B",,5'EZRAB>U25#Z"D0QJ1 MW_?_V(@!P'I+[@>V*A=J[@-5K0["'K%5M0 JH&-+8.\!\+0)>%\61587G >O M"4:=@5&VR"A;;(IMF)G>'>!#V@-LU!\898N,LL6FV(9IZCT"?H))P( #\%WU M>1"(HEKG"#@%QU>?B8 H-X#+!.G- CF(62!ZX^ZJ]6\)@:A:) $0MD.U2((H M?V1)(+U/($9\ M&[=D?SA!#(L56U.BC0'G]!(&_DR1_I+0*9M@@?.$O%!BV9 M3.]#UX1IRL<6&Z-LD5&VV!3;,#F]3R"'] G$J$\PRA8998M-L0W3U/L$\@2? M0 '0%0'L(10V%<;90#ET=!7"P6 (GL/YHY] #N(3". 3?/5I"@2BFGK M3(0D4-4#J(",K0F]32!&; (!;(*KK8 2'W3$P$@[(3JHS(098^M_[U-(-,V MX91=E,D*/6?9]BWZ4.?W<0N$4=-@E"TRRA:;8AOFJ3<-Y)"F@1@U#4;9(J-L ML2FV89IZTT">8!J(WL+[KMKH+R&4@UVU:$"O*8C>2D(P>^Q9"NUM SV(;:! M&Q\&ZA()H(B-5>, H!S;4]^O@JBQ%PRT-P[4B'&@>B>/7<]7]4(HWU?UZBB* M W51!%%CCPYI;Q[H3]XOL(N[5^B49TE>5YIVN3AE69+>/6[!F![GT3M9C#H* MHVRQ*;9AQO:V&QUTOY'9#4=F=QR9W7)T"$=!>T=!G^ HJ-[?NR14FTP(I;VX MC0 4MAU;?= "PB@=>?I >T]!#^(I*-#C.YYJ*D 4U0HH\%HA<%1/!:-&/!7M M704UXBHZEOUM7QBKCF$)HFS510$H@K4. 43M+3ZM7FMO6VS&RZMF/W*%5L5U M+MH]D+NSNSW/[YJ=OLKY$WRTQ,#Y"!_%[8[FGK[=8/V9E5=)7J&47\JA[#>^ M3$W9[EEN#T2Q;3;E7A1"%%GS<8+=S?/$_4$L#!!0 M ( J"-EH0P:F??P0 * 6 9 >&PO=V]R:W-H965T^I?EC=2G,7-EE2EE.NF.! TL=) M< [/9C@N LH1?S.Z45O7H)C*7(AOQJ)?:)85F8R. M[W72H*E9!&Y?OV2_+"=O)C,GBGX1V3\LU/5-?M0+L16 D", U0&HU%T5*E5>$$VF8RDV M0!:C3;;BHIQJ&6W$,5[\*O=:FK?,Q.GIE1#IAF49(#P%7[DF?,'F&07G2E&M MP EH!LR>P54FYL1421, M:BFS2@IR2!F &\'U4H$_>4K3U_&AF58S-_0RMQGR)KR@R2G \!- $>J!A_L+ M\.'=1T]>W*P9+O/B76OV[YTPGV9W;(A,_^N:<96HUYVH<-R96I&$3@)C*47E M$PVF[_^ @^BS1V:OD=GS99_.Z()QSOC";-N,\(1V":Q2#,H4A8.?IKT(1W@< M/G54[C>5^][*Y\GW-5.LL)TJ-U9JG*XV;\[5CUN5<6CX6C877;8E!WN M^+W)6C]WE?/&';@+1XVJT;',,OH-,F%D01C]NEWJ'-N_',0Q\/>X[*EI30C\HK*83Y M'D)M_,8#[#@]((M?Y,?OFRV$VC1V M6 A9$B,_B?>V4)WG)PO%COH6M\A_=-UM(=0^K,9]#!V%+3V1GYZ79"Y9 MZ3 M?/497(N NYJ+C@.>=CR%_]J=Z%.\*JIT^L/?BH<;C4- M&PO=V]R:W-H965TTN5Q+)"S@0L%=%545#U>@U$*+ETJNW9/4S=U)Z)&TTBB+G;-14##1O.G++@\=AR X MX!#L' *GNR%R*A<4:1(K61-E;QLTNW"A.F\CC@E;E$=4YI09/TQNI)K\Z]M'HL:A^NN.^;KB# M ]P+2"_(:/B%!(-@3)X>%^3TY.Q/&-^$T\84M#$%#G=T +V+7*E2YK"S#,]H$%MP4L^?QI&@Z]'A(]:X:-CZ,FM MDEJ3&ZK4*Q,;,B]D);!/9 ,3.1C;=MMD>AF%L;_M(1^WY..CY/,TK8J*4X3, M,BMD;]0V3A]_@Q1V^,^C:#KN%Q"V L)_*1L3ILF88'BD:.%_*%K4RHX^IFC1 MNZ0-+\,PZ$_:I&6?? S[Y-TG$TS#X>0O=K\S2>Q0OJ=JPX0F'-;&;W!AQYAJ M!EUCH"S=<%E)-*/*+7/S;P!E+YCSM92X-^R\:O\VR6]02P,$% @ "H(V M6ID4)7F/ P O! !D !X;"]W;W)K&ULM5AM M;],P$/XK5D ()%C>VJX;;:1N"3")21,3\ 'QP4VNK85C%]MM![\>V\E"4T+H MP'QI8_N>YWS/7>Q>)SLNOL@5@$)W)65RZJV46I_[OLQ74&)YPM? ],J"BQ(K M/11+7ZX%X,*"2NI'03#R2TR8ETSLW(U()GRC*&%P(Y#=?S."JF'J!V1%0R)6AP/IK"Y= J6'2^_A:DWJ-3P/A)E"N55"KQ*-4\EKSHL=H11A5J KIC!;DCD%-),2E$0O MT*PHB$DIIGJY*DR3X*^TMLS3OR\ MWLI%M97H-UN)T35G:B51Q@HH.O!I/W[4@_>U+(TVT;TV%U$O80KY"8K#YR@* MHD''?BZ/A\==X?R;]^ROO;?$B)M"B2U?_'>%DA*94RXW M"GV5PJH4^ SUTU M4'D9='LQQ^*Y7.,F2+'5) MECDB:V5IU&1I](>:;+)$;9;(09%VY67T:[6<#8?106GV.GZHX$>YS!RY;"EY MVBAYVJOD#8@_,_I=/U3T MXYQFKIQ6>OI[W5@)8FG;8(EROF&J^KW=S#:M]LPVF ?S%^'Y9=@QGYK6W'9_ M/^FKOOX:BR5A$E%8:%?!R:F^\D75*E<#Q=>V%YQSI3M+^[@"7( P!GI]P;FZ M'Q@'S1\6R0]02P,$% @ "H(V6B/'I3^P @ ' D !D !X;"]W;W)K M&ULM99K;]HP%(;_BI5)4ZL-5\_YQP;9UAI\VAS &1/A51V M%.2(Y5D8VBR'@MNV+D'1R%R;@B,US2*TI0$^\Z)"ADD4]<.""Q6D0]]W9]*A M7J(4"NX,L\NBX.;Y J2N1D$WEGJ!4V+C-1@+)" M*V9@/@K.X[.+.'("/^-!0&4WWID+9:KUHVN,9Z,@FQ@DN0TCD1 MQ^_:-&C6=,+-]Q?W:Q\\!3/E%BZU_"%FF(^"DX#-8,Z7$B>Z^@IU0#WGEVEI M_2^KZKE1P+*E15W48B(HA%H_^5.=B U!W-TA2&I!XKG7"WG**XX\'1I=,>-F MDYM[\:%Z-<$)Y:IRCX9&!>DPO=%Z5@DI&561$GW;WE(X38Q)TW,B??K[O#[E/38M+3L2MA,+Q6R M"=^.M=?&G9[=W9 OF:PY3*XK3@_ M;TG#Q@B%_;4-OW, _&Z#W]V;X\N<8($)Q<"BH--#$ M;T-?F\?K'>'^659I*VI'O6&XV@+5:Z!Z>Z%:=>%O2$>;U)7=;EM]K\L[$]=O M&/N'KGO_ /B#!G]PR+H/_JON)PW4R?ZZ]R)?]XE^YA*?=Y[WO2[O3-QIPWAZ MZ+J?'@ _CEXODNB0E:_=WY2^^T_IPXV[SGTW?.-F(91E$N:DB]H#.KQF?16O M&ZA+?_U--=)EZE]S^GP!XR;0^%QK?&FX&[7Y($K_ %!+ P04 " *@C9: MQ6.0-TD& M'0 &0 'AL+W=OZ1XB!GV$0T?O6GK'#H-.A[AZ%D+;Q 47\S@Z3 M$#)^25X[]$ 0]!*C,.BHW:[9":$?M4;#I&U%1D-\9($?H14!]!B&D/QZ0 $^ MW[>4UK5A[;_N6=S0&0T/\!5M$'L^K B_ZF0LGA^BB/HX @3M[EMC9>"H:FR0 M(/[RT9D6?H-X*B\8?X\O9MY]JQN/" 7(93$%Y%\G-$%!$#/Q5W4DFSR?S BF:X.!OWV/[^Y;5 A[:P6/ UOC\%:43,F(^%P3K;T&'V%X^ (>QW/> M+IN_61F6;FI=08$J2---2]"@"K(,2]#2J8)Z?/[)]U#D2=>[5QV *LQ6 A$$L:L01=>%JX#4=S_)U+&J\<$PA(6>5D&:UA>]H0JR=%W8 M-DX5U+-NQ8=^IE&_]C3:?!VO[0V8+3;*+])L^B)LGL)LF*F?3VXK@I'*V&UZJ%#)LI=9/QYX'T&['2RF =SQF!<>X MF (4N4?B,Q_1@50"I4G';93-;I3-:8JMO#QJOCQJK>].<,3=E?EQ'#UD1TOJ MLV_YJ5KQK)[2UD0OE:"T=K];^"BBRTJ)C7[Q(WJOQ$0OC*4L3Y[R*[5I[&C# ML/L=X$/\'( ?19$',-OS6O'(5:/Q9D<_CC[[!> 9$N]MP;3*(#6]NJTE*+.M MBQJ]!^7(4%;;N"%+GGXK]?GW--[&?/8-QCR]&J5TPQ*CU%2*,ZVJ/%*<6HUZ M,AQWMANYFI*G[XI1&_=*6>N*9ZB3Y7R^7(#DW)8J4%L/_';(:Y+-;I3-:8JM MO#)Y.:'4UQ.7XSKV1X]73I!GB@>^HQ/?E+GFPQMTWY1_I,MYL>H5\^)V7Q?= M68824VQ;@M+:8CWK2%':K1"85QU*?=EQW>N_(5@]X2W!>A(I+#$IEZ(J>E5! M6ENOZ"5#J;?TRFL7I;YX*1T9THG6VO_V1F^2S6Z4S6F*K;P2>86DU)=(XXCY M6<*YR1).8/]T@Z/'77I'< @F.#SPZC)YTL\S5,DCX6]/G!C,& JIW',;K;(: M9;,;97.:8BL_C,X++;6^T"HM:%Y!O)5;J-7*1@PK$H@0+FP)1,RV)) ;J98: MUT_EECQE5^M3=AX_P>4,BXK/2>*87$R_DFSU&KS?0/(_%P;N,8 QF+?7/X$A MV&6<(WWF!D/>WI8M<*?P9B9$Y#5YAT9YW\>(79Z$9JW9>[J'Y.V4T#Y1!E-% MTFXK T?6/E:5@:W*[ZC\3M)')Q_2Y47B'))7GZ?Y =KQX77;/;Z0Y/)N[G+! M\"%YE_2"&<-A\G./H(=(#.#W=QBSZT7<0?:&=/0O4$L#!!0 ( J"-EHW MJ=R"CP, #,0 9 >&PO=V]R:W-H965T*U6E&WA>[%:84&<^K>=6?#YE>UD2"BN.Q+ZJ,/]G 24[S!S? M.4X\D&TA]80[G^[P%AY!?MZMN!JY'24G%5!!&$4<-C/GSK]-?4\KU!)_$#B( MDV>D35DS]E4//N8SQ],[@A(RJ1%8_3S!$LI2D]0^_FZA3K>F5CQ]/M(_U,8K M8]98P)*5?Y)<%C/GVD$Y;/"^E _L\"NT!D6:E[%2U'_1H97U')3MA615JZQV M4!':_.+GUA$G"HIC5@A:A6"H,'E%(6P5PK>N,&D5)F]=(6H5:M/=QO;:<0F6 M>#[E[("XEE8T_5![O]96_B)4)\JCY.HM47IR_EA@#A<+Y>H<+5FE\D_@)H(T M1RLF) =).*C4D&@!%#9$"G26@,2D%.?H GU^3-#9NW/T#A&*[DE9*F4Q=:7: MFU[!S=I]+)I]!*_L(T3WC,I"H)3FD!OTDW']>$3?53[I'!,<';,(1H$)9)FLSY?ZNG_WGUGC/"+DO"FA>^PGLP),&7N[7*#G70_S)% MN^%-S#Q=_6[%#F[^87&T3EMB$I99@O:!,NJ!,QNCM MT5W71S<[/;KPK)_!%):&&-=$?8<\S?TPGKI/I]XVR$1>7R9Y*1-,_+Y,:I"Y MBCJ9GLE19W(T:O*JO:&.26@R<93PO9EG$Y;8A*668+TPQ%T8XM%RD"CG4Y5U M;1C0JL04)41D)1-[#NC+;^HU^BBA$L;B$-L,D4U88A.66H+U0G35A>AJ]*1\ M4M^8.^"$Y21#ZS9.F;K/T5G&(2?RW!28AAF='MEA=7@I$@6#XO!2) X'M>&E MB._=F&O#=6?Q]:C%O\L".&IN*ABM$*.<[TT_F[#$)BRU!.L%XZ8+QLT/K1 W M-D-D$Y;8A*668+T0^=ZW3W_O!]2(%GIZKU_XUX,/A*51*AH4D\0D%<8#5FJ4 M\OU!N7!/FJ *^+;N/H6R9T]E\Z7;S78=[EW=UPWF%_[MTC?,)[HCKINN;_BF MG;['?$NH0"5LU%+>Y94J;+SI4)N!9+NZ!5LSJ1JZ^K%073UP+:#>;QB3QX%> MH/L_P?Q?4$L#!!0 ( J"-EK@&PO=V]R:W-H M965TWN 1(&JG-HN@G;O MP^H^F&0 JT[,V@ZTTOWX&R=I&@XWW4K<[I<2)S/C9Q[/F]O="?F@U@":/$8\ M5CUGK?7FW'55L(:(JE.Q@1B_+(6,J,:E7+EJ(X&&J5+$W9KGM=R(LMCI=]-W M4]GOBD1S%L-4$I5$$95/%\#%KN?XSO.+&5NMM7GA]KL;NH(YZ/O-5.+*+:R$ M+()8,1$3",_#/AW[#**027QGL5.F9&%<60CR8Q23L.9Y!!!P";4Q0_-G" M$#@WEA#']]RH4^QI%,O/S]8O4^?1F055,!3\+Q;J=<_I."2$)4VXGHG=%>0. M-8V]0'"5_B6[7-9S2) H+:)<&1%$+,Y^Z6-.1$FAU7Y%H98KU'Y4H9XKU%-' M,V2I6R.J:;\KQ8Y((XW6S$/*3:J-WK#8'.-<2_S*4$_W9TP]D!L:XY'AX6@R M,+0RS4 1&H?DDC))OE*> +D!JA*92BGRF0S"D)F#H)Q,XBR)5F<01 M4P$7ACA%OEVC*3+1$*F_;31D^S;L^YI\/E<;&D#/P815(+?@]'__S6]Y?]A( M.9*Q/8KJ!47U*NO](55K M\3Y(D;#2D-ZF(2V6A(MX]5F#C##W%]H&-+/6+&&HM>L'2&U2[=>@-@NH MS6H>$RE-4FZ$3)/K "\F5A&!-NS- _[JA] M0IW7D+<*Y*U*Y*4D&2@%^H3, M-=59B4$O+EE,XX!A[9@*E981\FW\J$UW6' @XQA=DFE!L29*]=Y?[J[&,W+[ MY79X/YN-;^_(8#X?W\U/R%3"AK*0P",V0957.*'7(+'29DQ3 ]9&Y?#G[KE' M>KL@O?VCI%\SNF"P\!*>$(..+J>#"XFUY.[R7AN M8_PG;;9'=:>@NE.=F8)SI%4BD92;\>D)DU1I"$\(7:TDK/ C61:5QL9EQY*; M_\E,BXC7MB?F60'\[.WJES7TYV[U#[F/0Y#\"1=(G.'2AK?2[GN[TY&,[5'@ M>R\SC_>+6GB^\9%8.I:U?9I*HZ'_1AN7T@0%H9%(LOJ!P4&2(EJR'B06G*W2 MFF%EQ+=TQH,>]);4O@;T;_$>-(FWH'1: -\9\=7&WWV8_\=$YK^, M9'[]5\5\Y3#X;IJ.9&V?II?AT*^>#H\3\XV#PNU[C<.@MXCY9P=1[Y9N=^9J M?4,E'I&ULQ5C;;N,V$/T50ET4"=!$(F7YDMH&O#&"3;'9IDFS M?2CZP,BT340BO21M;X!^?$E)T%P=,CQGHLGN29$@>]Q MQ.3$62NUN7!=&:Y)C.4YWQ"FGRRYB+'2MV+ERHT@>)$XQ9&+/*_OQI@R9SI. MQF[%=,RW*J*,W H@MW&,Q?-'$O']Q('.R\ =7:V5&7"GXPU>D7NB'C:W0M^Y M.EJZ!">61\R=S<[V8.)YA1"(2*@.! M]=^.7)(H,DB:Q[<,U,G?:1S+UR_H5TGP.IA'+,DEC_Z@"[6>.$,'+,@2;R-U MQ_>?2!900C#DD4Q^P3ZS]1P0;J7B<>:L&<24I?_X>Y:(D@/L-3B@S ']5P<_ M<_"30%-F25ASK/!T+/@>"&.MTR7T4ZK]U/2.RB=P@YF> M,CTY"LQ,6JFB1 +,%N *4P&^XFA+P W!WOV]YIN<2$W."031[<#2<2..-,? M?X!][V=;4CH"JZ3(SU/DMZ%/:Y5GBS4%Z"< II'MIG#DH_[8W96#L%CU?13D M5A5VO9Q=KY6=60)IJ,DZ2"]G4A(KT10K*%$(>G6:AS80>7:204XR^%>2V;(^ M^4SQ(XVH>CZU$0P.7GZ&@J#&T&+D#T9VBOV<8K^5XIQ(NF)8Z6Z 95[[Q9JP MD6U%/+;$.P*K!#_(@Q^\4Q<8=)FBCL J*1KF*1J^M@L,#Q=.,.H/:\5KL?*A M[]NK=Y2S&W78!4:6+E!?8X@5'W^OHSZ0 54; :R3M%GY0;^!9DFC MP%::UTP174$*"-T/0,B9$EH12/!W69]D"\-*OA7^V*KO"JV:C$(@P/=2"+!3 MB= 56C5-A4B KU8)&4*Y6M$(]NHU;;,:-?0'6,@$V*5.@(K\D!&'AL]X1-#4,71;@_TB+ M=@9'KXVW$!>P4!?PO>0%[%1?=(5635.A,."K)08\5 ^^'XSJ96^Q@B/44/:% MQH!=B@QH41!UGFTFU>UL(3%05Q(#6<1#K][E;$:HH1FC0F"@=H%Q3 ,A2B^: MG7Z6G)>TJ([V=QZ]XWX+U8%*QQ+O=B[1[<'$6Z@.5*@.]&K5@0[U!/2]H"X[ M;&8>[#5\TE&A.U"7N@/9#BCJ7W6+4>/>!!7: W6E/3*@OE7Y9!0/3<[\>F]S M2\>HY@S[!@M=V!)$9*F]O/.!!A'IL7!ZH_@F.5E]Y$KQ.+E<$[P@PACHYTO. MUG_P!02P,$% @ "H(V6JQ)((7- P \0T !D !X;"]W M;W)K&ULQ5=M;]LV$/XK!ZT84J")9,FRO@P1M/PS[P$AGFXA$>B1MI_WU/4JRYA?%R#H!^V*+Y-US?.Z.QV-_*]63 M7B(:>,Y2H0?.TIC5M>OJ>(D9TU=RA8)6YE)ES-!0+5R]4LB27"E+7=_S.F[& MN'"&_7SN3@W[R&,,78 M6 1&?QL<8YI:(-K&WR6F4YFTBOO?._3W.7?B\L@TCF7ZE2=F.7!Z#B0X9^O4 MW,OM1RSYA!8OEJG.?V%;RGH.Q&MM9%8JTPXR+HI_]ESZ84^!<.H5_%+!/U9H MOZ 0E K!:RVT2X7V:RV$I4).W2VXYXZ+F&'#OI);4%::T.Q'[OU&=YS_00S)B@G*/H&1C9PW'#4P$0"[QE7\(6E:X09,KU6N92&2_A M.:AA1#*W4FL2_R0@0L4WS$9>PU3 'Y3F4T$#DT-_Q&1!"_<8RX7@WS$!+N#3 M> H7$1K&4_V68#\_1'#QYBV\L8LSGJ:43;KO&J)J-^S&):V;@I;_ JT 9E*8 MI8:)2#"IT8_.ZW?.Z+ODXLK/_L[/-_Y9P CC*PA:[\#W_';-?L:O5P_JZ/PW MZY.?MG[@C*!*NB#'"U[$V^4)Y8!\COD-(%!K,%0! M**;O8+OD\1*V3-,-LU\$D"E! K7GO-A,)]^,O?0VP[#;=S?[<3H5Z?B'(M&I M2,L[@IG4R 1>)7/@J[#R57C65[9(NJ6'#BF/J/#5T2WPPKU-]/SPB.^IS&7H MM8\8GPKYK2.@20U0*_RMGG*GHMPY2YFN;[J6$Y;:CD02M6%ZS>2:WKG9354YG+=N](*#H5"L+.49FI :)& MXJC,N'L];(9JD3\>--4+8EQT%M5L]3X9Y6WYT?Q-ZWK M0S.F%K:937%.IKRK+E5$53PPBH&1J[R#?I2&^O'\N0MC5E=^[Y.EI@S?257*&AE+E7.# W5PM93RR0ZFZM:4UW'_>L;]UOI,OCTSCK.H-VJ5!^]@@/&'0*0TZ M+]TA+ W"E^[0+0VPU3 !RKSJ:"!<=3O,%W0PCTFZ4OB_O@0P<6K2WAE$3.>9512>N@;\M>>VD]*WVX*W]HG?.O 3 JSU!"+ M%-,:^^B\?>^,O4]QKH+=W@7[IGV6,,+D"CK!+]!NM<.:\]R^W+Q3Y\[W[1[_ MY]T/@M&I*J_C^,(3?%-A4%%M@&(&(:%(*U(-#7_O%YVM&2J/NMR?9;?R>JU7 M+,&11_JI46W0&__\4]!KO:D+?)-D49-D<4-D!RD*JQ2%CKUS,N6[]YG>8VW4 MNGCYK3"4B=G7BXCK))-6(S3\\9ZH8&HPUY_KDA*&R Z2UZV2 MUSW[?DURN2;5E7,GU?Z%E>G+$^I;EZ*"O>?8[6UC,^Z0:FSV _\<$@3]0TQ4 MAVD=8N(:3'M080Z\[U7>]\YZ3[<(NB,(^H0JA2+Y2MZ>DIL/TM"72Q.:5E)@ MNBKN;T5?%Z"S!_BW-=PD6=0D6=P0V4$6^U46^_^3 /6;3%Z39%&39'%#9 ?) M&U3)&_Q0 1H\4X770?]8@IZ#]J6CB&@-47B$B9]CNOTC!?+W;MDYJH5K;S1) M"7E97'NJV:J#FKC&X6C^)KB^#6KF(^JXB@;I&WW1KLV86MCK=H9SVJIUU2?% M5$4+5 R,7+D[_J,TU#&XQR5UC:@L@-;G4IK=P&Y0]:'C?P!02P,$% @ M"H(V6E0K]AJS" 7DT !D !X;"]W;W)K&UL MS9QK;^,V%H;_"N$6BRDP'4LDY4LV,9!8*B; 3!(D:;= T0^*32="92DKT%H_#\KD0\;*NM$Z'U/-&PW6<9(/9:?W933$[ MS3Q%SD::5DCJ._S:B@UW,JN+^ZZ_JO]0GKT[F(2[%/$__DRSET]E@ M,B!+L8HWJ;S-7S^*YH2"2F^1IV7]E[PV9;T!66Q*F:^;RNH(UDFV_1]_:1*Q M5T'I=%>@307:KL#?J,":"NS8"+RIP(^-$#05ZE,?;L^]3EP8RWAV6N2OI*A* M*[7J19W]NK;*5Y)5#>5.%NK;1-63L_/%8K/>I+$42W(MGT1!YOE:-;FGJBV\ M"'*9+?*U&+[[E)?E3^1GA4+&25I_^^M=2-[]^!/Y MD209^9RDJ6H+Y>E0J@.MP@T7S4%=; ^*OG%0C'S.,_E4DBA;BF5'_1"N/P+J M#U6"=EFB7[-T04'!4"P^$.:_)]2CO.-XYL=79UVG\VW1H_\[NI$,MFLRK-9C M;S69RG75+M+-,LD>R4U>U)?\N91%\K"1\4,JB,S)5:Z:3B:+7+4"5>PRDZ(0 MI7Q/KD3=>.[C+^2/6_4M45?\:UPL_^QJ*-M#X=V'4O6B)^5SO!!G ]5F2U&\ MB,'L7S_X(^_?72YABH688A&2F.$GW_G)(?79A7A,LJSRZ"%.XVPANGS82HQJ MB>KF\S(+J,_]T^'+?H+M4GSB^=PL%79H>4$P-4M%'5IC;Q3L2AGG&NS.-0#; M[K:+6QA=7-)T<6G5Q;TG#T+=?E4+CK^<="4BP&R0F&(AIEB$)&:8--J9- (; M9-6_-"X48I'&99FLDD4LW[J9@&JNEF"*A5NQ8*\-_\RJ/MAHZ$@1C52/=ZD> M@ZD^7^>;3)9[>5;C -5YJ\M$#02R,D^393TV,.[[45Q4_46G&6 \5S,PQ<*Q M9<:XW35%2 $-+R8[+R:@%_>YC%.2N_1070: 05P-P!0+)Y8!;-JZ@T1( 0T# MICL#IK !:D0B5BN%,%UY!>NZYA53+)S:O8S/VHE%BF@DUOLH%/C=(Q!_C[A\,!>?1%F>D.HF%[>&S)DY M9$Z:(7/YGF3;,?,;ESPM8=KU./4N^-7DIQ>=%C//&5-03Z,09?9B[I[U*Q_)Q:;(I&)Z)[$1T4B5+4052W"4C,7 M'S0]4>_[&0=0D.1<7455"U'5(BPUTU7-@13FP*/& ;"&LQNH:$=MM//;XPFL MB&:.-=I1VO.H@X+LZ&P IEJ(JA9AJ9E6:2RE,):ZSOK#T+ MHP^TI!HM*;SHAS_Q#P=T]@.5'QNU?3^LCJH/**0:"BD,A4B3_W 49Q-0UR>I MC9;61=''LB/5C$KAA4=X 0"N[)Q;5/ZD]DJCU<#[@$JJH9+^(U )1W$V 76! MD=H :C7P/A88J:99"M,L_M(#'-#9#]3U1FJ3M'51]+'>2#5J4QBU#\\N4'MQ MSV_ONH&#.&?M<,0(*Z*Y_TSS,(-7$V_R4A9")L5V8'(A,K%*)+E16>P/L8*:29Y;U,MO*OVVV6=S-LKB[9?M@9Z;9F<'L[#I3 M S M UMQ<28KX"C.)J#",>O8C=LVH0\X9AJ.&0S'^),5<$!G/U"QF]G83=M^]$'= M7%,WAZG[\&0%M[?+CMI;[.=P%->T'1,RP@II)DY3,8<7>A7$BN0Q(_--48AL M\3>Y+^*L3.L!8V<:4<$652U$58NPU$QC--AR>'7X'YVNX*B C*H6HJI%6&JF MJYJD.;R0?-SO&5%A&54MY/;J<;6GD[;O!UA1S3SO_6P4WIW\[3,6'!6,4=5" M5+4(2\VT2B,TAQ':=<8"EG,V!A60>1<@CZQKHP]"YIJ0.4S(^',6<$!G2U!A MF=NP/ XL1_K 9:YQF1_ 99PY"SB*LPVH7,T[N'K:GK7 "FG:H,F:'R!K<-8" MKNR<751@YEW[LIF%>P,]?,S _\A!5GX@*.XNP#*BCS#E .1FT;^D#E0*-R M *,R_M0%'-#5$52U,.CX56[0,@0KHFF(1O 1O##-0.OG%+0]L)C#@9Q3 M=US4""OJ-GW#O>=%K47Q6#^HJU2W135FV3X':/?I[F%@Y_4CL%J?7_@G<[_C M\] _B;:/^M+RVR>/?8X+16>-78H)35S?&<[<$W23)D!-PH+G,(- MJ"_%E= ]MV5)" 4F"6=(P&KFG/HG<]\"[(RO!"K9:2.SE"7GMZ9SGLP6Z8M([?#:G3QC3 ;GO+_M$N7B]FB24L>/Z-)"J;.5,');#" M9:ZN>?4)F@6-#%_,!K,HSK' 4"EXA869K-M.P2[5H+8XPX\J-$OHKT3@5+3BE1.DT*XDP2]"" M,T58"BPF(-&;,U"8Y/)MZ"H=S$#U\3!'N(QNM14F40?6 +)WWA7BVR5 M!ENE\Z"7\ SB(S3PWZ' "X8HYB53X@[A,B$**;S!RQQ^_BH%D0FQAO>$'+3) M&=B0@STA+[B4CS+R_4+/0><*J/RQ*RDUX7 WH3EB)[+ ,M7 M_MA[WR-WV,H=]K%'GTNZ!('XJLF.T5L1E2&]^U4&*!5Z.$'Z1 ML,B31_3:/ MNY92!QO98.9PKZ.)%[KK'0)'K<#1,P4VAJ&N84;.OXVLM8V>:/-'>\2-6W'C M7G&7A!%:TEW1>H$O-'72RIH<>@]._H/<:2MW^DR+[N<.F3UP< M[#'QN U_W&\BWNPSL1?XPJSXWL,UZQW:QH;QP(H[A<$_G),-5]?*X6,KW4Z5 MHB!26XME?0/5!:L=;>O]:5WE'J;7/PN76*1$7Q@YK#34.YKHP**NOW5'\<+6 MO"57NH+:9J;_64"8"?K[BG.U[9@ [5]0] =02P,$% @ "H(V6L90R@X% M P ]@L !D !X;"]W;W)K&ULM59K;]HP%/TK M5E9-K=21!\]V$*FEJ]9IU5!1MP_5/IAP :M^9+;#X]_/=M(,I)".C7XA=N)S M?,^YU^;V5T(^JP6 1FM&N1IX"ZW32]]7R0(85@V1 C=?9D(RK,U4SGV52L!3 M!V+4CX*@XS-,N!?WW;N1C/LBTY1P&$FD,L:PW%P#%:N!%WHO+Q[(?*'M"S_N MIW@.8]"/Z4B:F5^R3 D#KHC@2,)LX%V%E\,PL "WXCN!E=H:(RME(L2SG=Q- M!UY@(P(*B;84V#R6, 1*+9.)XU=!ZI5[6N#V^(7]UHDW8B98P5#0'V2J%P.O MYZ$IS'!&]8-8?89"4-OR)8(J]XM6Q=K 0TFFM& %V$3 ",^?>%T8L04(NWL M40&(_A;0+ !-)S2/S,FZP1K'?2E62-K5ALT.G#<.;=00;M,XUM)\)0:GXW&6 MII2 1+>$8YX &DDQEY@I='H#&A.JSM ']#B^0:OB7C!MX4 7WC>Q2>U1JCQQ?\T#M MZ.FK68GN-##ULTIE3MNJIK4'[U*E.(&!9TZ6 KD$+W[_+NP$'ZLT'XELQX%F MZ4"SCCV^8B+C&DTS0%J8HYS[H5"*I28)2;$F?&YS/A[>5AF1LX>YP?;&6,;M M1J?O+[<%OK)H)_!6&7BK-O!]J3M'WR:4S+&](L[16&.30S *Q:Q823!%(Z&( MNT.>/JVUO9$F%- GGC&0#EB9\_IXKI+$.FF=VV!#5Y7H_V'8,:E=FM2NI;PG MG+",5:FI!1Y:P4*-^JLRH%ZVD[@D%5J:X'_J+97JNW5US1>[ZOI6N"A&3T2V8[& MBU+CQ=O4],4Q'3@2V8X#8?"G+0G>IJI?X0U[^^NZ'GJH9'^K*;,=\3V6<\(5 MHC S]$&C:ZY-F3>9^42+U/5I$Z%-U^>&"].8@[0+S/>9$/IE8EN_LM6/?P-0 M2P,$% @ "H(V6MA5J7WA! CR$ !D !X;"]W;W)K&ULM9IM;^(X$,>_BI5;G5JI;1Z 0'L0J26YVTK7W:IH[UZ<[H4; M#$2;Q)QM2O?;W^2A"0G!"[O3-R4QGM\D_YE./#CC+1=?Y8HQ15Z3.)438Z74 M^L8T9;AB"957?,U2^&;!14(5G(JE*=>"T7ENE,2F8UFNF= H-;QQ/O8HO#'? MJ#A*V:,@!MXBI8KE0V8WGA-EVS&U)?UHX SLZ+,HX2E M,N(I$6PQ,6[MF\#)#?(9?T5L*W>.278KSYQ_S4[NYQ/#RJZ(Q2Q4&8+"QPN; MLCC.2' =_Y50H_*9&>X>O]%_SV\>;N:92C;E\=_17*TFQL@@<[:@FU@]\>U' M5M[0(..%/);Y7[(MYKHP.=Q(Q9/2&*X@B=+BD[Z60NP8 *?;P"D-G+9!_X!! MKS3H'>NA7QKTVP;N 8-!:9#?NEG<>RZ<3Q7UQH)OBF%1B$ZJ-B-(E>11\*6A"+LDG*@3-8DC.?*9H%,MS&/TR\\G9 MAW/R@40I>8CB&&(MQZ:""\EP9E@ZO2N<.@><]L@#3]5*DB"=LWF'O:^W=[]G M'^CM;4<#,$'!2D;G3<8[1TOT67A%>O8%<2RGWW%!4[WYC*W!W#IH[O^<]^"' MO3?$Z%4YU]WP[/">2/7 M-&03 RIC3C2\7W^Q7>NW+MTQ83XF+$""-2+4KR+4U]$]J+%005,H,$*P-/Q& ME*"IC&E>NY?P>"%G,9?RO"L\6O*IX2E@;@[+GFDOWN7(LL;FRZ[LF!X#)%A# M]D$E^T K^WT:"@9/645C>,CN_I.$*RJ63$)9S4/25=/NM.Q3A<>$^9BP8+"7 M$K:SDQ(-X=U*>%5'D.M'C-8F($2%^0/EC(!V9C5Y]LYK"\B$*IX[@>OL!B5W3)IZ:>F(B;, MQX0%2+!&B$95B$;O^1 =848($^9CP@(D6"-"UU6$KG&*2H$9[%0#9] J*EI/ MIRJ\[V]XW2H^2/X:NME6W7-86N7R;.8+,J-QMV)Z^U/3%Y7FH]("+%HS$CO= MG_V>5::D8\4)D^:CT@(L6C-.3ATG!Z?6E)Q&L1FUBHW>U\DZ[WMTV^4&RV-3 MO;H?M;7-E/=9K9@@GWAZR=U\DZ[WL< MC@;M.H3DLBE?W87:^C;T ?JK9)-T"H;4#I;28M)\5%J 16O&H.Y\[>&[EAK4 MUA>5YJ/2 BQ:,TYU^VMK>S?O8R05%U&X_U,9A$Q>D&>VX((115\[PS3JZ+FL M=@%"[6N/<1E@N6R*6G>LMKYE?:"O!PL09@LZ1:7YJ+0 B];<**J;7\=ZSP+D MH+;&J#0?E19@T9IQJEMC1]O2_60!*N&[/P$/VAL;4_T5G*S^$2X#+)>%J.;. MQG/"8#&8[?A+4&B3JF+SM!JMWBJXS??26^-W]LVT>#>@QA2O*CS &C-*)8G9 M I#6U1 *K"AV_XL3Q=?Y]O8S5XHG^>&*T3D3V03X?L&Y>CO)'%3O8'C_ U!+ M P04 " *@C9:H+/>;9\$ !G' &0 'AL+W=OYD=&<) YQ9&-'&=BQSA,K-4BN_;(5@MZ$E&8 MD$<&^"F.,?NQ)A$]+RUHO5[8AON#2"_8J\41[\D3$5^/CTR>V25*$,8DX2%- M ".[I74/[SPT3ATRBS]#,2<;&OT5!N*PM&86",@.GR*QI>??29%0 M%J!/(Y[]!>?"UK& ?^*"QH6SC" .D_P7?R^(J#E(G&X'5#B@IL.HQ\$M'-QK M5Q@5#J.,F3R5C :B ,'OR8!"3K\/;W_1.-O2S9*2M K)6ND M!?2(?PM<^!D@!XTZXMGHW9_(4;H[O>[>_UY=R<8M"^QF>.Y5!99GA+T0\/>6 M1A&0;\X9L^"?KJ+EJ*-NU+0;W?$C]LG2DNTFP[16/_\$)\XO78R9!/,,@2EL MCDHV1SKTU9KLPR1)F7S&$4Y\TD6=%F(H=3G8) -+F_C+"DXF"_NESHC>1DET M7"8ZUB:ZH5S(]]H_,=;Y4J['K35'4S6L36XRKIG,9LW0VS9SU^T.?5*&/KD< M^A&'@9-6HS5,FZ7LO)CA3$ZDST#G+-(B#*V[23#/$)C"W+QD;OXN0V)N MDDV38)XA,(5-Z%2BRGG[F-!C#&6O0%->J%HG+924WDC-MB8AX=MF1>%?7Q:- M&\VEPP8VAT6'S:BG,T)418_>/B[T&(-K91+-*]"4B3'N::6PDHU0JZ.N&!D% M@%(QV"JK4>EW84DUU4K30;VHN^>R\C=;$F%!@O[1H4<9_ R81/-,H:D,5F(1 MCM]E?D"M"!U,J4DTSQ2:2FDE8J%>Q5XW0HS*6-B6GDZS ^M,U$PK;0KUXO3R M^&AKQ7FSS;1-W%;L'3;SGN KR0GUFO.ZZ6%4=1I%\PHT97KTTE+I2:@56-=, MC_FEAVVC7V-PHKH%U0]%EIWW11P(ZY\8>N^A=3>*YIE"4YFK-"."[S(Q MD%:*#J;4))IG"DVEM!*R2"]DKYH8>HS!_+6EIXL:;5=OH^9:J5.D5Z<79P;J M4(JC1G\I;.K?L&;NO!E^&V@V[OF7"562$^DEYU5C0X\QN%9&!6>!IHR-&>KC MI1*22/_9\?+<0.T/CQ/4+*Q1(:A?,4_4KNW Q(3MLYTL#GQZ2D2^\U!>+7?+ M[K,]HL;U-;S;Y'M>%4R^!?> F7R_.8C(3D(ZMU,9%LMWM?(308_9/L\S%8+& MV>&!X("PU$#>WU$J7D_2!&POO#!@MJ8]_C<^ZQ?4/<]DNS%.QAQI@) M%KF0Y8#,C"D^AF$YF;&J8-(BF=(Y-;:KIV%9:$;3$DBY"#NM5ASFE$LR M[,MY?I>;,IBHN30#TFU"@;M]20>D'5^3P,F-5,H&Y.GB_<^Y,K?O G<_^W!V MUGJZO-V-7U3 )0F]HC<'B%ZU<%V+8=+QMG0]W"JMF!BQ>YBG_:YP7[T#Y?>J M8^*)9]+GS9S/$5JW=9"G/8XJX; NI&$_4W)=3Q%Q 9N9YBQXIF) 1E3PL>; MRFC.Q=*%.Q"8**%T8&PA6RMMB)0O#FZ['M1XK9-SJ725VV5PO\?U\!U@U0.# M7(C&8(>XP+!?4&.8EG>V4PVN@J^@H&X_+@OK<*KILMVY(6M"=;-)QDJG3#=I MVF05&O8%R\".YM,9W(TJ0@"-4;EMI)Q.E:25AQ6C;EC9"1/B ;X ?F1;VHML M8T^K'95-TQJJFT[&=4!_4\UI;\I>OTDW*/BS,I_G=CJRZD.ML'O-,KZH^HNL M,8"IMW%U6A1B^4GPJV,*MR6F2XY\X)>OZ[ZSQEDFDJ-DW;VC_F57ZSXZC[KRQ7WRJ[AKT>Z[?Z ML9N\.063\2F8/(F:[)V"R>3X348GX+$^>QZ=R; ^"6TE;\>G+*-S81X;<$#6[6\LY?,\ M:4;=PT+4H];MKS"]=MR8&"[@-4.Y/?G@9KR*NQS $P( L !?3T\$MP>:4#M M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3 MY?YVX$G1H2)8%II%R=.B':5_'UET9# M82CX)L6C^WT^'+('Z>1:*NE_SK.XKT3&.JEE)Y]$,\^F&7.M>?QDK'PRVG.U MJJU1:I[EPXEOPGI9_U&\"I!?^=K%$L_7=QQ YMEL"C?<2.M\K!'OSX'Q04#E MX:CWYJ-47MA+[L65-?U.ZFVX#;S%)'F-&(?]=@CBN?V7,)K-1M;BTM1])[0? MXFB%"H#:M7+G,J9Y)^;9A7D0EBWY5H27@J=<-\,+>B!+PF7/)9RPUTUDI.31 MSBC9P-,;M@H0X0+'S(9]X%8GD 4"61P-\L)TNP2R1"#+_PCYGBNN:\%BBW0) M8(4 5D<#9"=+GD">(9!G1_O4JY;;!'*&0,Z."/F]2"!?(9"OCM=IN&L3R-<( MY&M:R/?"A=!4TQ,+#FQ6: O]UVO8CJ\]2U\[!!3*UH(*XP54TQ, M+3FY6[I.^N=O7OK?/N3O0I7"86')BLRSY3_80\TV\/,3O4KI:&=>/DD^!>:4@ M]LHU](H&OO!7RYL0PX6UD+\'^Z6,F& *8L&@BAZ-PPIT]D)LF .*9B;)B:>@E@\AQ+1*5LTC0R[Z92FQ-13_O\I#6!"CZ]# MZ6V*B=FG)+;/8I9B8A$IB"1W2^:7P7*I1TBPQ Y74*B2FH(E;0X2'Q*;OAUD+M%!-34$4] M#_H+YG-YBHE9J(H6FNP7D!NQD5HT-_ (!^4U5_72LK 9_G=79^$/U*97Z@+* M;O5GPYO]>O1^+?W=+U!+ P04 " *@C9:N2/:-[(! !4' &@ 'AL M+U]R96QS+W=OCN9U3O;_?F@$02-R@>-(6ABOJK01Z M*^JM!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM!'I;[["$0&]#O8U M;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]'O9U ;T>]G4!O1[V=0&]'O9U M;^\==A/H[:BW$^CMJ+<3Z.VHMS]2[Y1/NYAN/=7!E&ULS=G);L(P% 707T'9(F(\E X"-FVW+8O^@)L\2$026[:A M\/=UPB"UHJB(2KV;1(GM=U]LZ6PR?MM:\KU-735^DA0AV ?&?%90K7UJ+#5Q M9&Y\B:]]:9I)XJCR M2>]Q-['-FB3:VJK,=(CC;-WDWU(&^X0TKNSF^**TOA\G).QD0COR<\!^W>N: MG"MSZLVT"R^ZCK/8IF(^;"ORZ?D2)WHT\WF946ZR51V7I-XZTKDOB$)=I;NB M_?/)(>XP[:[\ZORNS+G .'/FC/7QQ!Q='G&UL4$L! A0#% @ "H(V6FS".9'N *P( M !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! A0#% M @ "H(V6IE&PO=V]R:W-H965T&UL4$L! A0#% M @ "H(V6EC6HJ_\!0 I!@ !@ ("!MQ$ 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ "H(V6D^HQG4_ @ M+ 4 !@ ("!/R, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ "H(V6HF-]?\ !P (1T !@ M ("!8CD 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ "H(V6K'E<'GJ"@ PQX M !D ("!V5 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ "H(V6F5926]%"@ 6!\ !D M ("!.60 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ "H(V6B&+N97P! MPL !D ("!?7D 'AL+W=O M&PO=V]R:W-H965TZ% M !X;"]W;W)K&UL4$L! A0#% @ "H(V6BQU M:+Y# @ B@8 !D ("!M8@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ "H(V6@HWG4^&PO M=V]R:W-H965T&UL4$L! A0#% @ "H(V6CQ2]U&#!0 %Q !D ("! M4*( 'AL+W=O" &0 @($*J >&PO=V]R:W-H965T] 0, P' 9 M " @>FK !X;"]W;W)K&UL4$L! A0#% M @ "H(V6G5CAH(G @ M00 !D ("!(:\ 'AL+W=OVX" !Y!@ &0 M@(%IPP >&PO=V]R:W-H965T&UL4$L! A0#% @ "H(V6B/'I3^P @ ' D !D M ("!U,D 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ "H(V6N!S"/,M! /Q !D ("! =< M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M"H(V6JM[W]V9 P DPX !D ("!+N0 'AL+W=O&PO=V]R:W-H965TR@( !$) 9 " @>CP !X;"]W M;W)K&UL4$L! A0#% @ "H(V6L90R@X% P M]@L !D ("!Z?, 'AL+W=O$$ "/(0 &0 @($E M]P >&PO=V]R:W-H965T&UL4$L! A0#% @ "H(V6A 04'Q# P [!0 T M ( !$P$! 'AL+W-T>6QE&PO=V]R:V)O M;VLN>&UL4$L! A0#% @ "H(V6KDCVC>R 0 5!P !H M ( !J D! 'AL+U]R96QS+W=O<&5S72YX;6Q02P4& #< -P#X#@ >@T! end XML 61 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.4 html 268 201 1 true 72 0 false 8 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.pg.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - Consolidated Statements of Earnings Sheet http://www.pg.com/role/ConsolidatedStatementsofEarnings Consolidated Statements of Earnings Statements 2 false false R3.htm 9952152 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 9952153 - Statement - Consolidated Balance Sheets Sheet http://www.pg.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 9952154 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.pg.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 9952155 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity Consolidated Statements of Shareholders' Equity Statements 6 false false R7.htm 9952156 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical) Sheet http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical Consolidated Statements of Shareholders' Equity (Parenthetical) Statements 7 false false R8.htm 9952157 - Statement - Consolidated Statements of Cash Flows Sheet http://www.pg.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 9952158 - Disclosure - Basis of Presentation Sheet http://www.pg.com/role/BasisofPresentation Basis of Presentation Notes 9 false false R10.htm 9952159 - Disclosure - New Accounting Pronouncements and Policies Sheet http://www.pg.com/role/NewAccountingPronouncementsandPolicies New Accounting Pronouncements and Policies Notes 10 false false R11.htm 9952160 - Disclosure - Segment Information Sheet http://www.pg.com/role/SegmentInformation Segment Information Notes 11 false false R12.htm 9952161 - Disclosure - Goodwill and Intangible Assets Sheet http://www.pg.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 12 false false R13.htm 9952162 - Disclosure - Earnings Per Share Sheet http://www.pg.com/role/EarningsPerShare Earnings Per Share Notes 13 false false R14.htm 9952163 - Disclosure - Share-Based Compensation and Postretirement Benefits Sheet http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits Share-Based Compensation and Postretirement Benefits Notes 14 false false R15.htm 9952164 - Disclosure - Risk Management Activities and Fair Value Measurements Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements Risk Management Activities and Fair Value Measurements Notes 15 false false R16.htm 9952165 - Disclosure - Accumulated Other Comprehensive Income/(Loss) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income/(Loss) Notes 16 false false R17.htm 9952166 - Disclosure - Commitments and Contingencies Sheet http://www.pg.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 9952167 - Disclosure - Supplier Finance Programs Sheet http://www.pg.com/role/SupplierFinancePrograms Supplier Finance Programs Notes 18 false false R19.htm 9952168 - Disclosure - Restructuring Program Sheet http://www.pg.com/role/RestructuringProgram Restructuring Program Notes 19 false false R20.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 9955511 - Disclosure - New Accounting Pronouncements and Policies (Policies) Sheet http://www.pg.com/role/NewAccountingPronouncementsandPoliciesPolicies New Accounting Pronouncements and Policies (Policies) Policies http://www.pg.com/role/NewAccountingPronouncementsandPolicies 22 false false R23.htm 9955512 - Disclosure - Segment Information (Tables) Sheet http://www.pg.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.pg.com/role/SegmentInformation 23 false false R24.htm 9955513 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.pg.com/role/GoodwillandIntangibleAssets 24 false false R25.htm 9955514 - Disclosure - Earnings Per Share (Tables) Sheet http://www.pg.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.pg.com/role/EarningsPerShare 25 false false R26.htm 9955515 - Disclosure - Share-Based Compensation and Postretirement Benefits (Tables) Sheet http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables Share-Based Compensation and Postretirement Benefits (Tables) Tables http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits 26 false false R27.htm 9955516 - Disclosure - Risk Management Activities and Fair Value Measurements (Tables) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables Risk Management Activities and Fair Value Measurements (Tables) Tables http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements 27 false false R28.htm 9955517 - Disclosure - Accumulated Other Comprehensive Income/(Loss) (Tables) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income/(Loss) (Tables) Tables http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss 28 false false R29.htm 9955518 - Disclosure - Restructuring Program (Tables) Sheet http://www.pg.com/role/RestructuringProgramTables Restructuring Program (Tables) Tables http://www.pg.com/role/RestructuringProgram 29 false false R30.htm 9955519 - Disclosure - Segment Information - Additional Information (Details) Sheet http://www.pg.com/role/SegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 30 false false R31.htm 9955520 - Disclosure - Segment Information - Percent Of Sales By Business Unit (Details) Sheet http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails Segment Information - Percent Of Sales By Business Unit (Details) Details 31 false false R32.htm 9955521 - Disclosure - Segment Information - Global Segment Results (Details) Sheet http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails Segment Information - Global Segment Results (Details) Details 32 false false R33.htm 9955522 - Disclosure - Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) Details 33 false false R34.htm 9955523 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails Goodwill and Intangible Assets - Intangible Assets (Details) Details 34 false false R35.htm 9955524 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails Goodwill and Intangible Assets - Additional Information (Details) Details 35 false false R36.htm 9955525 - Disclosure - Goodwill and Intangible Assets - Fair Value Impacts (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails Goodwill and Intangible Assets - Fair Value Impacts (Details) Details 36 false false R37.htm 9955526 - Disclosure - Earnings Per Share (Details) Sheet http://www.pg.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.pg.com/role/EarningsPerShareTables 37 false false R38.htm 9955527 - Disclosure - Share-Based Compensation and Postretirement Benefits (Details) Sheet http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails Share-Based Compensation and Postretirement Benefits (Details) Details http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables 38 false false R39.htm 9955528 - Disclosure - Risk Management Activities and Fair Value Measurements - Additional Information (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails Risk Management Activities and Fair Value Measurements - Additional Information (Details) Details 39 false false R40.htm 9955529 - Disclosure - Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) Details 40 false false R41.htm 9955530 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) Details 41 false false R42.htm 9955531 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) Details 42 false false R43.htm 9955532 - Disclosure - Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) Details 43 false false R44.htm 9955533 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.pg.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.pg.com/role/CommitmentsandContingencies 44 false false R45.htm 9955534 - Disclosure - Supplier Finance Programs (Details) Sheet http://www.pg.com/role/SupplierFinanceProgramsDetails Supplier Finance Programs (Details) Details http://www.pg.com/role/SupplierFinancePrograms 45 false false R46.htm 9955535 - Disclosure - Restructuring Program - Narrative (Details) Sheet http://www.pg.com/role/RestructuringProgramNarrativeDetails Restructuring Program - Narrative (Details) Details 46 false false R47.htm 9955536 - Disclosure - Restructuring Program - Restructuring Activity (Details) Sheet http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails Restructuring Program - Restructuring Activity (Details) Details 47 false false All Reports Book All Reports pg-20241231.htm pg-20241231.xsd pg-20241231_cal.xml pg-20241231_def.xml pg-20241231_lab.xml pg-20241231_pre.xml pg-20241231_g1.jpg http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 66 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pg-20241231.htm": { "nsprefix": "pg", "nsuri": "http://www.pg.com/20241231", "dts": { "inline": { "local": [ "pg-20241231.htm" ] }, "schema": { "local": [ "pg-20241231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "pg-20241231_cal.xml" ] }, "definitionLink": { "local": [ "pg-20241231_def.xml" ] }, "labelLink": { "local": [ "pg-20241231_lab.xml" ] }, "presentationLink": { "local": [ "pg-20241231_pre.xml" ] } }, "keyStandard": 187, "keyCustom": 14, "axisStandard": 17, "axisCustom": 1, "memberStandard": 33, "memberCustom": 37, "hidden": { "total": 11, "http://fasb.org/us-gaap/2024": 6, "http://xbrl.sec.gov/dei/2024": 5 }, "contextCount": 268, "entityCount": 1, "segmentCount": 72, "elementCount": 473, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 767, "http://xbrl.sec.gov/dei/2024": 77, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://www.pg.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "longName": "9952151 - Statement - Consolidated Statements of Earnings", "shortName": "Consolidated Statements of Earnings", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R3": { "role": "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome", "longName": "9952152 - Statement - Consolidated Statements of Comprehensive Income", "shortName": "Consolidated Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R4": { "role": "http://www.pg.com/role/ConsolidatedBalanceSheets", "longName": "9952153 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-19", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R5": { "role": "http://www.pg.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "9952154 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-19", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "longName": "9952155 - Statement - Consolidated Statements of Shareholders' Equity", "shortName": "Consolidated Statements of Shareholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-89", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-89", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical", "longName": "9952156 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)", "shortName": "Consolidated Statements of Shareholders' Equity (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "us-gaap:PreferredStockDividendsPerShareDeclared", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "us-gaap:PreferredStockDividendsPerShareDeclared", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.pg.com/role/ConsolidatedStatementsofCashFlows", "longName": "9952157 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-23", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-97", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R9": { "role": "http://www.pg.com/role/BasisofPresentation", "longName": "9952158 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.pg.com/role/NewAccountingPronouncementsandPolicies", "longName": "9952159 - Disclosure - New Accounting Pronouncements and Policies", "shortName": "New Accounting Pronouncements and Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.pg.com/role/SegmentInformation", "longName": "9952160 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssets", "longName": "9952161 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.pg.com/role/EarningsPerShare", "longName": "9952162 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits", "longName": "9952163 - Disclosure - Share-Based Compensation and Postretirement Benefits", "shortName": "Share-Based Compensation and Postretirement Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements", "longName": "9952164 - Disclosure - Risk Management Activities and Fair Value Measurements", "shortName": "Risk Management Activities and Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss", "longName": "9952165 - Disclosure - Accumulated Other Comprehensive Income/(Loss)", "shortName": "Accumulated Other Comprehensive Income/(Loss)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.pg.com/role/CommitmentsandContingencies", "longName": "9952166 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.pg.com/role/SupplierFinancePrograms", "longName": "9952167 - Disclosure - Supplier Finance Programs", "shortName": "Supplier Finance Programs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.pg.com/role/RestructuringProgram", "longName": "9952168 - Disclosure - Restructuring Program", "shortName": "Restructuring Program", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R20": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": null }, "R21": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-20", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.pg.com/role/NewAccountingPronouncementsandPoliciesPolicies", "longName": "9955511 - Disclosure - New Accounting Pronouncements and Policies (Policies)", "shortName": "New Accounting Pronouncements and Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.pg.com/role/SegmentInformationTables", "longName": "9955512 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsTables", "longName": "9955513 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.pg.com/role/EarningsPerShareTables", "longName": "9955514 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables", "longName": "9955515 - Disclosure - Share-Based Compensation and Postretirement Benefits (Tables)", "shortName": "Share-Based Compensation and Postretirement Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables", "longName": "9955516 - Disclosure - Risk Management Activities and Fair Value Measurements (Tables)", "shortName": "Risk Management Activities and Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables", "longName": "9955517 - Disclosure - Accumulated Other Comprehensive Income/(Loss) (Tables)", "shortName": "Accumulated Other Comprehensive Income/(Loss) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.pg.com/role/RestructuringProgramTables", "longName": "9955518 - Disclosure - Restructuring Program (Tables)", "shortName": "Restructuring Program (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.pg.com/role/SegmentInformationAdditionalInformationDetails", "longName": "9955519 - Disclosure - Segment Information - Additional Information (Details)", "shortName": "Segment Information - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "longName": "9955520 - Disclosure - Segment Information - Percent Of Sales By Business Unit (Details)", "shortName": "Segment Information - Percent Of Sales By Business Unit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-150", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-150", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "longName": "9955521 - Disclosure - Segment Information - Global Segment Results (Details)", "shortName": "Segment Information - Global Segment Results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-174", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R33": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "longName": "9955522 - Disclosure - Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details)", "shortName": "Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-23", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pg:GoodwillAcquisitionsandDivestitures", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R34": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails", "longName": "9955523 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets - Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-19", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "longName": "9955524 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)", "shortName": "Goodwill and Intangible Assets - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails", "longName": "9955525 - Disclosure - Goodwill and Intangible Assets - Fair Value Impacts (Details)", "shortName": "Goodwill and Intangible Assets - Fair Value Impacts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-194", "name": "pg:PercentChangeInEstimatedFairValue", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-194", "name": "pg:PercentChangeInEstimatedFairValue", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.pg.com/role/EarningsPerShareDetails", "longName": "9955526 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R38": { "role": "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails", "longName": "9955527 - Disclosure - Share-Based Compensation and Postretirement Benefits (Details)", "shortName": "Share-Based Compensation and Postretirement Benefits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "longName": "9955528 - Disclosure - Risk Management Activities and Fair Value Measurements - Additional Information (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-19", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails", "longName": "9955529 - Disclosure - Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-19", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "longName": "9955530 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "longName": "9955531 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-225", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-225", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "longName": "9955532 - Disclosure - Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details)", "shortName": "Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-32", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } }, "R44": { "role": "http://www.pg.com/role/CommitmentsandContingenciesDetails", "longName": "9955533 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-19", "name": "pg:NumberOfCountriesWithOnTheGroundOperations", "unitRef": "country", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "pg:NumberOfCountriesWithOnTheGroundOperations", "unitRef": "country", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.pg.com/role/SupplierFinanceProgramsDetails", "longName": "9955534 - Disclosure - Supplier Finance Programs (Details)", "shortName": "Supplier Finance Programs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-19", "name": "us-gaap:SupplierFinanceProgramObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:SupplierFinanceProgramObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "longName": "9955535 - Disclosure - Restructuring Program - Narrative (Details)", "shortName": "Restructuring Program - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-246", "name": "us-gaap:RestructuringReserveTranslationAdjustment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-246", "name": "us-gaap:RestructuringReserveTranslationAdjustment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails", "longName": "9955536 - Disclosure - Restructuring Program - Restructuring Activity (Details)", "shortName": "Restructuring Program - Restructuring Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-23", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsForRestructuring", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20241231.htm", "unique": true } } }, "tag": { "pg_A0.110NotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A0.110NotesDue2026Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.110% Notes due 2026", "label": "0.110% Notes due 2026 [Member]", "documentation": "0.110% Notes due 2026" } } }, "auth_ref": [] }, "pg_A0.230NotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A0.230NotesDue2031Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.230% Notes due 2031", "label": "0.230% Notes due 2031 [Member]", "documentation": "0.230% Notes due 2031" } } }, "auth_ref": [] }, "pg_A0.350NotesDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A0.350NotesDue2030Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.350% Notes due 2030", "label": "0.350% Notes due 2030 [Member]", "documentation": "0.350% Notes due 2030" } } }, "auth_ref": [] }, "pg_A0.900NotesDue2041Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A0.900NotesDue2041Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.900% Notes due 2041", "label": "0.900% Notes due 2041 [Member]", "documentation": "0.900% Notes due 2041" } } }, "auth_ref": [] }, "pg_A1.200NotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A1.200NotesDue2028Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.200% Notes due 2028", "label": "1.200% Notes due 2028 [Member]", "documentation": "1.200% Notes due 2028" } } }, "auth_ref": [] }, "pg_A1.250NotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A1.250NotesDue2029Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.250% Notes due 2029", "label": "1.250% Notes due 2029 [Member]", "documentation": "1.250% Notes due 2029" } } }, "auth_ref": [] }, "pg_A1.375NotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A1.375NotesDue2025Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.375% Notes due 2025", "label": "1.375% Notes due 2025 [Member]", "documentation": "1.375% Notes due 2025" } } }, "auth_ref": [] }, "pg_A1.800NotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A1.800NotesDue2029Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.800% Notes due 2029", "label": "1.800% Notes due 2029 [Member]", "documentation": "1.800% Notes due 2029" } } }, "auth_ref": [] }, "pg_A1.875NotesDue2038Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A1.875NotesDue2038Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.875% Notes due 2038", "label": "1.875% Notes due 2038 [Member]", "documentation": "1.875% Notes due 2038" } } }, "auth_ref": [] }, "pg_A25BpsIncreaseDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A25BpsIncreaseDiscountRateMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "+25 bps Discount Rate", "label": "25 bps Increase Discount Rate [Member]", "documentation": "25 bps Increase Discount Rate" } } }, "auth_ref": [] }, "pg_A25bpsDecreaseLongTermGrowthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A25bpsDecreaseLongTermGrowthMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "-25 bps Growth Rates", "label": "25 bps Decrease Long-Term Growth [Member]", "documentation": "25 bps Decrease Long-Term Growth [Member]" } } }, "auth_ref": [] }, "pg_A3.150EURONotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A3.150EURONotesDue2028Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.150% EUR Notes due 2028", "label": "3.150% EURO Notes due 2028 [Member]", "documentation": "3.150% EURO Notes due 2028" } } }, "auth_ref": [] }, "pg_A3.200EURNotesDue2034Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A3.200EURNotesDue2034Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.200% EUR Notes due 2034", "label": "3.200% EUR Notes due 2034 [Member]", "documentation": "3.200% EUR Notes due 2034" } } }, "auth_ref": [] }, "pg_A3.250EURNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A3.250EURNotesDue2026Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.250% EUR Notes due 2026", "label": "3.250% EUR Notes due 2026 [Member]", "documentation": "3.250% EUR Notes due 2026" } } }, "auth_ref": [] }, "pg_A3.250EURNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A3.250EURNotesDue2031Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.250% EUR Notes due 2031", "label": "3.250% EUR Notes due 2031 [Member]", "documentation": "3.250% EUR Notes due 2031" } } }, "auth_ref": [] }, "pg_A4.875EURNotesDueMay2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A4.875EURNotesDueMay2027Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.875% EUR Notes due May 2027", "label": "4.875% EUR Notes due May 2027 [Member]", "documentation": "4.875% EUR Notes due May 2027" } } }, "auth_ref": [] }, "pg_A5.250GBPNotesDueJanuary2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A5.250GBPNotesDueJanuary2033Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "5.250% GBP Notes due January 2033", "label": "5.250% GBP notes due January 2033 [Member]", "documentation": "5.250% GBP notes due January 2033" } } }, "auth_ref": [] }, "pg_A50BpsDecreaseLongTermRoyaltyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A50BpsDecreaseLongTermRoyaltyMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "-50 bps Royalty Rate", "label": "50 bps Decrease Long-Term Royalty [Member]", "documentation": "50 bps Decrease Long-Term Royalty" } } }, "auth_ref": [] }, "pg_A6.250GBPNotesDueJanuary2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "A6.250GBPNotesDueJanuary2030Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "6.250% GBP Notes due January 2030", "label": "6.250% GBP notes due January 2030 [Member]", "documentation": "6.250% GBP notes due January 2030" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r68", "r703" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r835" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r70" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postretirement Benefit Plans", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r13", "r20", "r86", "r159", "r518", "r810", "r811" ] }, "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation", "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r3", "r13", "r20", "r84", "r85", "r159", "r518", "r810", "r811" ] }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Securities", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest." } } }, "auth_ref": [ "r149", "r150", "r151", "r153", "r159", "r518", "r810", "r811" ] }, "pg_AccumulatedOtherComprehensiveIncomeGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "AccumulatedOtherComprehensiveIncomeGainLoss", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/(loss) recognized in AOCI", "label": "Accumulated Other Comprehensive Income, Gain (Loss)", "documentation": "Accumulated Other Comprehensive Income, Gain (Loss)" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r159", "r160", "r475", "r477", "r478", "r479", "r480", "r481" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r19", "r20", "r87", "r143", "r510", "r543", "r546" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r159", "r160", "r475", "r477", "r478", "r479", "r480", "r481" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income/(Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r13", "r20", "r455", "r458", "r487", "r539", "r540", "r809", "r810", "r811", "r822", "r823", "r824", "r825" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r753" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r78", "r703", "r926" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r559", "r822", "r823", "r824", "r825", "r869", "r927" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r766" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r766" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r766" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r766" ] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r799" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r725", "r735", "r745", "r777" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r728", "r738", "r748", "r780" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r800" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r766" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r773" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r729", "r739", "r749", "r773", "r781", "r785", "r793" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r791" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r420", "r421" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible asset amortization", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r272", "r275", "r673" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r210" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r25" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r25" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r114", "r121", "r137", "r172", "r214", "r222", "r240", "r244", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r442", "r446", "r473", "r506", "r600", "r666", "r667", "r703", "r716", "r862", "r863", "r885" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL CURRENT ASSETS", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r132", "r145", "r172", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r442", "r446", "r473", "r703", "r862", "r863", "r885" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT ASSETS", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r788" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r789" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r784" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r784" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r784" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r784" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r784" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r784" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r787" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r786" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r785" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r785" ] }, "pg_BabyCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "BabyCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Baby Care", "label": "Baby Care [Member]", "documentation": "Baby Care [Member]" } } }, "auth_ref": [] }, "pg_BabyFeminineFamilyCareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "BabyFeminineFamilyCareSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Baby, Feminine & Family Care", "label": "Baby, Feminine & Family Care Segment [Member]", "documentation": "Baby, Feminine & Family Care Segment" } } }, "auth_ref": [] }, "pg_BeautySegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "BeautySegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beauty", "label": "Beauty Segment [Member]", "documentation": "Beauty Segment Member" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodStartLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD", "periodEndLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r98", "r171" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r98" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r806", "r893" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r764" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r761" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r759" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r126", "r140", "r141", "r142", "r172", "r198", "r202", "r207", "r209", "r216", "r217", "r253", "r311", "r314", "r315", "r316", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r473", "r552", "r553", "r554", "r555", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r588", "r609", "r627", "r643", "r644", "r645", "r646", "r647", "r803", "r819", "r826" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r765" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r765" ] }, "us-gaap_CollateralAlreadyPostedAggregateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollateralAlreadyPostedAggregateFairValue", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral already posted, aggregate fair value", "label": "Collateral Already Posted, Aggregate Fair Value", "documentation": "The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features." } } }, "auth_ref": [ "r58" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r104", "r303", "r304", "r650", "r854", "r859" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and dividend equivalents, common stock (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r105" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r706", "r707", "r708", "r710", "r711", "r712", "r713", "r822", "r823", "r825", "r869", "r924", "r927" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r77" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r77", "r588", "r606", "r927", "r928" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r77", "r509", "r703" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r770" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r769" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r771" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r768" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation and Postretirement Benefits", "label": "Compensation and Employee Benefit Plans [Text Block]", "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r106", "r107", "r108", "r109" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "pg_CompensationandEmployeeBenefitPlansTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pg.com/20241231", "localname": "CompensationandEmployeeBenefitPlansTableTextBlock", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and Employee Benefit Plans", "label": "Compensation and Employee Benefit Plans [Table Text Block]", "documentation": "Compensation and Employee Benefit Plans [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r21", "r156", "r158", "r166", "r502", "r519", "r521" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r8", "r44", "r47", "r156", "r158", "r165", "r501", "r519", "r520" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL COMPREHENSIVE INCOME", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r47", "r111", "r156", "r158", "r164", "r500", "r519" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income/(Loss)", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r83", "r163", "r499", "r518" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r26", "r27", "r65", "r66", "r250", "r649" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r26", "r27", "r65", "r66", "r250", "r548", "r649" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r26", "r27", "r65", "r66", "r250", "r649", "r805" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk (in percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r26", "r27", "r65", "r66", "r250" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r26", "r27", "r65", "r66", "r250", "r649" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r119", "r173", "r214", "r224", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r311", "r312", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r666", "r667", "r862", "r863" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r119", "r173", "r214", "r224", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r311", "r312", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r666", "r667", "r862", "r863" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r16", "r239", "r240", "r241", "r242", "r245", "r831" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of products sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r89", "r90", "r493" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Debt due within one year", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r138" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r10", "r123", "r821" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "DEFERRED INCOME TAXES", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r423", "r424", "r507" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net periodic benefit cost (credit)", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r362", "r378", "r683", "r684" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r214", "r227", "r244", "r666", "r667" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r448" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair\u00a0Value\u00a0Asset", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r146", "r147", "r465", "r466", "r470", "r472", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r594", "r595", "r634", "r637", "r638", "r639", "r640", "r641", "r658", "r696", "r699", "r708", "r871", "r872", "r873", "r925" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r578", "r580", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r601", "r602", "r603", "r604", "r615", "r616", "r617", "r618", "r621", "r622", "r623", "r624", "r634", "r635", "r638", "r640", "r706", "r708", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in Earnings", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r867" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r54", "r56", "r57", "r113", "r578", "r580", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r601", "r602", "r603", "r604", "r615", "r616", "r617", "r618", "r621", "r622", "r623", "r624", "r634", "r635", "r638", "r640", "r658", "r706", "r708", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r15", "r54", "r56" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Fair Value (Liability)", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r146", "r147", "r465", "r466", "r470", "r472", "r571", "r572", "r573", "r574", "r576", "r577", "r578", "r579", "r580", "r601", "r603", "r604", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r658", "r871", "r872", "r873", "r925" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r448" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r865", "r866" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_DilutiveSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DilutiveSecuritiesAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add effect of dilutive securities:", "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r7", "r105" ] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPreferredStock", "crdr": "debit", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Preferred", "terseLabel": "Less: Preferred dividends", "label": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r7", "r105" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r720" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r752" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r763" ] }, "pg_ESOPDebtImpacts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "ESOPDebtImpacts", "crdr": "credit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "ESOP debt impacts", "label": "ESOP Debt Impacts", "documentation": "ESOP Debt Impacts" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "NET EARNINGS PER COMMON SHARE", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r167", "r183", "r184", "r185", "r186", "r187", "r188", "r195", "r198", "r207", "r208", "r209", "r213", "r437", "r440", "r463", "r464", "r503", "r522", "r659" ] }, "pg_EarningsPerShareBasicAndDilutedEPSAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pg.com/20241231", "localname": "EarningsPerShareBasicAndDilutedEPSAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "NET EARNINGS PER COMMON SHARE", "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]", "documentation": "Earnings Per Share, Basic and Diluted EPS" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r167", "r183", "r184", "r185", "r186", "r187", "r188", "r198", "r207", "r208", "r209", "r213", "r437", "r440", "r463", "r464", "r503", "r522", "r659" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.pg.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r194", "r210", "r211", "r212" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r474" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separation Costs", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitiesTable", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r718" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r718" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r718" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationLineItems", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r802" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r718" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r718" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r718" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r718" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r757" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r798" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r798" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r798" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r127", "r159", "r160", "r161", "r174", "r175", "r176", "r180", "r187", "r189", "r191", "r215", "r254", "r257", "r278", "r328", "r427", "r428", "r432", "r433", "r434", "r438", "r439", "r440", "r454", "r455", "r456", "r457", "r458", "r460", "r462", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r484", "r487", "r518", "r539", "r540", "r541", "r559", "r627" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r767" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r725", "r735", "r745", "r777" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r722", "r732", "r742", "r774" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r773" ] }, "pg_FabricCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "FabricCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fabric Care", "label": "Fabric Care [Member]", "documentation": "Fabric Care [member]" } } }, "auth_ref": [] }, "pg_FabricHomeCareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "FabricHomeCareSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fabric & Home Care", "label": "Fabric & Home Care Segment [Member]", "documentation": "Fabric & Home Care Segment" } } }, "auth_ref": [] }, "us-gaap_FacilityClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FacilityClosingMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-Related Costs", "label": "Facility Closing [Member]", "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_FairValueHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueHedgingMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hedging", "label": "Fair Value Hedging [Member]", "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk." } } }, "auth_ref": [ "r51" ] }, "pg_FamilyCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "FamilyCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Family Care", "label": "Family Care [Member]", "documentation": "Family Care [Member]" } } }, "auth_ref": [] }, "pg_FeminineCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "FeminineCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Feminine Care", "label": "Feminine Care [Member]", "documentation": "Feminine Care [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Risk Management Activities and Fair Value Measurements", "label": "Financial Instruments Disclosure [Text Block]", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r135", "r258", "r274", "r673" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r258", "r274", "r497", "r673" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets with determinable lives", "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency interest rate contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r658", "r682", "r695", "r696" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r729", "r739", "r749", "r781" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r729", "r739", "r749", "r781" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r729", "r739", "r749", "r781" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r729", "r739", "r749", "r781" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r729", "r739", "r749", "r781" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r762" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss/(gain) on sale of assets", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r817" ] }, "pg_GilletteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "GilletteMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gillette", "label": "Gillette [Member]", "documentation": "Gillette [Member]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r134", "r259", "r498", "r667", "r672", "r697", "r703", "r839", "r846" ] }, "pg_GoodwillAcquisitionsandDivestitures": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "GoodwillAcquisitionsandDivestitures", "crdr": "debit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions and divestitures", "label": "Goodwill, Acquisitions and Divestitures", "documentation": "Goodwill, Acquisitions and Divestitures" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r837", "r849" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillLineItems", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r672" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillRollForward", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Translation and other", "label": "Goodwill, Translation and Measurement Period Adjustments", "documentation": "Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r0", "r838" ] }, "pg_GroomingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "GroomingMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grooming", "label": "Grooming [Member]", "documentation": "Grooming" } } }, "auth_ref": [] }, "pg_GroomingSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "GroomingSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grooming", "label": "Grooming Segment [Member]", "documentation": "Grooming Segment [Member]" } } }, "auth_ref": [] }, "pg_HairCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "HairCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hair Care", "label": "Hair Care [Member]", "documentation": "Hair Care [Member]" } } }, "auth_ref": [] }, "pg_HealthCareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "HealthCareSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Health Care", "label": "Health Care Segment [Member]", "documentation": "Health Care Segment [Member]" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r15", "r452" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r15" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r15" ] }, "pg_HistoricalRestructuringCostsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "HistoricalRestructuringCostsBeforeTax", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Historical restructuring costs, before tax", "label": "Historical Restructuring Costs Before Tax", "documentation": "Historical Restructuring Costs Before Tax" } } }, "auth_ref": [] }, "pg_HomeCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "HomeCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Home Care", "label": "Home Care [Member]", "documentation": "Home Care [Member]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows", "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived intangible asset impairment charge", "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)", "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [ "r272", "r817", "r852", "r853" ] }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "EARNINGS BEFORE INCOME TAXES", "terseLabel": "Earnings/(Loss) Before Income Taxes", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments." } } }, "auth_ref": [ "r88", "r811" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r279", "r281", "r295", "r468", "r469", "r471", "r536", "r538", "r612", "r653", "r698", "r895" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r281", "r295", "r468", "r469", "r471", "r536", "r538", "r612", "r653", "r698", "r895" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r122", "r124", "r190", "r191", "r214", "r230", "r244", "r425", "r426", "r429", "r523", "r692" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Change in accounts payable and accrued and other liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in other operating assets and liabilities", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible preferred shares (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method." } } }, "auth_ref": [ "r203", "r204", "r209" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options and other unvested equity awards (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r199", "r200", "r201", "r209", "r393" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r271", "r273", "r276", "r673" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets [Line Items]", "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r271", "r276", "r277", "r673" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gross Carrying Amount", "terseLabel": "Indefinite-lived intangible asset", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r258", "r276", "r673" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets with indefinite lives", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r271", "r273", "r276", "r673" ] }, "us-gaap_IndefinitelivedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefinitelivedIntangibleAssetsMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets with Indefinite Lives", "label": "Indefinite-Lived Intangible Assets [Member]", "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r729", "r739", "r749", "r773", "r781", "r785", "r793" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r791" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r721", "r797" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r721", "r797" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r721", "r797" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Carrying Amount", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r134" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r271", "r851", "r852" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r226", "r813" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestRateContractMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate contracts", "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r654", "r658", "r682", "r696" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r102", "r656" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r144", "r655", "r703" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNetAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "INVENTORIES", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Materials and supplies", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments." } } }, "auth_ref": [ "r102", "r807" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Work in process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r102", "r657" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r214", "r225", "r244", "r666", "r812" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r18", "r69", "r70", "r71", "r72", "r73", "r74", "r75", "r172", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r443", "r446", "r447", "r473", "r587", "r660", "r716", "r862", "r885", "r886" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r82", "r116", "r513", "r703", "r820", "r836", "r882" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Shareholders' Equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL CURRENT LIABILITIES", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r71", "r133", "r172", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r443", "r446", "r447", "r473", "r703", "r862", "r885", "r886" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT LIABILITIES", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "pg_LongTermDebtCurrentMaturitiesMeasuredAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "LongTermDebtCurrentMaturitiesMeasuredAtFairValue", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt instruments", "label": "Long-Term Debt, Current Maturities Measured At Fair Value", "documentation": "Long-Term Debt, Current Maturities Measured At Fair Value" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of long-term debt", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r870", "r871", "r872", "r873" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LONG-TERM DEBT", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r139" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r305", "r306", "r307", "r310", "r422", "r680", "r860", "r861" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r305", "r306", "r307", "r310", "r422", "r680", "r860", "r861" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r391", "r422", "r467", "r492", "r535", "r537", "r547", "r579", "r580", "r630", "r631", "r632", "r633", "r642", "r651", "r652", "r671", "r681", "r691", "r699", "r700", "r701", "r702", "r704", "r864", "r887", "r888", "r889", "r890", "r891", "r892" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r765" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r765" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r391", "r422", "r467", "r492", "r535", "r537", "r547", "r579", "r580", "r630", "r631", "r632", "r633", "r642", "r651", "r652", "r671", "r681", "r691", "r699", "r700", "r701", "r704", "r864", "r887", "r888", "r889", "r890", "r891", "r892" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r81", "r115", "r172", "r253", "r311", "r314", "r315", "r316", "r320", "r321", "r473", "r512", "r590" ] }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestPeriodIncreaseDecrease", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Noncontrolling interest, net", "label": "Noncontrolling Interest, Period Increase (Decrease)", "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period." } } }, "auth_ref": [ "r43" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r784" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r792" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r766" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r170" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r170" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r98", "r99", "r100" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE", "terseLabel": "Net Income (Loss) Attributable to Parent", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r91", "r100", "r117", "r131", "r154", "r157", "r161", "r172", "r179", "r183", "r184", "r185", "r186", "r187", "r190", "r191", "r205", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r437", "r440", "r464", "r473", "r517", "r608", "r625", "r626", "r714", "r862" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net earnings attributable to noncontrolling interests", "verboseLabel": "Less: Net earnings attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r46", "r112", "r154", "r157", "r187", "r190", "r191", "r516", "r811" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings attributable to P&G available to common shareholders (Basic)", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r168", "r183", "r184", "r185", "r186", "r195", "r196", "r206", "r209", "r440" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CONSOLIDATED AMOUNTS", "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Hedging", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r52" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsandPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements and Policies", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r125", "r129", "r177", "r178", "r181", "r182", "r192", "r193", "r251", "r255", "r256", "r435", "r436", "r438", "r440", "r459", "r461", "r486", "r488", "r489", "r494", "r495", "r496", "r542", "r543", "r544", "r545", "r546" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsandPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements and Policies", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r765" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r729", "r739", "r749", "r773", "r781" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r756" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r755" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r773" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r792" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r792" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r42", "r328", "r822", "r823", "r824", "r825", "r927" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NondesignatedMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r15" ] }, "pg_NumberOfCountriesWithOnTheGroundOperations": { "xbrltype": "integerItemType", "nsuri": "http://www.pg.com/20241231", "localname": "NumberOfCountriesWithOnTheGroundOperations", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries with on the ground operations", "label": "Number of Countries With On-The-Ground Operations", "documentation": "Number of Countries with On The Ground Operations" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.pg.com/role/SegmentInformationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r662", "r670", "r829" ] }, "pg_NumberofAuditsTypicallyUnderway": { "xbrltype": "integerItemType", "nsuri": "http://www.pg.com/20241231", "localname": "NumberofAuditsTypicallyUnderway", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of audits underway", "label": "Number of Audits Typically Underway", "documentation": "Number of Audits Typically Underway" } } }, "auth_ref": [] }, "pg_NumberofTaxableJurisdictions": { "xbrltype": "integerItemType", "nsuri": "http://www.pg.com/20241231", "localname": "NumberofTaxableJurisdictions", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of taxable jurisdictions", "label": "Number of Taxable Jurisdictions", "documentation": "Number of Taxable Jurisdictions" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "totalLabel": "OPERATING INCOME", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r120", "r661", "r828", "r830", "r832", "r833", "r834" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r238", "r239", "r240", "r241", "r242", "r245", "r666", "r667" ] }, "pg_OralCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "OralCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Oral Care", "label": "Oral Care [Member]", "documentation": "Oral Care [Member]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/BasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r67", "r110", "r549", "r550" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER NONCURRENT ASSETS", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r136" ] }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains/(losses) on investment securities", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax", "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r149", "r150", "r152", "r518" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "OCI before reclassifications", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r160", "r475", "r478", "r481", "r518", "r809" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income/(loss), before tax", "label": "Other Comprehensive Income (Loss), before Tax", "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r163", "r475", "r476", "r481", "r499", "r518", "r809", "r810" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodChangeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodChangeAbstract", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income/(loss), before tax:", "label": "Other Comprehensive Income (Loss), before Tax Period Change [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of gain (loss) excluded from effectiveness testing, which was recognized in earnings", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r148", "r152", "r449", "r451", "r453" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r518" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in OCI on Derivatives", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r450" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX", "verboseLabel": "Other comprehensive income/(loss)", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r14", "r17", "r155", "r158", "r163", "r187", "r475", "r476", "r481", "r499", "r518", "r809", "r810" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: OCI attributable to noncontrolling interests, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests." } } }, "auth_ref": [ "r8", "r13", "r111", "r155", "r158", "r187" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized gains/(losses) on defined benefit postretirement plans", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r4", "r5", "r86", "r87", "r518" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax effect", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r6", "r159", "r163", "r425", "r430", "r431", "r475", "r479", "r481", "r499", "r518" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER NONCURRENT LIABILITIES", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r73" ] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashExpense", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Noncash Expense", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r100" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating income/(expense), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r93" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-operating Income (Expense)", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r765" ] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Retiree Benefits", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r683", "r684", "r685", "r686", "r687" ] }, "us-gaap_OtherRestructuringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherRestructuringMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Costs", "label": "Other Restructuring [Member]", "documentation": "Restructuring and related activities classified as other." } } }, "auth_ref": [ "r676", "r677", "r678", "r679" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r727", "r737", "r747", "r779" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r730", "r740", "r750", "r782" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r730", "r740", "r750", "r782" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r754" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForProceedsFromInvestments", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other investing activity", "label": "Payments for (Proceeds from) Investments", "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets." } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock purchases", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r96" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cost paid/settled", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r294", "r816" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends to shareholders", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r96" ] }, "us-gaap_PaymentsOfDividendsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfDividendsAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and dividend equivalents:", "label": "Payments of Dividends [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r22" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r95" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r764" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r764" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r392", "r683", "r684", "r688", "r689", "r690" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r756" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r773" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r766" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r755" ] }, "pg_PercentChangeInEstimatedFairValue": { "xbrltype": "pureItemType", "nsuri": "http://www.pg.com/20241231", "localname": "PercentChangeInEstimatedFairValue", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in estimated fair value (in percent)", "label": "Percent Change in Estimated Fair Value", "documentation": "Percent Change in Estimated Fair Value" } } }, "auth_ref": [] }, "pg_PersonalCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "PersonalCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personal Care", "label": "Personal Care [Member]", "documentation": "Personal Care" } } }, "auth_ref": [] }, "pg_PersonalHealthCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "PersonalHealthCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personal Health Care", "label": "Personal Health Care [Member]", "documentation": "Personal Health Care [Member]" } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r757" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r801" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r756" ] }, "pg_PotentialImpactsToEstimatedFairValueDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "PotentialImpactsToEstimatedFairValueDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Potential Impacts to Estimated Fair Value [Domain]", "label": "Potential Impacts to Estimated Fair Value [Domain]", "documentation": "Potential Impacts to Estimated Fair Value [Domain]" } } }, "auth_ref": [] }, "pg_PotentialImpactstoEstimatedFairValueAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.pg.com/20241231", "localname": "PotentialImpactstoEstimatedFairValueAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Potential Impacts to Estimated Fair Value [Axis]", "label": "Potential Impacts to Estimated Fair Value [Axis]", "documentation": "Potential Impacts to Estimated Fair Value [Axis]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockDividendsPerShareDeclared", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and dividend equivalents, preferred stock (in dollars per share)", "label": "Preferred Stock, Dividends Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding." } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r706", "r707", "r710", "r711", "r712", "r713", "r924", "r927" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r76", "r508", "r703" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r808" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r23", "r552" ] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net additions/(reductions) to other short-term debt", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r814", "r815", "r818" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from asset sales", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r94" ] }, "us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to short-term debt with original maturities of more than three months", "label": "Proceeds from Short-Term Debt, Maturing in More than Three Months", "documentation": "The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year)." } } }, "auth_ref": [ "r23" ] }, "pg_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "ProceedsFromStockOptionsExercisedAndOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Impact of stock options and other", "label": "Proceeds From Stock Options Exercised And Other Financing Activities", "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes, the net cash inflow (outflow) from other financing activities." } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r101" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows", "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.pg.com/role/EarningsPerShareDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "NET EARNINGS", "terseLabel": "NET EARNINGS", "verboseLabel": "Net earnings", "netLabel": "Net Earnings/(Loss)", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r131", "r154", "r157", "r169", "r172", "r179", "r187", "r190", "r191", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r437", "r440", "r441", "r444", "r445", "r464", "r473", "r504", "r515", "r558", "r608", "r625", "r626", "r693", "r694", "r715", "r811", "r862" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "PROPERTY, PLANT AND EQUIPMENT, NET", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r11", "r485", "r505", "r514", "r703" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r754" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r754" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r351", "r391", "r416", "r417", "r418", "r422", "r467", "r490", "r491", "r492", "r535", "r537", "r547", "r579", "r580", "r630", "r631", "r632", "r633", "r642", "r651", "r652", "r671", "r681", "r691", "r699", "r700", "r701", "r702", "r704", "r708", "r855", "r864", "r872", "r888", "r889", "r890", "r891", "r892" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r351", "r391", "r416", "r417", "r418", "r422", "r467", "r490", "r491", "r492", "r535", "r537", "r547", "r579", "r580", "r630", "r631", "r632", "r633", "r642", "r651", "r652", "r671", "r681", "r691", "r699", "r700", "r701", "r702", "r704", "r708", "r855", "r864", "r872", "r888", "r889", "r890", "r891", "r892" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified to the Consolidated Statement of Earnings", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r160", "r475", "r480", "r481", "r518", "r809" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://www.pg.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Revenue from Segments to Consolidated", "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues." } } }, "auth_ref": [ "r31", "r32" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r722", "r732", "r742", "r774" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Reductions in long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r97", "r555" ] }, "us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reductions in short-term debt with original maturities of more than three months", "label": "Repayments of Short-Term Debt, Maturing in More than Three Months", "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year)." } } }, "auth_ref": [ "r97" ] }, "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of fair value in excess of carrying value", "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount", "documentation": "Percentage of fair value of reporting unit in excess of carrying amount." } } }, "auth_ref": [] }, "pg_ReserveForEsopDebtRetirement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "ReserveForEsopDebtRetirement", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reserve for ESOP debt retirement", "label": "Reserve For ESOP Debt Retirement", "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for the ESOP debt retirement is also recorded." } } }, "auth_ref": [] }, "pg_ReserveforESOPDebtRetirementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "ReserveforESOPDebtRetirementMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for ESOP Debt Retirement", "label": "Reserve for ESOP Debt Retirement [Member]", "documentation": "Reserve for ESOP Debt Retirement [Member]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r723", "r733", "r743", "r775" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r724", "r734", "r744", "r776" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r731", "r741", "r751", "r783" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/RestructuringProgram" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Program", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r291", "r292", "r294", "r297", "r302" ] }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedCostIncurredCost", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental restructuring charges incurred", "label": "Restructuring and Related Cost, Incurred Cost", "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost." } } }, "auth_ref": [ "r293", "r296", "r299", "r301" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring charges", "terseLabel": "Cost incurred", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r10", "r298", "r299", "r856" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r293", "r294", "r299", "r300" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r293", "r294", "r295", "r296", "r299", "r300", "r301" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r294", "r300" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveTranslationAdjustment", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation gain (loss)", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve." } } }, "auth_ref": [ "r857", "r858" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r79", "r105", "r511", "r542", "r546", "r556", "r589", "r703" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r127", "r174", "r175", "r176", "r180", "r187", "r189", "r191", "r254", "r257", "r278", "r427", "r428", "r432", "r433", "r434", "r438", "r439", "r440", "r454", "r456", "r457", "r460", "r462", "r482", "r484", "r539", "r541", "r559", "r927" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r392", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r392", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "NET SALES", "verboseLabel": "Net Sales", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r118", "r119", "r162", "r172", "r214", "r223", "r224", "r238", "r244", "r247", "r249", "r250", "r253", "r311", "r312", "r314", "r315", "r316", "r317", "r318", "r320", "r321", "r473", "r504", "r666", "r862" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r792" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r792" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r250", "r804" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r883", "r884" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan [Table]", "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r12", "r37", "r38", "r39", "r40" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss)", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r54", "r56", "r452" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r15", "r48", "r49", "r50", "r53", "r55", "r56", "r63", "r64" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.pg.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r827" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r673", "r850" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Goodwill [Table]", "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason." } } }, "auth_ref": [ "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r672" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r672", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Asset, Indefinite-Lived [Table]", "label": "Intangible Asset, Indefinite-Lived [Table]", "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset." } } }, "auth_ref": [ "r271", "r276", "r277", "r673" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r673", "r852" ] }, "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period." } } }, "auth_ref": [ "r868" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Restructuring Cost [Table]", "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve." } } }, "auth_ref": [ "r293", "r294", "r295", "r296", "r299", "r300", "r301" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.pg.com/role/RestructuringProgramTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring Reserve by Type of Cost", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r33", "r103" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r28", "r29", "r30" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.pg.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r28", "r29", "r30" ] }, "pg_ScheduleofPotentialImpactstoEstimatedFairValuesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pg.com/20241231", "localname": "ScheduleofPotentialImpactstoEstimatedFairValuesTableTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Potential Impacts to Estimated Fair Values", "label": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]", "documentation": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r717" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r719" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r118", "r119", "r120", "r121", "r214", "r219", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r250", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r277", "r296", "r301", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r663", "r666", "r667", "r672", "r705", "r894", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r121", "r214", "r218", "r219", "r220", "r221", "r222", "r234", "r236", "r237", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r250", "r662", "r664", "r665", "r666", "r668", "r669", "r670" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expense", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r92" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, General and Administrative Expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419" ] }, "pg_SkinCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20241231", "localname": "SkinCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Skin Care", "label": "Skin Care [Member]", "documentation": "Skin Care" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationGlobalSegmentResultsDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r118", "r119", "r120", "r121", "r130", "r214", "r219", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r250", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r277", "r280", "r296", "r301", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r663", "r666", "r667", "r672", "r705", "r894", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r126", "r140", "r141", "r142", "r172", "r198", "r202", "r207", "r209", "r216", "r217", "r253", "r311", "r314", "r315", "r316", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r473", "r552", "r553", "r554", "r555", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r588", "r609", "r627", "r643", "r644", "r645", "r646", "r647", "r803", "r819", "r826" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r77", "r80", "r81", "r127", "r159", "r160", "r161", "r174", "r175", "r176", "r180", "r187", "r189", "r191", "r215", "r254", "r257", "r278", "r328", "r427", "r428", "r432", "r433", "r434", "r438", "r439", "r440", "r454", "r455", "r456", "r457", "r458", "r460", "r462", "r475", "r477", "r478", "r479", "r480", "r481", "r482", "r484", "r487", "r518", "r539", "r540", "r541", "r559", "r627" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r174", "r175", "r176", "r215", "r484", "r493", "r551", "r570", "r581", "r582", "r583", "r584", "r585", "r586", "r588", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r601", "r602", "r603", "r604", "r605", "r607", "r610", "r611", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r627", "r709" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r174", "r175", "r176", "r215", "r252", "r484", "r493", "r551", "r570", "r581", "r582", "r583", "r584", "r585", "r586", "r588", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r601", "r602", "r603", "r604", "r605", "r607", "r610", "r611", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r627", "r709" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r726", "r736", "r746", "r778" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock conversions (in shares)", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r14", "r34", "r77", "r80", "r105", "r322" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r14", "r76", "r77", "r105" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock conversions", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r14", "r77", "r80", "r81", "r105" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r41", "r76", "r77", "r105" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r42", "r43", "r45", "r127", "r128", "r160", "r174", "r175", "r176", "r180", "r187", "r189", "r254", "r257", "r278", "r328", "r427", "r428", "r432", "r433", "r434", "r438", "r439", "r440", "r454", "r455", "r456", "r457", "r458", "r460", "r462", "r475", "r477", "r481", "r483", "r487", "r540", "r541", "r557", "r590", "r606", "r628", "r629", "r648", "r715", "r820", "r836", "r882", "r927" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS\u2019 EQUITY", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsegmentsAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Axis]", "label": "Subsegments [Axis]", "documentation": "Information by business subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsegmentsDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Domain]", "label": "Subsegments [Domain]", "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierFinanceProgramLineItems", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Line Items]", "label": "Supplier Finance Program [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r284", "r286", "r287" ] }, "us-gaap_SupplierFinanceProgramObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierFinanceProgramObligation", "crdr": "credit", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount due to suppliers participating in SCF", "label": "Supplier Finance Program, Obligation", "documentation": "Amount of obligation for supplier finance program." } } }, "auth_ref": [ "r286", "r287", "r288", "r289", "r290", "r675" ] }, "us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]", "label": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program." } } }, "auth_ref": [ "r287" ] }, "us-gaap_SupplierFinanceProgramPaymentTimingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierFinanceProgramPaymentTimingPeriod", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment terms for suppliers (in days)", "label": "Supplier Finance Program, Payment Timing, Period", "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r284" ] }, "us-gaap_SupplierFinanceProgramTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierFinanceProgramTable", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Table]", "label": "Supplier Finance Program [Table]", "documentation": "Disclosure of information about supplier finance program." } } }, "auth_ref": [ "r284", "r286", "r287" ] }, "us-gaap_SupplierFinanceProgramTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierFinanceProgramTextBlock", "presentation": [ "http://www.pg.com/role/SupplierFinancePrograms" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Programs", "label": "Supplier Finance Program [Text Block]", "documentation": "The entire disclosure for supplier finance program." } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r674" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r772" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r764" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r771" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r791" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r793" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r794" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r795" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r795" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r793" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r793" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r796" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r794" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r35" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r35", "r36", "r80" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock purchases (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r14", "r77", "r105" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock purchases", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r14", "r35", "r105" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r293", "r294", "r299", "r300" ] }, "us-gaap_UnderlyingAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnderlyingAssetClassAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Asset Class [Axis]", "label": "Underlying Asset Class [Axis]", "documentation": "Information by underlying asset class." } } }, "auth_ref": [] }, "us-gaap_UnderlyingAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnderlyingAssetClassDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Asset Class [Domain]", "label": "Underlying Asset Class [Domain]", "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance)." } } }, "auth_ref": [ "r61" ] }, "pg_UnderlyingDebtObligationCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20241231", "localname": "UnderlyingDebtObligationCarryingAmount", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount of the underlying debt obligation", "label": "Underlying Debt Obligation, Carrying Amount", "documentation": "Underlying Debt Obligation, Carrying Amount" } } }, "auth_ref": [] }, "us-gaap_UnderlyingOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnderlyingOtherMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying, Other", "label": "Underlying, Other [Member]", "documentation": "Represents a subset of hybrid instruments that have embedded credit derivatives with an underlying(s) other than corporate or sovereign debt or a structured finance product." } } }, "auth_ref": [ "r59", "r60", "r62" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r790" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r760" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r197", "r209" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r195", "r209" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SHARES IN MILLIONS", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r758" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-16" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4H", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4J" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4K", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4L", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4L" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/220/tableOfContent" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/710/tableOfContent" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "712", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/712/tableOfContent" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/715/tableOfContent" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-50/tableOfContent" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-4" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/420/tableOfContent" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-11" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477128/405-50-55-3" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477128/405-50-55-5" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r712": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r713": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r714": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r715": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r716": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r803": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 67 0000080424-25-000013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000080424-25-000013-xbrl.zip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

)KWW+"56*1?#:@2QY %7?'0SD$T()(4EADO O MHH"XE_JH0QSM4ZBN?V0^6KXH:J/AL16.K735 0"?KJ;TV3AGL@59"QM4T72VR(0DO:@CA3[2^]86\?CJ MY5[JRXXYG=NII0>,W:G8E"X&P8,%D8,$Q7PDB=!^<5BB05E?'&Z.J9=2O;R7 M8I^L7MY'REW5FY'59(GG!$'6,BK+:-RPLH?)X[]&^WNO-#M?+UEJS M?834@0$XZ.9>2LY$8G1*"Y[H'V1(T2D#T>LH%#,RZ1//Q7GYM68G"A@/4^+( M5S47]1UOOA!7M:[C0?)G@KIX+15YC('7)YVC(;EE"3*F>B,AK=#I6ZKD%( MC'/F.$*DX(BPLWDGG5-\)JRAD(S[9W0>"4$':4@KX!#"M'6&>T(*%6$R"PW MC.M:@=Y8" <3.ZY]:H*C^R?;:137@1]VZ_EY+GS(M5M.F'J[3DP LCH,/DDM M#8_.-Y_??;/ZN!@ZD;H7363?Q:C NQ);KY?3<+Z^$-JO"_J+^9J6I/_X,_D+ MF;2YGF3NF&8JDX_I$)2+'+R@?S6ZY)0U#R*VKM/;F\AQKWK&0>&PFNP/K!.= MG R1HFS#"SFHT6ZJB.K#/!9#,=GZ..C1.F[&L@.0[:6!9H,I#X?/V^FW:2*7 M=_7QBH"-F":HHO"H'$A>GQS.2@,J4Y^LC%AD(/L=6[^FMH64<3,.XT"JA58Z M<,!V%]YK7$WC1+.BK L*7$8.2LM<+Y-(9$:S%+7A%'&/%AAL2!SW5=D.[%MC M+79@ ?\C3S]_J;*B4QD_YU_/:\KY0]G$6ZL/Y^O5&N>U6^]2I#>-!9MLT,T+ M!SHJEZP!RQAQK5CM<*WC.;S-WFI-,5GK>YXVE(_K%PX2X8Z@T@ZL[:Y<7^Q2 MSK+GBI@CR7I0:.@HJ46;Q@S0J\6-#F6ZG$-[YC8;:?,#N"[Y02[/+ > M'&23Z$P00@7@AIA2%B,XSC4XAE++5%C2K;&Z)XGC9C@[\ B&5.F(Z8"OGQ_$ MHAO/^E5]ZW[#VKN/O]]$I\(Y82R#E$JM2-.:9%='H"67BI'2.W,O4_5(<MI=\AA"YE-(G"6R5U@#WNG;:6N-T]B:HUA=*%')T MHV,.%#+R>U4*(*P,@NXJ+W@*J7-#J&$QN/1]Z0'9Z&:=T>I3>?V6O$\ATNWMN]8YR MS@O7#B&%>MPIQ<%KHT"FE$56-@AL'8H_1].X..X&/#N!^D!-=H#,=V=?9XOO M.6_RM1^^5FE>]H%%)@W319-75UOL52S@2S)T="ICM),RE>8^\#9B>L3BH3J_ M[P W44 '2#IRQ_Y\W?(3N144109PCM5G5P)"<"R!--K'I%+TH75Q1RO:>YGP M\M+/_L/ \/(WP>6$YR#H=#(R@DH,:Q$_G4V.%R@6DT@JR)":/PS=@O >S?30 MF&L+_ , T%]SXLVE6N4USU>;;^$\?5Q0')[7TXM[N==YGLOTB#'?!ZYS9&MC M"^X:=3[>)N#5//UVO?@C YD9!N^+YB!BKCX*&7)G4X* 67,N"5>^=9"]!WE' MV]W9YG:.?=G_7'//$8K,C6@G32@G+>@9/. ^.6Y>1$0-X\T[ 39>-: MSJ%P], XMM=2!V?^C=OUMO:WYW2Y]3_.<'YK-/KEF 1RH[(S19%7'Q0=+H4! M:@I#'N]7RVVU62 MRZ N3 E(]$.].\[@96U:)P$I7@HKKO5Q^!Q-O8'I$,W?'Q#04@T=P.K#^DM> M/AIO/<$BL6)B=J!D+TLCK XT-/ MXL:1N,DKA6"U+UZ#S2P19T%"4$J"L;J.A]51-Q_%LQ-AO62MA_;'VFNI2^C] MFNN#@M-%FL;+/WU#FZ^^.+L;0I33>Y MT]G[>5DLSS9+'YP-;KKZD3GBX231*'/\EL#W#>LEQ?LY' +?UU5%5Q^X'RR':'(TT@GL7FAN2@\D]WK[NO?3E4>6S M*@8=0HF)CBIEZFB&B. W/I/.F+'U@(V#B1W; I\&C0_M\BETVX63\ BC?R/' MODX9>?W]DM_?\FRC\M67Z==-!B.;HMGF@0U/H:%2N8#748$I]8%CZ;QI'IP? M1NF+@^\A,-H%O&UUV@%R'V'C*B3%Q'VFP%!EED$Y[<%+U,!5"$H6_8 X:=[S,6HIL9^>L M;$MC*SDK3UJXRIQ-L;V;I&/-KS\ 25$BQ4M?T *4^"6Q92UT57T?"H5"H;"( MTVU7$P8551ZJL&]CP4)$>Q!/M 'T4%JA:(7I*!U*#TJ3-[LS#H,2V;X %OT6 M-G/-]"&&";$+_M/C9D8BHS6B\3U8&:^]<2"(84!QAH6% C*:.O8Z)DOF]A!9 MHJLDN!3*K\T$- X28[P%P=WJ, &9 J)R#,@*:X\-@C2YESHN3=YU+@W:+2C4 MP_1%D6AUEK/QM-95(5 D&@@D:7RJ5@:?*R#@4@@N>7"X/G4QW4%!RJ-.'Y2/ MDJ>OR0O@31_7_91QK["+[R?&>[JL @0S J34!'AM,38$5@:GO@0]2."\?4,* M2D*,@G !=+Y4\R_O_[T,"D]7:BXN5=/$*;I^44A[YF.I!##.QJ<7C O[%X% M^!ERQC--DE^8.RU1@5F)<:A1CX93 :Q[?,S]G=.+I^>K*D41PT2%]&?%"0M[WSU[2VIP]@U-C!Y.?<4TT;E MKO1TX!I[;Z5MTU- M%GZ- $(!B^23*5>[L.U+R%?^PV2F9F:BIM?U?+*^9;2(U; A\GT_"R9O5MK? M,LJIB)V!E(_92*I6KR/+$!-SJ:T16)#45VZ'RISW>8Q\2^^K8ET4MW^=*#V9 M3A8/W76VFB&*O 05CC>*O8E%993'=LR,.00K+]-7_PV7NQ7'V5^9XZ^$>0$\ MOZRGTZ!BHZ87T\8I^Q!KQD.L0AW.DG60<(,40(&'R@G@Q'W#L MH1+!TH:DSERW%JX58_E?C['CH/?VBUP_UNO"SG5<%;'8_MK\RO_W4DTG?A5W MS>S'>O;T]^T;*K$Y57ZUH]E6U>>4BW'Q(%5#4BYG3 MW%D&: C\XVF7!@)6$J#*A9] X6WZ)PC?8E&O-TJ%S1 $C%8A=N2X LIY"(@E MP7<1&;;>!=CIK1?U=F%CNJ+>+M@6$"\=4C3ZO/7E8\JRE/>5SKA_I1.@V$H Z/;X _BEL#!ZUV90X__=?(G/-NTI8S5QE@0]D#0X-O+C0&L:WR S%B*&*3(^=17W*8%*.2Q-3*=T M(!3 J)Z7*7 %K185 XCY"A E/5#*A&@!.D6DMP17J2\,C'A5JJ@#^W$BL<28 M%L#<$Z7V!C,"G0[;*18FM_?Q01ZK@8<4ZHH:AT7J-?6O=56J$Q/:7Y7J $L! M_#IR;0=)04F\1F:0#S&MD1;(8"\@I:+0$*H%2EV)],:N2G6!N=U5J2XV+X Y M)Z[K>"PKYRH=3&+BVU$\GLIZ#F(5GO2:">=$8O:\P:M2 QB4R/8%L.B=FX^Y\)9L?*6L8W# MJ]1H%$"PC1J/FD5XXN*OE$->20,JX6/G'R^!5,P YZ24%EJ'?>KTUF%)WEXU MY/#0/0$F13)K,P,Y94ASZ4!8O<-"KF,[L\IRP(E1AG#"4/*RLV.R%!$^#<+Y M+'5Z&+T \GRL9W;K;!\]J^;!;Q,"J [^-$RD"F@=HL#@9RNIC/ $I>;- 3%* MHTP??/?#I8'&+H OPVJ F(;2>T)!)4-@0##S0"O#0V2HC*\$JB0=KU!PK%MW M195PCY3/&@7AHNB\6Z!SZ[#&4O *5 3)L F&#(CX4AK63A(L&'$X=17@,5D* M3&J-0X>C1!R 35$<6Y64SV^UI)33L'/!E.AX[Q\!A;D$PAEOI6<.[=]V2GT= MX TFZE-SJ@<617'IL70[6.D642NMUA7P\7H@,82%K7 %@2!<&1SB"\7'NU_R M3)"WMX=,S:J^J'2GEEQ3:[:J?[8WI50DQ^..:/1XY.'F5[,GT\Q_F;U(%[KY M)V?JN]GD?YV=S*XN?WFU6N-$^.Q(;\%0%$$ .TX"P^ M!5"%J8(HAN/YKS=4'XPEH81@!""J6'Q;F@#!L(BO::!*:4XJ^J,^^%79F*X^ MN NV104BARH1A:-2D7BBK>/V$U9 8!_^2@DS1ECCQ&ML\]]Z?7 G2G2J#^Z M3U%<.U!;QA#76'@)3&S$2'PE@?94 QK"+R>XJCQ+78;W5NN#NZ#>I3ZX"P0% MT.ET12&$E- 0\ /FXALP5/.P%Z0<.$>D$D(AY\HKZ\Q3)=P)]TYEG5U *(!1 MPW:>F G+;-@G:L-MF)=2 <4=!1#"2ONJXI85\.1%QZ1X4;FC<9;3<1 N@,ZK MII#QL=S&?8DW_Z/28YMM=\8PT'A8(Z-BVHE ?$AFVG,E3$ M&S)$//E%?F2=YN;!?&+.^7L6>'/6:31S]Q6U$JO54( M.*W"NBPT THY#J 4RGN+0^"W5U9YH"5;AP^^Y5.*/N0<$8ZWWT%E2$;]O6IF M ;+7:Y"24M@W=')QTLX%'%]([6/IEP,6_&N]K]MHXONJ#>Y?BB"P0%T.E$?PUHXFNU M8<:)^&8MH=@$ZT@1_RH]9$P1]:.]25?$V[;!="1$J6'> M" ^8]<9;!JVFZ#7V!7_9]B:I(['$F!; W./7F ERA-D09U#+< @[% )280(\ MPLHXS+FUJ8OU_UKM33HQH75[DRZP%,"O(ZTV#(H]^\)TM"K6&VI6 >E]\._> M(&:J"J+DKV2^K?8FG6!NU]ZDB\T+8,Z1N\O(,Z0=-\!(J0&!G@')HF$JK6%\ M:0(F/S+\:_4-&+(F)L"D2&8]3CI/D*76 H*0#Y/.K9YK=*"2K#(2:F])ZOS7 MF^H;T GGMGT#NAB] /(!^F]C1>>*(^O@0@&&%)>2:REIZG?5'T[ M?0,ZX=NB;T 78Q? EV''WI0[BB23@'/!PPY;AQ@2:0L<=]I#@X4:L0GTWZAO M0/*-XB@(%T7GQPW0\R/MCVYQJXD7FF@'D'$B=N-F0-F* BN\@)65R";O/7=6 MJ +WC^,0Y"@U4Z!57M%+B_*>J/3VD:_:7PRY:SOL .8L>_"1@.E@,5T.U?7]MJ6Q<[7 M^4/)/,11A2I>PA4, AT\,H ,5AXQZ"!*?3IP4J"\E!J/!_58H!3 L#T=-ELR MZ1S3WC!@=3RW$\P!Q90'&!MEG(,5@ZGK]@X*DI=1"8&N4UN] .JTF'";'7D( M'X774 .C8D-:9 70F"O@J3)>*&),\IO(K84K81T<1(3NRV$/5,JBVTY5]./& M)>@V7=JP7;JNFQ5\BT4STT#'^"QO@*"ETYG3JN M'E>CO&?8Z#)G@ ;0$B& M0GSK^9B< M;R5C\6X_3>)B5.@*H.9^1X4/P=0M=%[/YL6U:R9U#">O_(WZODU-$N>%)]8! M*K$%1%4&:"T,@#@L;5Y+SX1+3-\Q]"A^5S" >75A-"A@*GQ>U.9?7^II@'6^ MSC'T6:%N$7<$\O@@/(EM%2JV>H)! 4ZP%S V#:*IZYW22)Z7[OD9^")E_>IT MZ#T)OJ[4_[Q0S6+T#C7K=B+!RFN;7ZYNFFPMKBS#V ?_8Y'2@+CX@'@(RL): M"XF7U"#D4M] ["ULWA"F.,*_#N@%./KSBNYC\Z3_K:(Z/@R'@8NOQ84Y'9L) MFEBS"3&DUGC,Z*L3_+B\>9WZ*U&J,Y$3X5L EU-XD6?*,TV]=PX(&=8IPA$" M89]? 6^D@\Q+9%3J0Z>D"N3UZ'G8GH\!J9^9&#E>N<602R,X!-+$/K A_ H& MQBS8VV*&H>"H2KTM;258WH1@J3ZZ*V+]G7&]4-/1:;B:7,$@4%=1"8@!@40! M63$!E C_8 5V3J4NYCLC4E[JO:D0N"N ;\,[/IKOUB*$=>4UT)#B6+-,@(S/ M#5E+!&6"&R)2+_UMY,I[]^%-$;07E(5[S4>=NF1N(K:+\",=' M,*D#.H9"2%$M+.;$\-1UNL>ER7OXF3 @2&SXO&\7?5Q&SE_YRWH9-N%!B?\W M67RYFMU\<3\WX4?V*NR1US4(MXH*2Z#6(&S!39A=@@%EJ@I(55D=@FGJR5X$ M>>#IHO;?*RR [ EN/;:E2Z!/';-'<3[]WV4SF=N)6:MAF84*2@XJ)4E\@Y(" M64D&*F:%-)!AS7%+PAS^0F$N)1%%$EBS#%)<+.UD,;]Y^#HQ:CI]^&T6\/A3 M/=Q2$J(G4T% *X, B37ATA@#?-B/*VR0KMR9/-CYC^0].1Z/&BEL6EY/I\_+ MKU^G$]=\F,S4S+CKIKYKU'W_/.F9\0;F2+M(FR@_>JT>HD>(":\+8YJEFLZW M&2Z'7-"<6. I58 H%S8JVGC J(/(ASVP(*E+/D^(,_@XZ:!Q-]&:\I8RQ 'C M84DD<7.F/<6 :6(E5/%B7>IX]H0X>0.45(QX<7Z3R/XE)+]622 FO6 JR.L= M#^NF<18H1RDPB&*ON7'4M+K@_C82G\G@.YC][&++$@BPV=$K1EQE%0;4QC, M25#8VUL'.+25PAJS"KT=-I:UN]_X]K*?O8'O;;\"LI^'U[NG[98)MF!8Q2:Z*.R+%(9 (@J! M)8C3H J2.O69^1F1\B8M4L<'8^!0+*U"S!W+#FXF][&::54\=.LHHHY5%G!O MPGX>:P($$<&&1&K)#7:DW6G+8((=$*[$4+0G)5K1;2@^Q1+O2D\G=RO@;B65 MTF%GPF8.2D H)4 :"(&I-,,$"HOF3BX\QF,6RB2O$VAH?5=.LWD;HG6YN->K MI'-WR1.EGG<^?#&SJX?KG'UZP6*;=C0$56%[Z '%,>$@K =":A\K9H@BSFK5 MKL2PT_7LEL(-]ISFB[/+J;OR1SYY6<\7FZ("#&'%.*J @C2N.#Z80!L$$!/( M,HR3')WL6T)A'C,V#'#O-,4D A($X;(+35H*+$X8IH M%?8Z?[TD=R>PCB2YNU@N=ZYS)TD+!5(8^PK8*K[NZ@D"DHJPP66<*(NMQJS5 M>>C;2W)W@NQHDKN+_7(#OY.DY=XKZ2L*H(R/ZQCO@'1A3TNYT%(*"2'ZBR:Y M>P/?VWX%;-O7=S:W>[5?:_/L?59N+"=, !2D!@3'[@]A!*"X$H@1*9%*W='N MA#B94T$CQPFI\2B76IM72RR4L!(5!I+$.Q $6: M-R!,'V8J(QU/GMTY*5#> M,#09[.WHU .# @CUV:TN;N_GVF)DQ M%[9S .E8Z8R0!))Q"RR!,'IDSVGR]&$7 8LD7!]B[&^01T.I I&+W_E/ZOI M5H%*0L^(0D!8%4P%L0J[!*H!J@2Q6C!5R=2=K5X(D7=I'(]*PZQ= %U6/3(^ MUK-Z?0$C-J&(MMK,@8U.U&M)'0I*A!WGNAY&(*&!]O%FH'#*F]1ML]O(E;?, M?3Q2)<>D )[MQ*1QUJSBTKEKOKEGIY4&ABWI:B/*,2 ZQ*92Z>!YB4>4\_!3 MF/YM@O-RY>79:\7UR1'*>P_G'V$]KYMX4>2%8L\["DO"*FHMH)I+0"H2#.:H M#SMJ))5E4"NVMX$\"EQW1:IX3+W45_)-*-"U)I[-OU]"$6B.W+ M5G^^E9Y5GFL.%*+Q!K=R(=X(H0:#3B).-:4N]?N%+47+W;SV-9F7"*#2>'?Y M135W;GXK%2(,:PC"[\=74CR/&^#XY"&BU$OI0C0[:E2VEB-WM]G79%0?T_>F MSS?7Z/KU*HYVI\ZZ].$A:?71R2^,4(G47J-7KTJ2F%KN*@H8P2:>"\=[\R3L M#R@F#F-C"#1_AZHD&';ARA('F([] Y06(.R+$& 5#%.)5#!$ 3^JDE*R:4A5 M4A>TBELU=]:&U?&(4=!*BPF $@4OCBT"@J_Z'W#N$+<0TM1-K\^(]'8JFCI1 MH7U&HS,N!=#L)OS>GLDVR48D."+$2U Y!F-3>0@T)@88JYUESDO,4[>$/2I, M0;YL*.3U&/8O@$CO0UA5/SCWV870+U;&/W:0(]HX@T78%;/P'Q)/<#7C00U7 M&W>@'D^:#,9!KBV\MI/0^&V2AA%3$0B6@)2D'8 MLX1]KN 60.^L_CH@2]Z0*PCK<=/41 MQH-1:&0EO*;A?ZG+ 9.='Q91%SA2M-T/H=)8MU'F4SV=?JB;/U5CXYMCS"N! M 7(Z3")#"5 AJ S:&:4\KBK6[B;*P+.?9R(5&W[WY$"+$Y^^@!3*KUOE./1& M>N""@P;$,@\DCD7?F IMI:%VM()01-?6)P3):"SI 3,RB)]?N(CF6?GK7ZOSQ\ Z%G@^Z9H^Q3Z0Y_(6.Q\.]A1]X$AP^ M=;O^ROWJ$T][S;[F.#YB3^?P?,!_SKY.XJ W0>V?PC_^*XF8+T?-$K*>Q>)Q MXK:R2,;88$<^M_A2V\1X[8V9)4#LA]9A:Q2"U77X[**YG]D/4W67!*G=$;.$ M8;UP.FB)0E"*,_YR-K=-.ICVALP2Z?3V?B]M40A0_ZC_?)(OK0<\,G26)\5[ M 7?:-ID!W*ZIDWMG0X0=GW[^74T'3[=3XV9Y_[H3="VL4L+$F\?C37=3;\5= MO9"=;O:=&;\-CCS_%&QGI6+Q' G&5NB)0M$K!+1?9G;R;6*7:KHJ$!P"U-Y0 M>3=EIVU>GS- [JDTG3[)]7B7?M D.C1@-H2.V+QN9X "TNCK^1]^^)=^8[\FMMA:Y>-_>GCZG4V.?J7, MDT8S>SU5LX_JWFW*7=-B/HJ(60]R#Y-A_W+ B,@40+QMZ>ESQWV'%MT0"$4-TV^B'@=N0P,Y6HS1>QNU9Y<2H/MM9IOIP]UG M9Y;-^@[=_6(X;@=';>7:87[43IFD!,C>?V_,=3,Q">;7TU"MP"G@1/*%\B4@ M\G-8 1;OU,)]4)/F=S5=)H#FP)BM,"K@'/*X.3*#M3NS'_[YK\6*2I=?9G?7 M9IC;.S-T*^CR'DVV,T[^QV(.5[*\;U;G!2.5X+P?'*F_N:: MARO_XELOR-"+]ZT^,&#*;D9]_,SPY/S! ;/E%;O@\WRRGC)+9B<;J_TVK2;C M&C X27]HO&QXG;1[W;%P-F<6M_(H(V9Q\U3V;T/B_^==V8J^9F MWKR?+R;W:GVTE*Y*OM4'LE6*]D6UB]DR(WRU7 0?'];QV5U"5WI\U&REHWVQ M/&N@!- @:_WNIIA,_,1OI;]3W MG]S,^V=BV+$L&-3=5L(_ O]U]CM^F@@%[U/4P3N_7[ M8K[:@$2DZ&;9]H6?W+^7DV;K5](XY0Z?:05R4:FO[C8LM0KH^MM8%4"[(R>I_CDA;(+* MGVOU\/O\VC5AMW4?FWBG+OQI,_Z >1V,,[S69SM(M@/7#B@\GY'[VN<^$/KN MS#*^.'T9W,1=W3P,+ATY/&(^F/;M7;=4/G3K=%V_B$A61'!\X7_7522CJ M;G;)#-VUJQ/@]#1*SIJ2\[:N3RB>O\@GB/0Q"1S[8^6["]T1E"-&^%&K^)HK MS8_ZQ!_UB=VPL?]S4Z_VXT.GQ^Y(V:SWU68O)^7]_?KO-5\,;O1L:?QQ=>IGO[1I,"L\]=R M1FK'$*L3F*\ V*/,0<7YYV_FA,_QM]FV^L D( MT/NC94S];OC6Z8R=F2MQ>_7+;"/_OJ3[^H1@XX\FQ7K>_ZME.(W>;!EL[LQT M^3TH>/=N<9#O08_PSUO:)Z!)]Z]E"PK3T*.W>G\TVS7/Y#ZDE[%SES$_"KZ6=V9?KIMKQ_=A:E>Z7=8S.W_7A#^D8DXB$;)= M+$W#H[1 9&;5NV_6SJ^:J\67YGV0<'YMKV9;;3XNXL__G'_R4Q/5NEE,HX'B MPQZI*)7B^]DNMZ;A4T(($1\YW_]\/KI%UREY<%4>RV%NO* M^XD)XWZ8I9EKYT?/YP+[8=G:7KE]IG/-STV]_/K+?+Y,B.BI<;/%OGW]Z'D; MY?:H7V+O?KL5-!6*I\;-%G'V]:[G;91]+M8W]4)-4US?VQ\K6Y>4WG/NH"WR M(W1A%DLUG3Y[9+[QZ*#Y.I3TC3+/F*<@]%:2/?,0*4$\-':^]B()L#QA MK!)*7F:GO$^706WT@7Z>19%@?-UMQ"+](,H^%](D/M4*\J-Q1#S-F M1OZ ^XF:;Y)?:4!O^XU6>)>4?>IHO.(F^=7BBVM&GM^'O]$*ZI(25QV-EWM6 M*[VJT^S\#OCMT*Q%(26"?-DSW: MV8N\ATZ_@P.V@JND!-0IL^3N4!L#JJA1(L .C=<*KY(21B>,4D**/\FK9L\' M:@5025F>0V;('H34@TLE'\=HA4=).9@]YUV7SVT\POXA6B9/7'1\9L=2>@I*S(&>-DKR!XNOV5KE3@\)BM MH"LI#7+&.*6^/O#+;#X)QKQIU.KER::)==/Q586]#,# IPA.?";)NP1MU4CP M2,&+3[V@1<]FOT>''9*!W@[W4WS)9OCS! <'S-@)]QP6.SGG$\;(?5*P%6WP M7=*]H;)A<]+:!U$IZ';IQ71ZP)>D:9=[?. "L#K1.?>L07YT7L\UAWYT8?_1 MA;U;1FO13&]<-#?Q*$\V?&#;;'.H6(YPW3/9((4J5XN7&W9&RW9_O M&L,=4+\42&XFB\'A]\!*,6*9S@SG#9;K3W M<82'#%&0,[QI[F>+M+[PV9#9[K+W=X4O#5*6)TP$V/%1LUUC'^0'BX/M<3DQ0X+JIS8C'P3N?&>$X^+@:R8^#GW_J!4<2G L?'G_0H/M\ MZ%1[[_.C%W)T?!*WW9.6EO;*?AAV2,Z/]6(C:II\?_NO%)+^'XCS"?N-[]$W M_Q#_H]7<_==__']02P$"% ,4 " *@C9:P9X[GYL' ##)@ '0 M @ $ 9GDR-#(U<3)O;F0Q,"UQ97AH:6)I=#,Q,2YH=&U02P$" M% ,4 " *@C9:,F(2'8D' #4)@ '0 @ '6!P 9GDR M-#(U<3)O;F0Q,"UQ97AH:6)I=#,Q,BYH=&U02P$"% ,4 " *@C9:R4VA M?WX$ "J$0 '0 @ &:#P 9GDR-#(U<3)O;F0Q,"UQ97AH M:6)I=#,R,2YH=&U02P$"% ,4 " *@C9:@+A4F&H$ "%$0 '0 M @ %3% 9GDR-#(U<3)O;F0Q,"UQ97AH:6)I=#,R,BYH=&U02P$" M% ,4 " *@C9: ;I LJ%) 0"64Q4 #P @ 'X& <&&UL4$L! A0#% @ "H(V6K1^:I1S0 Y,0" !, ( ! M*(@! '!G+3(P,C0Q,C,Q7V1E9BYX;6Q02P$"% ,4 " *@C9:=OCYQ@49 M ".&0 $@ @ ',R $ <&+L_G+Q0 4J,' !, ( ! >(! '!G M+3(P,C0Q,C,Q7VQA8BYX;6Q02P$"% ,4 " *@C9:UZDZ?SAR D604 M$P @ ']IP( <& XML 68 pg-20241231_htm.xml IDEA: XBRL DOCUMENT 0000080424 2024-07-01 2024-12-31 0000080424 us-gaap:CommonStockMember 2024-07-01 2024-12-31 0000080424 pg:A1.375NotesDue2025Member 2024-07-01 2024-12-31 0000080424 pg:A0.110NotesDue2026Member 2024-07-01 2024-12-31 0000080424 pg:A3.250EURNotesDue2026Member 2024-07-01 2024-12-31 0000080424 pg:A4.875EURNotesDueMay2027Member 2024-07-01 2024-12-31 0000080424 pg:A1.200NotesDue2028Member 2024-07-01 2024-12-31 0000080424 pg:A3.150EURONotesDue2028Member 2024-07-01 2024-12-31 0000080424 pg:A1.250NotesDue2029Member 2024-07-01 2024-12-31 0000080424 pg:A1.800NotesDue2029Member 2024-07-01 2024-12-31 0000080424 pg:A6.250GBPNotesDueJanuary2030Member 2024-07-01 2024-12-31 0000080424 pg:A0.350NotesDue2030Member 2024-07-01 2024-12-31 0000080424 pg:A0.230NotesDue2031Member 2024-07-01 2024-12-31 0000080424 pg:A3.250EURNotesDue2031Member 2024-07-01 2024-12-31 0000080424 pg:A5.250GBPNotesDueJanuary2033Member 2024-07-01 2024-12-31 0000080424 pg:A3.200EURNotesDue2034Member 2024-07-01 2024-12-31 0000080424 pg:A1.875NotesDue2038Member 2024-07-01 2024-12-31 0000080424 pg:A0.900NotesDue2041Member 2024-07-01 2024-12-31 0000080424 2024-12-31 0000080424 2024-10-01 2024-12-31 0000080424 2023-10-01 2023-12-31 0000080424 2023-07-01 2023-12-31 0000080424 2024-06-30 0000080424 us-gaap:CommonStockMember 2024-09-30 0000080424 us-gaap:PreferredStockMember 2024-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000080424 us-gaap:TreasuryStockCommonMember 2024-09-30 0000080424 us-gaap:RetainedEarningsMember 2024-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2024-09-30 0000080424 2024-09-30 0000080424 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2024-10-01 2024-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0000080424 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2024-10-01 2024-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0000080424 us-gaap:PreferredStockMember 2024-10-01 2024-12-31 0000080424 us-gaap:CommonStockMember 2024-12-31 0000080424 us-gaap:PreferredStockMember 2024-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2024-12-31 0000080424 us-gaap:RetainedEarningsMember 2024-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2024-12-31 0000080424 us-gaap:CommonStockMember 2024-06-30 0000080424 us-gaap:PreferredStockMember 2024-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000080424 us-gaap:TreasuryStockCommonMember 2024-06-30 0000080424 us-gaap:RetainedEarningsMember 2024-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2024-06-30 0000080424 us-gaap:RetainedEarningsMember 2024-07-01 2024-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-12-31 0000080424 us-gaap:CommonStockMember 2024-07-01 2024-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-12-31 0000080424 us-gaap:PreferredStockMember 2024-07-01 2024-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-07-01 2024-12-31 0000080424 us-gaap:CommonStockMember 2023-09-30 0000080424 us-gaap:PreferredStockMember 2023-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000080424 us-gaap:TreasuryStockCommonMember 2023-09-30 0000080424 us-gaap:RetainedEarningsMember 2023-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2023-09-30 0000080424 2023-09-30 0000080424 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2023-10-01 2023-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0000080424 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2023-10-01 2023-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0000080424 us-gaap:PreferredStockMember 2023-10-01 2023-12-31 0000080424 us-gaap:CommonStockMember 2023-12-31 0000080424 us-gaap:PreferredStockMember 2023-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2023-12-31 0000080424 us-gaap:RetainedEarningsMember 2023-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2023-12-31 0000080424 2023-12-31 0000080424 us-gaap:CommonStockMember 2023-06-30 0000080424 us-gaap:PreferredStockMember 2023-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000080424 us-gaap:TreasuryStockCommonMember 2023-06-30 0000080424 us-gaap:RetainedEarningsMember 2023-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2023-06-30 0000080424 2023-06-30 0000080424 us-gaap:RetainedEarningsMember 2023-07-01 2023-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-12-31 0000080424 us-gaap:CommonStockMember 2023-07-01 2023-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-12-31 0000080424 us-gaap:PreferredStockMember 2023-07-01 2023-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2023-07-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2024-10-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2024-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2023-10-01 2023-12-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2023-12-31 0000080424 us-gaap:CorporateNonSegmentMember 2024-10-01 2024-12-31 0000080424 us-gaap:CorporateNonSegmentMember 2024-07-01 2024-12-31 0000080424 us-gaap:CorporateNonSegmentMember 2023-10-01 2023-12-31 0000080424 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-12-31 0000080424 pg:BeautySegmentMember 2024-06-30 0000080424 pg:GroomingSegmentMember 2024-06-30 0000080424 pg:HealthCareSegmentMember 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember 2024-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-06-30 0000080424 pg:BeautySegmentMember 2024-07-01 2024-12-31 0000080424 pg:GroomingSegmentMember 2024-07-01 2024-12-31 0000080424 pg:HealthCareSegmentMember 2024-07-01 2024-12-31 0000080424 pg:FabricHomeCareSegmentMember 2024-07-01 2024-12-31 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2024-12-31 0000080424 pg:BeautySegmentMember 2024-12-31 0000080424 pg:GroomingSegmentMember 2024-12-31 0000080424 pg:HealthCareSegmentMember 2024-12-31 0000080424 pg:FabricHomeCareSegmentMember 2024-12-31 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-12-31 0000080424 pg:GilletteMember 2024-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A25BpsIncreaseDiscountRateMember 2024-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A25bpsDecreaseLongTermGrowthMember 2024-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A50BpsDecreaseLongTermRoyaltyMember 2024-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2024-10-01 2024-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2023-10-01 2023-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2024-10-01 2024-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2023-10-01 2023-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2024-07-01 2024-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2023-07-01 2023-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-10-01 2024-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-10-01 2023-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-07-01 2024-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-07-01 2023-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2024-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2024-06-30 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2024-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2024-06-30 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2024-12-31 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-06-30 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2024-06-30 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2024-12-31 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2024-12-31 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2024-06-30 0000080424 us-gaap:ForeignExchangeContractMember 2024-10-01 2024-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2023-10-01 2023-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2024-07-01 2024-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2023-07-01 2023-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2024-10-01 2024-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2023-10-01 2023-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2024-07-01 2024-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2023-07-01 2023-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-10-01 2024-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-01 2023-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-07-01 2024-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-07-01 2023-12-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-06-30 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-06-30 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-06-30 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-07-01 2024-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-07-01 2024-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-07-01 2024-12-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-12-31 0000080424 srt:MinimumMember 2024-07-01 2024-12-31 0000080424 srt:MaximumMember 2024-07-01 2024-12-31 0000080424 srt:MinimumMember 2024-12-31 0000080424 srt:MaximumMember 2024-12-31 0000080424 2024-07-01 2024-09-30 0000080424 2023-10-01 2024-09-30 0000080424 us-gaap:CostOfSalesMember 2024-10-01 2024-12-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-10-01 2024-12-31 0000080424 us-gaap:OtherNonoperatingIncomeExpenseMember 2024-10-01 2024-12-31 0000080424 us-gaap:CostOfSalesMember 2024-07-01 2024-12-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-12-31 0000080424 us-gaap:OtherNonoperatingIncomeExpenseMember 2024-07-01 2024-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2024-06-30 0000080424 us-gaap:FacilityClosingMember 2024-06-30 0000080424 us-gaap:OtherRestructuringMember 2024-06-30 0000080424 us-gaap:EmployeeSeveranceMember 2024-07-01 2024-09-30 0000080424 us-gaap:FacilityClosingMember 2024-07-01 2024-09-30 0000080424 us-gaap:OtherRestructuringMember 2024-07-01 2024-09-30 0000080424 us-gaap:EmployeeSeveranceMember 2024-10-01 2024-12-31 0000080424 us-gaap:FacilityClosingMember 2024-10-01 2024-12-31 0000080424 us-gaap:OtherRestructuringMember 2024-10-01 2024-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2024-07-01 2024-12-31 0000080424 us-gaap:FacilityClosingMember 2024-07-01 2024-12-31 0000080424 us-gaap:OtherRestructuringMember 2024-07-01 2024-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2024-12-31 0000080424 us-gaap:FacilityClosingMember 2024-12-31 0000080424 us-gaap:OtherRestructuringMember 2024-12-31 shares iso4217:USD iso4217:USD shares pg:segment pure pg:country pg:taxable_jurisdiction pg:audit 0000080424 --06-30 2025 Q2 false http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent 10-Q true 2024-12-31 false PROCTER & GAMBLE CO OH 1-434 31-0411980 One Procter & Gamble Plaza Cincinnati OH 45202 513 983-1100 Common Stock, without Par Value PG NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Yes Yes Large Accelerated Filer false false false 2344851814 21882000000 21441000000 43619000000 43312000000 10418000000 10144000000 20839000000 20645000000 5723000000 5522000000 11242000000 11127000000 0 1341000000 0 1341000000 5741000000 4433000000 11538000000 10200000000 240000000 248000000 478000000 472000000 119000000 133000000 254000000 262000000 224000000 177000000 -330000000 309000000 5845000000 4496000000 10985000000 10299000000 1187000000 1003000000 2339000000 2250000000 4659000000 3493000000 8646000000 8049000000 29000000 25000000 56000000 60000000 4630000000 3468000000 8589000000 7988000000 1.94 1.44 3.59 3.33 1.88 1.40 3.49 3.23 4659000000 3493000000 8646000000 8049000000 -770000000 492000000 256000000 83000000 0 -1000000 1000000 -2000000 -24000000 75000000 -3000000 30000000 -747000000 416000000 260000000 51000000 3912000000 3909000000 8906000000 8100000000 26000000 25000000 54000000 58000000 3887000000 3884000000 8852000000 8041000000 10230000000 9482000000 6234000000 6118000000 1949000000 1617000000 879000000 929000000 4192000000 4470000000 7020000000 7016000000 2158000000 2095000000 25642000000 24709000000 22074000000 22152000000 39898000000 40303000000 21833000000 22047000000 13192000000 13158000000 122639000000 122370000000 14495000000 15364000000 9879000000 11073000000 9424000000 7191000000 33797000000 33627000000 25263000000 25269000000 6725000000 6516000000 5411000000 6398000000 71195000000 71811000000 788000000 798000000 4009200000 4009200000 4009000000 4009000000 68283000000 67684000000 707000000 737000000 -11637000000 -11900000000 137112000000 133379000000 127544000000 123811000000 275000000 272000000 51443000000 50559000000 122639000000 122370000000 2355042000 4009000000 791000000 68102000000 -707000000 -10893000000 -134823000000 125361000000 300000000 52141000000 4630000000 29000000 4659000000 -744000000 -3000000 -747000000 1.0065 1.0065 2375000000 2375000000 72000000 72000000 14716000 2520000000 2520000000 4057000 181000000 228000000 408000000 469000 -3000000 3000000 0 51000000 51000000 2344852000 4009000000 788000000 68283000000 -707000000 -11637000000 -137112000000 127544000000 275000000 51443000000 2357051000 4009000000 798000000 67684000000 -737000000 -11900000000 -133379000000 123811000000 272000000 50559000000 8589000000 56000000 8646000000 263000000 -3000000 260000000 2.013 2.013 4754000000 4754000000 144000000 144000000 26269000 4462000000 4462000000 12827000 598000000 720000000 1318000000 1243000 -10000000 1000000 9000000 0 30000000 41000000 71000000 51000000 51000000 2344852000 4009000000 788000000 68283000000 -707000000 -11637000000 -137112000000 127544000000 275000000 51443000000 2356886000 4009000000 812000000 66822000000 -782000000 -12583000000 -131029000000 120443000000 321000000 48014000000 3468000000 25000000 3493000000 416000000 416000000 0.9407 0.9407 2225000000 2225000000 70000000 70000000 6879000 1008000000 1008000000 2630000 113000000 147000000 260000000 385000 -3000000 3000000 0 52000000 52000000 2353021000 4009000000 809000000 66935000000 -782000000 -12167000000 -131887000000 121617000000 294000000 48829000000 2362120000 4009000000 819000000 66556000000 -821000000 -12220000000 -129736000000 118170000000 288000000 47065000000 7988000000 60000000 8049000000 53000000 -2000000 51000000 1.8814 1.8814 4450000000 4450000000 140000000 140000000 16722000 2516000000 2516000000 6351000 378000000 356000000 734000000 1273000 -10000000 1000000 9000000 0 39000000 48000000 87000000 52000000 52000000 2353021000 4009000000 809000000 66935000000 -782000000 -12167000000 -131887000000 121617000000 294000000 48829000000 9482000000 8246000000 8646000000 8049000000 1434000000 1423000000 241000000 275000000 221000000 -154000000 -787000000 3000000 0 1341000000 262000000 839000000 170000000 32000000 -1157000000 302000000 748000000 704000000 135000000 346000000 9127000000 10004000000 1918000000 1742000000 47000000 8000000 6000000 0 153000000 489000000 -2029000000 -2224000000 4886000000 4578000000 5905000000 2798000000 571000000 5862000000 -2705000000 3740000000 995000000 254000000 1478000000 2335000000 4449000000 2503000000 985000000 397000000 -6205000000 -8087000000 -144000000 -49000000 748000000 -356000000 10230000000 7890000000 Basis of PresentationThe accompanying unaudited Consolidated Financial Statements of The Procter &amp; Gamble Company and subsidiaries ("the Company," "Procter &amp; Gamble," "P&amp;G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results. New Accounting Pronouncements and Policies<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.</span></div> New Accounting Pronouncements and Policies<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, “Segment Reporting: Improvements to Reportable Segment Disclosures.” This guidance requires disclosure of incremental segment information on an annual and interim basis. This amendment is effective for our fiscal year ending June 30, 2025 and our interim periods within the fiscal year ending June 30, 2026. The guidance will require additional disclosures in the Segment Information footnote, but will not have a material impact on our Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures.” This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. We are currently assessing the impact of this guidance on our disclosures. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization, and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028 and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.</span></div> Segment Information<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric &amp; Home Care and 5) Baby, Feminine &amp; Family Care. Our five reportable segments are comprised of:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Beauty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Grooming</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Grooming (Appliances, Female Blades &amp; Razors, Male Blades &amp; Razors, Pre- and Post-Shave Products, Other Grooming);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Health Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care); </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Fabric &amp; Home Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&amp;G Professional, Surface Care); and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Baby, Feminine &amp; Family Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments as a percentage of consolidated net sales are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net sales by operating segment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fabric Care</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baby Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Family Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hair Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grooming</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feminine Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skin Care </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">% of Net sales by operating segment excludes sales recorded in Corporate.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of reportable segment results:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.848%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beauty</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grooming</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">568</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,249</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">974</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,575</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,567</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,285</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,066</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,188</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,464</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,847</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,332 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,009)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,882</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,985</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,646</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5 5 <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments as a percentage of consolidated net sales are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Net sales by operating segment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fabric Care</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baby Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Family Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hair Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grooming</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feminine Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skin Care </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">% of Net sales by operating segment excludes sales recorded in Corporate.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.</span></div> 0.23 0.23 0.23 0.23 0.12 0.12 0.12 0.12 0.09 0.09 0.09 0.10 0.09 0.09 0.09 0.08 0.09 0.09 0.09 0.09 0.08 0.08 0.08 0.08 0.09 0.09 0.08 0.08 0.06 0.06 0.07 0.07 0.06 0.06 0.06 0.06 0.05 0.05 0.06 0.05 0.04 0.04 0.03 0.04 1 1 1 1 <div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of reportable segment results:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.848%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings/(Loss) Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Earnings/(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beauty</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,741</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grooming</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">568</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,249</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">974</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,575</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,567</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,285</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,066</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,188</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,415 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,049 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,464</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,847</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,332 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,009)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,882</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,985</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,646</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3848000000 996000000 780000000 7741000000 2063000000 1620000000 3849000000 1112000000 868000000 7946000000 2361000000 1839000000 1752000000 568000000 459000000 3475000000 1090000000 885000000 1734000000 538000000 440000000 3458000000 1071000000 862000000 3249000000 974000000 758000000 6397000000 1928000000 1499000000 3172000000 932000000 719000000 6245000000 1821000000 1408000000 7575000000 1989000000 1567000000 15285000000 4066000000 3188000000 7415000000 2018000000 1577000000 15061000000 4049000000 3146000000 5298000000 1464000000 1119000000 10400000000 2847000000 2185000000 5146000000 1437000000 1102000000 10332000000 2845000000 2177000000 159000000 -146000000 -24000000 322000000 -1009000000 -731000000 126000000 -1541000000 -1214000000 270000000 -1849000000 -1383000000 21882000000 5845000000 4659000000 43619000000 10985000000 8646000000 21441000000 4496000000 3493000000 43312000000 10299000000 8049000000 Goodwill and Intangible Assets<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is allocated by reportable segment as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at June 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,723 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,633 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,638 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,499 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill at December 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,898</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill decreased from June 30, 2024, primarily due to currency translation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets at December 31, 2024, were comprised of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with determinable lives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,965 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,552 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,684)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended December 31, 2024 and 2023, was $80 and $84, respectively. For the six months ended December 31, 2024 and 2023, amortization expense was $163 and $171, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the carrying value of the Gillette indefinite-lived intangible asset was impaired during the fiscal year ended June 30, 2024. The impairment charge arose due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of a new restructuring program focused primarily in certain Enterprise Markets, including Argentina and Nigeria. Following the impairment charge, the carrying value of the Gillette indefinite-lived intangible asset was equivalent to the estimated fair value as of December 31, 2023.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our impairment testing performed during the three months ended December 31, 2024, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of December 31, 2024, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation, or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger a further impairment charge.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rates), discount rate and royalty rates. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rates represent the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rates utilized in our fair value estimates are consistent with the brand operating plans and approximate expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2024, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Percent Change in Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+25 bps Discount Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-25 bps Growth Rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-50 bps Royalty Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gillette indefinite-lived intangible asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is allocated by reportable segment as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at June 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,723 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,633 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,638 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,499 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill at December 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,799</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,898</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 13723000000 12633000000 7638000000 1810000000 4499000000 40303000000 0 0 0 0 0 0 -139000000 -104000000 -107000000 -11000000 -44000000 -405000000 13584000000 12529000000 7531000000 1799000000 4456000000 39898000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets at December 31, 2024, were comprised of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with determinable lives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,965 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,552 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,684)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets at December 31, 2024, were comprised of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with determinable lives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,965 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,684)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,552 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,684)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 8965000000 6684000000 19552000000 28517000000 6684000000 80000000 84000000 163000000 171000000 0.10 12800000000 The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Percent Change in Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+25 bps Discount Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-25 bps Growth Rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-50 bps Royalty Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gillette indefinite-lived intangible asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> -0.05 -0.05 -0.04 Earnings Per Share <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter &amp; Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter &amp; Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings per common share were calculated as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">CONSOLIDATED AMOUNTS</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,646</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,589</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G available to common shareholders (Basic)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,558</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,849 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SHARES IN MILLIONS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,351.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,354.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,359.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and other unvested equity awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,458.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,462.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">NET EARNINGS PER COMMON SHARE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.88</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Excludes approximately 8 million and 9 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.</span></div> <div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings per common share were calculated as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">CONSOLIDATED AMOUNTS</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,646</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,630</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,589</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G available to common shareholders (Basic)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,558</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,849 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SHARES IN MILLIONS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,351.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,354.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,359.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and other unvested equity awards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,458.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,468.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,462.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">NET EARNINGS PER COMMON SHARE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.88</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Excludes approximately 8 million and 9 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the three months ended December 31, 2024 and 2023 respectively, and 4 million and 5 million for the six months ended December 31, 2024 and 2023 respectively, of weighted average stock options outstanding because the exercise price of these options was greater than their average market value or their effect was antidilutive.</span></div> 4659000000 3493000000 8646000000 8049000000 29000000 25000000 56000000 60000000 4630000000 3468000000 8589000000 7988000000 72000000 70000000 144000000 140000000 4558000000 3398000000 8445000000 7849000000 2351900000 2358000000 2354100000 2359000000 71300000 73900000 71600000 74300000 34900000 36400000 36400000 38500000 2458100000 2468400000 2462100000 2471800000 1.94 1.44 3.59 3.33 1.88 1.40 3.49 3.23 8000000 9000000 4000000 5000000 Share-Based Compensation and Postretirement Benefits<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost for pension benefits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) for other retiree benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost for pension benefits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) for other retiree benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 136000000 150000000 241000000 275000000 26000000 52000000 63000000 109000000 -180000000 -156000000 -360000000 -311000000 Risk Management Activities and Fair Value Measurements<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. Except for the impairment of the Gillette indefinite-lived intangible asset discussed in Note 4, there were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the six months ended December 31, 2024 or during the fiscal year ended June 30, 2024.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents were $8.7 billion and $8.0 billion as of December 31, 2024 and June 30, 2024, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $27.3 billion and $27.7 billion as of December 31, 2024 and June 30, 2024, respectively. This includes the current portion of long-term debt instruments ($3.3 billion and $3.8 billion as of December 31, 2024 and June 30, 2024, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosures about Financial Instruments</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(215)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,054</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">545</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,133 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">545</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES AT FAIR VALUE</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,325 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $2.7 billion as of December 31, 2024 and June 30, 2024. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $10.4 billion and $11.9 billion as of December 31, 2024 and June 30, 2024, respectively. The increase in notional balance of the derivative instruments designated as net investment hedges is primarily driven by the Company's decision to leverage favorable interest rate spreads in the foreign currency swap market.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-770"><span style="-sec-ix-hidden:f-771">Derivative assets</span></span> are presented in Prepaid expenses and other current assets or Other noncurrent assets. <span style="-sec-ix-hidden:f-772"><span style="-sec-ix-hidden:f-773">Derivative liabilities</span></span> are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $33 and $307 as of </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024 and June 30, 2024, respectively. The Company has not been required to post collateral as a result of these contractual features.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in OCI on Derivatives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">857</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the six months ended December 31, 2024 and 2023, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$215 and $(159) for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">six months ended December 31, 2024 and 2023, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(174)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&amp;A).</span></div> 8700000000 8000000000.0 27300000000 27700000000 3300000000 3800000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2024 and June 30, 2024, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,914</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(215)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,054</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,140 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">545</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,133 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">545</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(215)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES AT FAIR VALUE</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,325 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2914000000 2993000000 0 0 215000000 325000000 13054000000 10140000000 545000000 119000000 0 31000000 15968000000 13133000000 545000000 119000000 215000000 356000000 3359000000 3192000000 1000000 1000000 40000000 23000000 19326000000 16325000000 546000000 120000000 255000000 379000000 2700000000 2700000000 10400000000 11900000000 33000000 307000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in OCI on Derivatives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">857</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $57 and $62 for the three months ended December 31, 2024 and 2023, respectively. The amount of gain excluded from effectiveness testing was $107 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the six months ended December 31, 2024 and 2023, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $825 and $(504) for the three months ended December 31, 2024 and 2023, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$215 and $(159) for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">six months ended December 31, 2024 and 2023, respectively.</span></div> 857000000 -487000000 356000000 -202000000 57000000 62000000 107000000 130000000 825000000 -504000000 215000000 -159000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(174)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 34000000 117000000 110000000 128000000 -174000000 128000000 -48000000 57000000 Accumulated Other Comprehensive Income/(Loss)<div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter &amp; Gamble (AOCI), including the reclassifications out of AOCI by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Postretirement Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total AOCI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    OCI before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Amounts reclassified to the Consolidated Statement of Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), before tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: OCI attributable to noncontrolling interests, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,262)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,637)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below provides additional details on amounts reclassified from AOCI into the Consolidated Statement of Earnings:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation amounts are reclassified from AOCI into Other non-operating income/(expense), net. These amounts relate to accumulated foreign currency translation losses recognized due to the substantial liquidation of operations in Argentina recorded in the period ended September 30, 2024.</span></div> <div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter &amp; Gamble (AOCI), including the reclassifications out of AOCI by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Postretirement Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total AOCI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,900)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    OCI before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Amounts reclassified to the Consolidated Statement of Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), before tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: OCI attributable to noncontrolling interests, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,262)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,637)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 10000000 613000000 -12522000000 -11900000000 1000000 38000000 -362000000 -323000000 0 38000000 -752000000 -714000000 1000000 0 390000000 391000000 0 -3000000 134000000 131000000 1000000 3000000 256000000 260000000 0 2000000 -5000000 -3000000 11000000 614000000 -12262000000 -11637000000 Commitments and Contingencies<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Uncertainties</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we do not anticipate over the next 12-month period any significant audit activity concluding related to uncertain tax positions for which we have existing accrued liabilities. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</span></div> 70 150 30 40 Supplier Finance Programs<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in <span style="-sec-ix-hidden:f-840"><span style="-sec-ix-hidden:f-841">Accounts payable</span></span> was approximately $5.6 billion as of December 31, 2024 and June 30, 2024.</span></div> P60D P180D 5600000000 5600000000 Restructuring Program<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded approximately $0.8 billion after tax of incremental charges, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the program beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024, were approximately $1.2 billion after tax.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2024, the Company incurred total before tax charges of $47 including $28 in Costs of products sold, $25 in SG&amp;A and $(5) in Other non-operating income/(expense). For the six months ended December 31, 2024, the Company incurred charges of $933 including $69 in Costs of products sold, $79 in SG&amp;A and $785 in Other non-operating income/(expense).</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents restructuring activity for the six months ended December 31, 2024: </span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Separation Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset-Related Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE JUNE 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the three months ended September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the three months ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the six months ended December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs paid/settled for the six months ended December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE DECEMBER 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separation Costs </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset-Related Costs </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include accumulated foreign currency translation losses, asset removal and termination of contracts.</span></div> 250000000 500000000 -800000000 1200000000 47000000 28000000 25000000 -5000000 933000000 69000000 79000000 785000000 <div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents restructuring activity for the six months ended December 31, 2024: </span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Separation Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset-Related Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE JUNE 30, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the three months ended September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the three months ended December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the six months ended December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs paid/settled for the six months ended December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE DECEMBER 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 133000000 0 32000000 166000000 16000000 30000000 839000000 886000000 25000000 9000000 14000000 47000000 41000000 39000000 853000000 933000000 58000000 39000000 823000000 921000000 115000000 0 62000000 178000000 false false false false Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.